















Epitopes, Aggregation and Membrane Binding:
Investigating the Protein Structure-Function
Relationship
Author: Craig Robert Gregor
THESIS SUBMITTED IN FULFILMENT OF THE
REQUIREMENTS FOR THE DEGREE OF
Doctor of Philosophy
THE SCHOOL OF PHYSICS AND ASTRONOMY
THE UNIVERSITY OF EDINBURGH
2011
Acknowledgements
I am indebted to a number of people, and without whose help, completion of this work would
not have been possible. I would therefore sincerely like to thank the following people for their
contributions in either providing inspiration, guidance, or simply support over the course of my
PhD:
Firstly I would like to thank my supervisors Jason Crain and Will Hossack for their expert
guidance and motivation throughout. Secondly, I would like to thank Eleonora Cerasoli and
Maxim Ryadnov for providing me with their experimental knowledge and supervision whenever
I decided to venture into a laboratory. Paul Tulip for providing daily supervision (whether he
wanted to or not) as I attempted to build upon legacy simulations. Glenn Martyna for whenever
I had questions regarding the simulation software (provided I was prepared for the answers to be
in the form of a haiku). Raph Troitzsch for showing me that even someone who can’t count can
successfully navigate a PhD. Iain Robinson, Colin McGuinness, Chrissy Wong, Mira Nishimura
and Jay Gillam for being gracious enough to share an office and put up with me. Tony Hart and
Morphy Richards for providing an outstandingly named coffee machine.




I hereby declare that the writing of this thesis is my own work and that, to the best of my
knowledge and belief, it contains no material previously published or written by another person
nor material which to a substantial extent has been accepted for the award of any other degree or
diploma of the university or other institute of higher learning, except where due acknowledge-






The three-dimensional structure of a protein, formed as a result of amino-acid sequences
folding into compact domains, is regarded as a key factor in its biological function. How and why
proteins fold into specific topologies, remain the key focus of scientific research in the field of
biophysics. By stripping down complex reactions down to the most basic elements, biophysicists
aim to develop simplified models for biological phenomena such as antibody discrimination,
viral fusion or self-assembly.
Focusing on small model peptide systems, rather than the full proteins from which they were
derived, was hoped to result in accurate structural measurements and provide a more transpar-
ent comparison between simulation and experiment. The aim of this research was therefore to
investigate how accurate these models were when compared against experiment. Furthermore,
while breaking down the complex biological phenomena into simple models, there was also a
conscious effort to ensure that the models were representative of real biological systems, and a
major focus was therefore aimed at determining whether any meaningful biomedical insight may
be extrapolated from such models.
Peptides found in hormones (human chorionic gonadotropin, luteinizing hormone), viruses
(HIV) and amyloid diseases (transthyretin) were selected in order to probe a variety of questions
in relation to the aforementioned biological phenomena. Namely, how the primary sequence
influenced the three-dimensional structure (and thus its biological function), how its environment
could influence such a confirmation, and how these systems aggregated.
This doctoral study has made use of a combination of computer simulations and experi-
mental techniques to investigate a selection of biologically relevant peptides; utilising classical
atomistic molecular dynamics (MD) simulations to characterise the free-energy landscapes of
the chosen peptides, and compare these findings with the secondary structure content predicted
by spectroscopic methods such as circular dichroism and infrared spectroscopy. The peptide
systems studied within, were found to be characterised by rugged free-energy landscapes unlike
their protein counterparts (defined by singular, deep minima). Furthermore, these landscapes
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A protein’s three-dimensional structure is regarded as being a key factor in defining the functional
properties of the biological role that the protein has evolved to fill. This structure arises due to
amino-acid sequences in proteins folding into compact domains of specific topology (Appendix
A). It is these domains that can act as binding sites for other molecules, or act as building blocks
for larger more complex biomolecules such as viruses. One would therefore wish to predict a
protein’s three-dimensional structure from its constituent amino-acids, in order to shed light on
the protein’s biological function. However, such a prediction has been found to be fraught with
difficulty and therefore, the questions of how and why a protein folds into a specific topology
has remained a key focus of continuous scientific research. Such research is at the heart of the
field of biophysics.
Molecular biophysics is an interdisciplinary are of research crossing the boundaries of phys-
ics, biology, chemistry and mathematics. Its purpose is to study the biophysical processes of
complex macromolecular systems by focussing on intermolecular and intramolecular interac-
tions and the resulting structural and electronic changes. The mechanisms by which proteins
fold into their single native structures (corresponding to a global minimum of free energy) has
been the subject of considerable interest from both theorists and experimentalists; the fact that
a protein typically adopts a single structure is in contrast to most polymers, where individual
monomers can adopt a variety of conformers.
1.1. MOTIVATION
In addition to explaining biological function, the study of peptides and proteins has led to the
field of molecular self-assembly. Defined as the spontaneous organisation of individual compon-
ents into an ordered structure without human intervention [12], molecular self-assembly is ever
present in nature and has emerged as a new strategy in chemical synthesis, polymer science and
engineering [13]. The challenge being to design molecular building blocks that can undergo this
spontaneous organisation, using non-covalent bonds such as hydrophobic interactions, hydrogen
bonds and electrostatic interactions [14]. While these forces are very week separately, combined
they are strong enough to drive the self-assembly process. A major focus of nanotechnology has
been the attempt to use biological molecules in constructing supramolecular structures [15, 16],
with peptides being exploited in forming ribbons [17], nanotubes [18, 19], and monolayers with
nanoscale order [20]. As such, the design of small peptide-based molecules with extended β-
strand conformation that self-assemble has been an active area of research [21]. Furthermore,
a higher order of self-assembly leads to the formation of fibrils and gels [22] - not only is this
important in the design of biomaterials, but it is also useful in studying pathogenesis of certain
age-related diseases; many fatal neurodegenerative diseases such as Alzheimer’s, Parkinson’s,
and prion related diseases are associated with the self-assembly of mis-folded proteins (or poly-
mer fragments) into amyloid fibrils [23–25].
In order to probe structural variations in proteins (rationalising biological phenomena such
as antibody discrimination, viral fusion or fibril formation), biophysicists seek to study such re-
actions from the perspective of physical sciences by stripping the complex reactions down to
the most basic elements. To aid in the investigation into protein folding, this doctoral study has
made use of a combination of computer simulations and experimental techniques to investigate
a selection of biologically relevant peptides. This has comprised of utilising classical atomistic
molecular dynamics (MD) simulations to characterise the free-energy landscapes of the chosen
peptides, and compare these findings with the secondary structure content predicted by spec-
troscopic methods such as circular dichroism and infrared spectroscopy. As MD can provide
information about the conformational properties of molecular systems and how the conforma-
tion changes with time, such a combination of techniques should allow one to probe any changes
to this structure arising from variations in the environment or mutations introduced at the se-
quence level. While this work sought to break down the complex biological phenomena into
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simple models, a major driving force was to ensure that the models were representative of real
biological systems. To that end, a collection of peptides found in hormones, viruses and amyl-
oid diseases were selected in order to probe a variety of questions. Namely, how the primary
sequence influenced the three-dimensional structure (and thus its biological function), how such
a conformation could be influenced by its environment, and how these systems aggregated.
1.2 Thesis Layout
In order to understand the methods used throughout this work, Chapter 2 introduces the classical
molecular dynamics simulation methodology for the benefit of those with no prior exposure to
this field. This introduction covers how the trajectories of atoms are computed, the forces acting
on said atoms, and some tricks of the trade. As part of the attempt to compare and contrast results
obtained from such simulations to those obtained experimentally, Chapter 2 also describes the
experimental techniques used.
Chapter 3, introduces the transmembrane HIV fusion peptide gp41659−671 and probes how
the environment can induce variations in the secondary structure of this peptide. This is achieved
by predicting the structure of gp41659−671 using a variety of classical atomistic force fields and
through solvents mimicking the various environmental conditions experienced in its native en-
vironment.
In Chapter 4, the interactions of a dimeric system gp41532−544 and gp41659−671 are invest-
igated under both aqueous and mixed lipidic conditions in order to probe structural variations
induced during the hemifusion phase of viral infection. Computer simulations are exploited to
probe if the secondary structure of each peptide is affected by the presence of the other, while
simultaneously ascertaining the tertiary contacts of this system in comparison to experimental
data.
Chapter 5 is concerned with the structural determination of the human chorionic gonado-
tropin (hCG) hormone using both experimental and computer simulation techniques. This chapter
also covers an investigation into structural variation between hCG, the near identical luteinizing
hormone (LH) and a variety of other individual amino-acid mutations, utilising molecular dy-
namic simulations. Particular emphasis is placed on the effect a point mutation has on finer
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structural elements of the peptides.
In Chapter 6, the structure of various oligomers of the amyloid fibril forming human tran-
sthyretin (TTR) fragment TTR105−115 are studied utilising gas-phase molecular dynamics sim-
ulations. The results of which are used to compute collisional cross-sectional areas which are
subsequently compared to values obtained previously from ion-mobility mass spectrometry (IM-
MS), in order to gain further insight into the early aggregation states.
4
2
Simulation and Experimental Methodology
In this chapter, the basics of Molecular Dynamics will be introduced for the benefit of individuals
with no prior exposure to the field. Further reading in the form of Allen & Tildesley [26],
Leach [27] and Frenkel & Smit [28] is recommended. The latter half of the chapter focuses on
the experimental techniques employed throughout the thesis.
2.1 Molecular Dynamics
Before discussing the theory behind the computer simulations, it is important to consider why
such simulations are conducted. Primarily, they allow one to study properties of a many-particle
system by generating information at the microscopic level (atomic positions etc.) and convert
this into macroscopic terms (energy, pressure etc.). This is because some of the detailed micro-
scopic information such as instantaneous positions and velocities cannot be directly compared
to experimental data, which usually measures a property averaged over numerous particles and
time. It is therefore important to consider which averages such simulations can compute, there-
fore a brief introduction to Statistical Mechanics is necessary. This branch of physics concerns
the calculation of thermodynamic properties via ensemble averages, and it can be shown that
such averages are themselves directly comparable to averages acquired by measuring a quantity
over a specific time period, which is the basis of Molecular Dynamics simulations.
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2.1.1 Statistical Mechanics
The 1st and 2nd laws of thermodynamics state that the energy of the universe is conserved and
that the entropy of the universe only increases. This results in an expression for an infinitesimal
change in energy dE, which relates the energy input due to heating, TdS; where T is the tem-
perature, and dS is the change in entropy; and the work done, PdV ; where P is the pressure
and dV is the change in volume (Eq. 2.1). This can be expanded for an open system of variable
particle number, dN , of chemical potential µ (Eq. 2.2).
dE = TdS − PdV (2.1)
dE = TdS − PdV + µdN (2.2)
In a theoretical system of energy E with two weakly interaction subsystems of E1 and E2
(fixed volume and particle number), it is found that while E1 and E2 may fluctuate (i.e. E1 →
E1 +dE1, E2 → E2 +dE2), the total energy is fixed (E2 +dE2 = E2−dE1). Furthermore, the
change in total entropy (S = S1 +S2) is found to be zero at equilibrium (Eq. 2.3) as the entropy
is at a maximum.






















The 0th law of thermodynamics tells us that if the two subsystems are in equilibrium (Eq. 2.4)
they must have the same temperature, T . This results in the thermodynamic definition of tem-









By rearranging the expression for an infinitesimal change in energy dE (Eq. 2.2), in favour of
dS (Eq. 2.6), one can see that such a definition can be obtained directly. Furthermore, additional




































The basic laws of Statistical Mechanics can be easily derived using a basic knowledge of quantum
mechanics. All that is required is the understanding that a quantum mechanical system can be
found in different states, and for the purposes of this discussion such states (|i>) are limited to
those that are eigenvectors of the Hamiltonian H of a system. That is to say, for any of these
states,H|i> =Ei|i> whereEi is the energy of that state. Furthermore, the number of eigenstates
with energyE in a system of volume V andN particles, may be denoted Ω(E, V,N). Finally, in
a system with fixed E, V , and N , the system is likely to be found in any of its eigenstates Ω(E).
In the theoretical system of two weakly interaction subsystems, for any given value of E1,
Ω(E1) × Ω(E2) gives the total number of degenerate states - however it is more convenient to
express this in a form utilising the natural logarithms (Eq: 2.8).
ln Ω(E1, E − E1) = ln Ω1(E1) + ln Ω2(E − E1) (2.8)
One may then evaluate the most likely value of E1 as the value that maximises ln Ω(E1, E−
E1) (Eq. 2.9).
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By introducing a shorthand notation (Eq. 2.10), this can be redefined as β(E1, V1, N1) =
β(E2, V2, N2). These two subsystems are therefore in (thermal) equilibrium when this condition
is met and there is no net energy flow between them.
β(E, V,N) ≡
(





The second law of thermodynamics states that the entropy, S, of a system is at a maximum
when at thermal equilibrium, and can be linked to ln Ω via the Planck relationship using the
Boltzmann’s constant kB (Eq. 2.11).
S(E, V,N) ≡ kB ln Ω(E, V,N) (2.11)
Exploiting the fact that two bodies in thermal equilibrium have the same temperature, T , one
can use the thermodynamic definition of temperature (Eq. 2.5) to define a relationship between





If system in a heat bath, b, has a state i with energy Ei, the bath therefore has energy Eb =
E −Ei and degeneracy Ωb(E −Ei). The probability of finding system 1 in state i is dependent
on this degeneracy (Eq. 2.13), and can be evaluated by using a rearranged Planck relationship
(Eq. 2.14) and a taylor expansion assuming Ei E (Eq. 2.15).
Pi =
Ωb(E − Ei)∑
j Ωb(E − Ei)
(2.13)

















The 3rd term of this taylor expansion can be shown to tend to zero as it relates to the heat
capacity of the bath, Cb = ∂E/∂T (Eq. 2.16), where it is assumed that the bath can transfer





























Setting Sb(E) as a constant, results in the well-known Boltzmann distribution (Eq. 2.17)




















This average makes use of the shorthand notation Z = ∑j exp(−Ej/kBT ) which is known
as the partition function.
2.1.1.2 Classical
If one wished to generalise the relationship for the average energy 〈E〉 to find the average of
some observable A, one would use the expectation value of the operator A in quantum state i
(< i|A|i >) in conjunction with the probability that a system at temperature T being found in an
energy eigenstate Ei (Eq. 2.19).
〈A〉 =
∑
i exp(−Ei/kBT ) < i|A|i >∑
j exp(−Ej/kBT )
(2.19)
Solving such a relationship would appear to be difficult, as it suggests that one solve the
Schrödinger equation for a many-body system. Furthermore if this was indeed feasible, the
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number of resulting quantum states would be too large to evaluate. As such, an alternative
method should be sought. In Section 2.1.1.1, it was noted thatH|i >= Ei|i >, therefore one can
use the Hamiltonian,H, as the basis for an expression relating to −Ei/kBT (Eq. 2.20) which in
turn could be incorporated into the expression for 〈A〉 (Eq. 2.21).
exp(−Ei/kBT ) =< i|exp(−H/kBT )|i > (2.20)
〈A〉 =
∑
i < i|exp(−H/kBT )A|i >∑





The trace of a matrix, Tr, is the sum of the (complex) eigenvalues and is invariant with
respect to a change of basis set; if Λ is a n-by-nmatrix with real or complex entries, and λ1 . . . λn
are the (complex) eigenvalues of Λ, then the trace of the matrix is Tr(Λ) =
∑
λi.
The Hamiltonian operator, H, is itself a sum of the kinetic energy operator, K, and the
potential energy operator, U . The former relates to the momenta of particles (K = p2/m) and as
such, momentum eigenstates are eigenfunctions of this operator. The later relies on the positions
of all particles, therefore the ideal basis set would be constructed around position eigenfunctions.
Unfortunately, in order to exploit the use of eigenvectors and eigenvalues, H = K + U and
exp[−β(K+U)] would need to be diagonal in either basis set, which they are not. Furthermore,
one can not simply replace exp(−βH) with exp(−βK)exp(−βU) due to the commutator [K,U ]
(Eq. 2.22).
exp(−βK)exp(−βU) = exp{−β[K + U +O([K,U ])]} (2.22)
A commutator [a, b] indicates if a binary operation is not commutative, i.e. changing the
order changes the end result; [a, b] = ab − ba 6= 0. Applying this in the field of quantum
mechanics, [K,U ] = −i~, where ~ = h/2π and h is Planck’s constant (Eq. 2.23).
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However in the limit ~ → 0, this term can be ignored (Eq. 2.24) and exp(−βH) can be
approximated in terms of exponentials of K and U (Eq. 2.25).
exp(−βK)exp(−βU) = exp{−β[K + U +O([K,U ])]}
≈ exp{−β[K + U ]} (2.24)
Tr exp(−βH) = Tr exp[−β(K + U)]
≈ Tr exp(−βU)exp(−βK) (2.25)
This approach results in directly evaluable terms for the potential energy operator, U (Eq. 2.26)
and the kinetic energy operator, K (Eq. 2.27). Which in turn can be integrated over all coordin-
ates and momenta of the system (Eq. 2.28), factoring in the indistinguishability of identical
particles (1/N!) and that every quantum state corresponds to a volume of hdN , where d is the




















p2i /(2mi) + U(rN )
]}
≡ Zclassical (2.28)
Such an approach can also be applied to derive an expression for Tr exp(−βH)A, which
allows one to evaluate the classical average of 〈A〉 (Eq. 2.29).
〈A〉 =
∫
dpNdrNexp{−β[∑i p2i /(2mi) + U(rN )]}A(pN ,qN )∫
dpNdrNexp{−β[∑j p2j/(2mj) + U(rN )]}
(2.29)
2.1.2 Ergodicity
So far, the expected value of an observable A has been shown to be obtained from an en-
semble average using classical statistical mechanics. However within the context of experi-
mental measurement, one does not typically measure an average over all possible states. Instead,
one typically measures a quantity over a specific period of time, then averages accordingly.
Properties such as pressure and density depend upon the positions (r) and momenta (p) of the
many particles with a system, which will naturally vary over time due to interactions between
particles. The experimentally acquired average is therefore the average of the instantaneous value
A(pN (t), rN (t)) over the time of the measurement. Intuitively, as this period of time increases to
infinity (Eq. 2.30), one would expect the average measurement to approach an acceptable ‘true’







dt′A(pN (t′), rN (t′)) (2.30)
The density of a fluid (ρ) is a prime example of a time dependent quantity of any system. At a
distance r from an atom i, the density ρi(r) will depend on the coordinates of all particles in the
system which will naturally vary over time. Once can therefore evaluate the time evolution of the
density if the initial coordinates and momenta of all particles are known; ρi(r; rN (0),pN (0), t).
Furthermore, one could assume that over a significantly large time period, the average ρi(r)











While this may not strictly be true for finite time periods, in the case of a macroscopic exper-
iment it can be assumed that the result of ρi(r) would be independent of the initial coordinates
(I.C.). As such, one would expect the result of ρi(r) to be same as if we averaged over a large
number of systems of disparate I.C. (NI.C.) and momenta (Eq. 2.32), but with identical values























From the previous section, such an ensemble average is typically expressed as 〈f〉, which






dt′〈ρi(r; rN (0),pN (0), t′)〉NV E (2.34)
The ensemble average can be regarded as being time independent and averaging over the
initial phase space coordinates would naturally be the same as averaging over the phase space
coordinates at a later time. This results in a simple relationship between the time averaged ρi(r)
and the ensemble averaged 〈ρi(r)〉NV E (Eq. 2.35).
ρi(r) = 〈ρi(r)〉NV E (2.35)
If one therefore wishes to calculate the average of a function dependent on the coordinates
and momenta of a many-body system, then one can either do so by means of an ‘ensemble’ or
‘time’ average. The former is typically the approach of Monte Carlo Simulations, while the later
is the basis of Molecular Dynamics which is used extensively throughout this body of work.
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2.1.3 General Classical Molecular Dynamics
Molecular Dynamics (MD) simulations essentially investigate motions of a system of discrete
particles which are influenced by internal and external forces. The underlying principles of MD
are that the interactions of said particles are empirically described by a potential energy function,
from which may be derived the forces acting on each particle. Successive configurations of the
system of particles are subsequently generated by integrating Newton’s laws of motion. These
laws state that in the absence of an external field, a body will continue to move in a straight
line and for every force there is a corresponding equal and opposite force. Furthermore, they
explicitly equate the force acting on an object to the subsequent change in momentum that the




= fi, i = 1...n (2.36)
One can calculate the trajectories of the atoms by solving the differential equations associated
with this relationship.
2.1.3.1 Newtonian Dynamics & Basic Algorithms
As the positions of particles varies with time, the interactions between particles will also change.
The force is therefore dependent on the particles position relative to its neighbours, and as this
position fluctuates so will the force. It is therefore important to break down the integration into
small time steps of δt. The procedure is therefore to evaluate the force on each particle at time t
on the basis of its interactions with other particles. The acceleration is the derived from the force
and, in combination with the position at time t, is used to calculate the positions of the particles
at time t+ δt. It should be noted that the assumption made is that the force is invariant over the
course of δt From these new positions, the new force on each particle is evaluated on order to
generate a new set of positions at time t+ 2δt etc.
Several algorithms have been developed to integrate the Newtonian equations of motion,
which assume that the dynamic properties can be treated as a Taylor expansion about δt (Eq. 2.37).
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(δt)3 + ... (2.37)
Combination of the Taylor expansions for r(t+ δt) and r(t− δt) results in an expression for
r(t+ δt) based on the positions and accelerations at time t (i.e. r(t) & r̈(t)) in conjunction with
the positions from the previous step, r(t−δt) (Eq. 2.38). This is the basis of the Verlet algorithm
and is perhaps the most widely used method for integrating the equations of motion.
r(t+ δt) + r(t− δt) = 2r(t) + r̈(t)(δt)2 +O(δt)4
r(t+ δt) ≈ 2r(t)− r(t− δt) + r̈(t)(δt)2 (2.38)
An important feature of the Verlet algorithm relates to the symmetrical roles of r(t+ δt) and
r(t − δt), resulting in it being time-reversible (which is an accurate representation of Newton’s
equations of motion). Another notable feature is that the velocities ṙ are not required in order to
compute the trajectories of the particles, as they have been eliminated as a consequence of the
summation of the Taylor expansions about r(t). If so desired, one can evaluate the velocities ṙ(t)
in a variety of ways with a simple approach being a manipulation of the Taylor expansion for
r(t+ δt) and r(t− δt) (Eq. 2.39).
r(t+ δt)− r(t− δt) = 2ṙ(t)δt+O(δt)3
ṙ(t) =
r(t+ δt)− r(t− δt) +O(δt)3
2δt
≈ r(t+ δt)− r(t− δt)
2δt
(2.39)
Even though the velocities are not necessary in order to advance the positions of the particles,
they are useful for estimating the Kinetic energy (K) and hence the total energy of the system
(H = K + U). A major drawback evident from this is that the velocities are only available after
the positions have been calculated for the next time step. Other potential drawbacks of the Verlet
algorithm lie in the approximation of r(t+δt) and ṙ(t). In these expressions there are associated
errors of (δt)4 and (δt)2 respectively. Additionally at time t = 0 there is no information regard-
ing r(−δt), necessary for the generation of r(δt). This can be circumnavigated by truncating
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the Taylor expansion; r(−δt) = r(0) − δtṙ(0). Several other variations of the Verlet algorithm
have been developed in order to tackle some of the deficiencies associated with the algorithm.
One such example is the leap frog algorithm which evaluates the positions at time r(t+ δt) and
velocities at ṙ(t + 12δt). The major weakness of this algorithm is its inability to compute these
quantities at the same time, resulting in the kinetic and potential energies being undefined at the
same time.
The final algorithm of note is the so-called Velocity Verlet algorithm. This algorithm makes
use of both positions and velocities calculated at equal times, with the new velocities being
evaluated after the new positions and forces have been calculated (Eq. 2.40).




ṙ(t+ δt) = ṙ(t) +




As mentioned above, the essential features of a MD simulation revolve around the step by step
evaluation of the classical equations of motion. The forces acting on atoms, fi, are usually
derived from a potential energy U(rN ) where rN = (r1, r2...rN ) represents the complete set
of 3N atomic coordinates. The potential energy itself can be regarded as being made up from
contributions attributed to two types of interaction, these being non-bonded & bonded.
2.1.4.1 Non-Bonded Interaction
The part of the potential energy which represents contributions from non-bonded interactions,





















j>i represents the summation over distinct pairs, ensuring no double counting
occurs (the same care is taken for triplets etc). The initial 1-body term may represent either an
externally applied field or the effects of the container wall. In the case of periodic simulations of
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bulk materials, this term is redundant and therefore dropped. The remaining terms, ν2, ν3, etc.,
represent particle interaction. 4-body terms (& higher) are expected to be small in comparison to
ν2 & ν3 and are therefore neglected. It is also common practise to neglect the 3-body term and
focus on the 2-body interactions. This is due in part to the computation time involved in eval-
uating the 3-body effects. In order to compensate for this, the effects from 3-body interactions
may be included in an ‘effective pair potential’ νeff2 . The noticeable difference in this ‘effect-
ive’ potential is that it may be dependent on the density or temperature of the system involved,
whereas a true 2-body potential is not. At this point it should be noted that as the pair potential
only depends on the magnitude of the pair separation rij = |rj − ri|, one may write the potential
as ν2(rij). The most commonly used potential is that of the Lennard-Jones interaction (Eq. 2.42)










The exact value of these two parameters is material dependent and in the instances where the
material in question is not monoatomic, the are approximated according to the Lorentz-Berthelot








Finally, if electrostatic charges are present then interactions are modelled through the cou-
lombic potential (Eq. 2.45), which is defined in terms of the charges, q1 & q2, the relative dielec-
tric constant, ε, and the permittivity of free space, εo; ε is set to one in calculations with explicit
solvents [29]. This is a long range interaction, and can be successfully handled via the Ewald








So far we have only concerned ourselves with the interactions of monoatomic systems. However
in the case of molecules we must also consider intramolecular bonding interactions (Eq. 2.46).
One can follow these through a molecules equilibrium bond-lengths and angles etc. By treating
bonds (and also angles) as pseudo-springs, one can assign a potential energy to deviations from





























kξijkl(ξijkl − ξeq)2 (2.46)
The first term,
∑
bonds, relates to the bond stretching between two covalently bonded atoms i
and j. The second term,
∑
angles, is concerned with the bond-angle vibration between the triplet





This triplet of atoms may be further restrained by use of an additional potential function
known as the Urey-Bradley potential (Eq. 2.48). Taking a similar form to
∑
bonds, it acts by













improper, relate to the torsional potentials and are defined
by a quartet of atoms i-j-k-l (Fig. 2.1). The proper, or ’dihedral angle potential’, is used to
restrict rotation around a bond, with the torsional angle φijkl defined as the angle between the
i-j-k and j-k-l planes (Fig. 2.1a). The angle equating to the potentials minimum value is denoted
φ0, however the potential may posses numerous minima and the number of which (multiplicity)
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is denoted m. The improper term is used to restrict groups of atoms to within a plane as in the
case of aromatic rings (Fig. 2.1b) or to retain chirality (Fig. 2.1c), and the angle between the i-j-
k and j-k-l planes is denoted ξijkl. Such a potential generally only has one minima, therefore is















Figure 2.1: Illustration of (a) torsional angle φijkl in proper dihedral angle potential, (b) restric-
tion of atoms to within a plane in the improper potential, and (c) angle ξijkl in improper torsion.
The force acting on an individual atom can therefore be deduced by evaluating all possible
potential energy terms associated with it. In order to achieve this, one must know which para-
meters to use for the numerous atomic combinations and environments in each of the terms.
This information is usually stored in a collective database known as a ‘force field.’ It should be
noted that while CHARMM force fields (introduced in Section 2.1.4.3) generally makes use of
improper dihedrals, Urey-Bradley potentials are only used in special cases [29].
2.1.4.3 Which Force Field?
An important feature to consider in setting up a molecular dynamics simulation is the choice of
force field itself. This choice not only defines the functional form of the potential energy, but
also defines the various parameters (e.g. σ, q, req) used in its evaluation. It is important to note
that one may encounter two such force fields with identical functional forms yet each comprised
of a unique set of values for these parameters. Interestingly, regardless of completely disparate
parameters, these two force fields may be of comparable accuracy. Furthermore, an additional
force field defined by a different functional form may also yield comparable accuracy.
Within the force field itself, it is not uncommon to find various types of the same element
listed with different parameters. The rationale for this is that (for example) the carbon atom may
be found in nature in a variety of forms (i.e. sp3, sp2, sp2 aromatic, and sp). The equilibrium
angle θeq is expected to be unique in each of these hybridisations; sp3-hybridised C is tetrahedral
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and the angle is 109.5◦, whereas sp2-hybridised C is trigonal therefore resulting in an angle
of 120◦. The neighbouring atoms are also an important feature to consider, for example the
oxygen atom can be bound to hydrogen (e.g. water, alcohol) or carbon (e.g. ketone, ether) and
parameters such as bond length and strength are expected to be different in each case. Such
parameters are usually based on experimental values, for example the equilibrium bond lengths
between two atoms may be obtained from electron diffraction data, whereas the force constant
for such a bond may be obtained from IR.
In molecular modelling, force fields are primarily designed to predict the structure prop-
erties of molecules. Out of the countless variety of force fields available, AMBER [30] and
CHARMM [31] have been designed to study macromolecules such as proteins and polymers
and have highly similar functional forms, allowing for the possible use of one force field within
the others primary software package; other force fields of note are GROMOS and OPLS. How-
ever, there are subtle differences between the two force fields, with CHARMM having additional
bonded terms in the form of the four-body quadratic improper potential and the two-body Urey-
Bradley term (both absent in AMBER); as mentioned in Section 2.1.4.2, the latter is only used
in special cases [29]. There are also differences in the treatment of the electrostatic and van der
Wall scaling factors of 1-4 non-bonded interactions (i.e. atoms separated by two covalent bonds).
CHARMM uses values of 1.0 for both, while AMBER uses 1.2 and 2.0 respectively; a value of
1.0 denotes no modification, while a larger value strengthens these non-bonded interactions.
Several studies have noted that the original AMBER force fields (referred to as ff94 and
ff99) did not provide an acceptable energy balance between helical and extended regions of
peptide and protein backbones. As such, attempts have been made in order to improve the con-
formation sampling and two notable examples are ff99SB and ff03. AMBER-ff99SB presents
a re-parameterisation of the backbone torsion terms in ff99 and achieves a better balance of
the four basic secondary structure elements (i.e. β, αL, αR and pPII). The new dihedral para-
meters were obtained by fitting the energies of multiple conformations of glycine and alanine
tetrapeptides to high-level ab initio quantum mechanical calculations. The second modification
of note is AMBER-ff03, which is also a modified version of ff99. In addition to a modifica-
tion of the φ, ψ backbone torsions in order to decrease the preference for helical conformations,




Over stablisaton of helical content at the expense of other secondary structure motifs is not
restricted to AMBER force fields [32]. Observed differences between experimental and clas-
sically calculated two-dimensional φ/ψ free energy surfaces using the CHARMM22 force field
resulted in the CMAP correction term [33, 34]. CMAP is a function of two sequential backbone
dihedrals and is a numerical energy correction that transforms the classical energy map to match
that of a quantum mechanical calculated map. It should be noted that this study does not make
use of CMAP corrections, instead it utilises unmodified CHARM22 [31], AMBER-ff99SB [35],
and AMBER-ff03 force fields [36, 37].
In addition one may choose from a variety of water models in order to simulate the molecule
in aqueous solution. For example, the explicit model TIP3P (which CHARMM is optimised
against) describes the water molecule as a rigid three-charge site molecule of fixed bond length,
rOH = 0.9572Å, and angle, ∠HOH = 104.52◦, while the TIP4P model (4-site) shifts the charge
on the oxygen to a dummy site along the bisector of the HOH angle: resulting in improved
electrostatic distribution. Implicit solvents are an alternative to explicit water models, which rep-
resent the solvent as an effective mean-field potential and are capable of accurately reproducing
experimentally measurable quantities [29, 38]. While such an approach requires significantly
less computational time than utilising explicit models, investigations utilising implicit solvents
have shown that they appear to overestimate secondary structure and intramolecular hydrogen
bonding [38]. Such water models may therefore be inappropriate for studying the structure of
the models investigated herein, therefore this body of work has utilised the explicit TIP3P model
throughout.
2.1.5 Periodic Boundary Conditions
In order to simulate the bulk phase of a system, yet using only a relatively small number of
particles, one may employ periodic boundary conditions to a simulation. The cubic box of
particles is replicated throughout space to form a periodic array: for example, a two dimensional
cell will be surrounded by 8 identical neighbours (Fig. 2.2), whereas a three-dimensional cell will
be subsequently surrounded by 26 identical neighbours. During the course of the simulation,
movements of particles in the central original box are replicated across this periodic array; in
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reality, the positions of the particles contained within these mirror images are obtained through
manipulation of the co-ordinates of the central cell by adding (or subtracting) integral multiples
of the length of the box, L (i.e. x+nL, y+nL, z+nL). A consequence of this is that if a particle
crosses a boundary and leaves its box, a particle from a neighbouring ‘mirror image’ will enter
via the opposite boundary. Therefore one only needs to store the co-ordinates of the central box,
and only consider the co-ordinates of the mirror images when a particle crosses such a boundary
(Fig. 2.2).
Figure 2.2: Periodic boundary conditions can be visualised as surrounding the central simulation
box with an (infinite) number of copies. As atoms reach one edge of the box they immediately
appear at the opposite side. The dashed box indicates the limit which a particle can interact with
its nearest periodic neighbours (which need not necessarily belong to the same periodic image).
So far only cells based on a cubic geometry have been mentioned. This does not mean that
other cell shapes are impossible, in fact the only caveat is that the shape must fill all of space when
replicated by translational operations. This is satisfied by five shapes: the aforementioned cube, a
hexagonal prism, rhombic dodecahedron, truncated octahedron, and ‘elongated’ dodecahedron.
A parallelepiped cell (closely related to the cubic cell) also fulfils this requirement.
Periodic boundary conditions therefore appear to be a perfect solution to simulating bulk
phase properties, however a major problem lies in the question whether the properties of a macro-
22
2.1. MOLECULAR DYNAMICS
scopic system can be accurately represented by a small infinitely periodic system. A long-ranged
potential will have considerable contribution from interactions between particles and their own
periodic images. Such an interaction is undesirable as it imposes an anisotropic nature to the
intended isotropic system. As a consequence of this, several techniques have been developed
in order to calculate the potential energy of a system subjected to these periodic boundary con-
ditions. For short-ranged interactions one may exploit the ‘mirror image convention’ which
restricts the summation of the contributions to the potential energy to a region whose size and
shape is identical to that of the original central cell (Fig. 2.2). Furthermore, as the largest contri-
bution stems from interactions with a particles ‘nearest neighbours,’ one may further restrict the
summation by applying a spherical cut-off to the potential. This equates to the potential being
zero for distances r  rc where rc is the cut-off; for a cubic cell of dimension L the value of rc
cannot be > L2 .
If such a potential is not precisely zero for distances in excess of rc, then one would expect
the total potential energy Utot to posses systematic errors. This lost energy can be captured
by evaluating a tail contribution Utail in addition to the truncated potential Uc (Eq. 2.49). This
relies on the average number density ρ and assumes that the radial distribution function g(r);
the probability density of finding an atom at distance r from another atom at r = 0; is unity for
distances in excess of the imposed cut-off.





dr U(r) 4πr2 (2.49)
Such an approach assumes that the the intermolecular interactions decay rapidly. Clearly,
such a statement is true only for potential energy functions which decay faster than r−3, as the
Utail term would be infinite for any potential which decayed slower than this. The Coulombic
interaction is a long-ranged potential and decays as r−1, therefore one must find an alternative
method that will effectively handle these intermolecular interactions. As mentioned in Section




A major difficulty in simulating complex systems is that the energy landscape of the system is
generally very rugged. As a consequence of this, low temperature sampling of the configurational
space is often hindered by the inability to cross high-energy barriers. Whilst such simulations
will have precise sampling of that particular region of phase space, they are trapped within low
energy minima. In order to ensure that a simulation effectively explores the entire configurational
space, several techniques such as Parallel Tempering (or Replica Exchange Method) have been
developed.
Parallel tempering simulations amount to simulating N replicas of the system of interest in
parallel. These are typically simulated in the canonical ensemble with each replica (or ‘tem-
perer’) at a different temperature ranging from T1 to TN , with TN chosen to ensure that the
replica can easily traverse the entire phase space. If so desired, one may replace these different
temperatures with another variable thermodynamic property such as pressure or chemical poten-
tial. Good sampling of the phase space is achieved by allowing systems at different temperatures
to swap their complete configurations at regular intervals during the course of the simulation.
At regular intervals (i.e. after a certain number of time-steps) an attempt is made to swap the
configurations of a pair of replicas i and j. This swap between i and j is accepted (or conversely
rejected) according to a criterion guaranteeing detailed balance (Eq. 2.50), which is dependent on
the energy difference between the two systems, ∆Eij , and the difference in inverse temperatures,
∆βij . From this criteria, it is apparent that swaps between systems become exponentially less






1 + exp[∆βij∆Eij ]
}
(2.50)
The major benefit of running a Parallel Tempering simulations is that configurations sampled
by high temperers will eventually swap with those sampled by low temperers. A consequence of
this is that unlike in a conventional MD simulation, low temperature replica may jump between
local minima separated by high energy barriers. While this body of work does refer to results
obtained through parallel tempering, it does not make use of the technique explicitly. Therefore
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further information on the topic can be found in literature.
2.2 Experimental Techniques
2.2.1 Circular Dichroism
Circular Dichroism (CD) measures differences in the absorption of left- & right-handed polarised
light, arising due to structural asymmetry. The difference in absorption (δA = AL - AR) or
difference in molar extinction coefficient (δε = εL - εR) is recorded at each wavelength, λ, of
the absorption band. Since εL & εR (or AL & AR) typically have nearly the same magnitude,
δε may take on either small positive or negative values for optically active compounds, or may
be zero as in the case of achiral compounds and racemic mixtures (i.e. equal amounts of left- &
right-handed enantiomers).
2.2.1.1 Circular Birefringence & Circular Dichroism
When circularly polarised light passes through an optically active medium, two related phe-
nomena occur. Circular Birefringence occurs when one of the circularly polarised components
(Fig. 2.3a) experiences a different refractive index than the other component. This difference
in refractive index, δn, is typically 1 millionth of the absolute value of nL or nR and results
in one of the components being retarded and the linear polarisation vector being rotated by an
angle α (Fig. 2.3b). Circular Dichroism occurs when the medium absorbs the two circularly
polarised components to a different extent. This results in the superposition of the two compon-
ents no longer corresponding to a linearly polarised wave but instead tracing out an ellipsoid path
(Fig. 2.3c). This superposition is referred to as elliptically polarised light and the degree to which
the plane-polarised light becomes elliptical is entirely dependent upon the difference between the
absorption’s of the two components. In reality it is rare to find a material only exhibiting one of
these phenomena, and the resultant superposition comes from a combination of these two effects
(Fig. 2.3d).
There exists two requirements for a molecule to exhibit a CD spectrum. Firstly is the pres-
ence of a chromophore (a molecule which can absorb radiation through the electronic configur-
ation of its ground state at room temperature). Due to the absorption of energy, the excited state
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Figure 2.3: Diagrammatic representation of the combination of left, εL, and right, εR, circularly
polarised light. Resulting in (a) plane-polarised light, (b) rotation of linear polarisation vector as
a result of Circular Birefringence, (c) elliptically polarised light as a result of Circular Dichroism,
and (d) combination of both phenomena.
interacts with its environment in a unique way which differs from that of its ground state inter-
action. In the far UV spectral region (190-250nm), the major chromophore is that of a peptide
bond. The second requirement for CD is that the chromophore must be in (or closely associated
with) an optically asymmetric environment. When a peptide bond is part of a regular folded
structure, such as an α-helix or β-sheet, it satisfies this requirement as it is associated with a
conformationally asymmetric structure.
2.2.1.2 Mathematical Theory
The absorption of left-handed polarised light can be defined in terms of I0L and IL, which are the
intensities of the light incident on the sample and after travelling a distance l through the sample
of molar extinction coefficient εL and molar concentration C (Eq. 2.51).
AL = log10(I
o
L/IL) = εLCl (2.51)
In combination with a similar term for the absorption of right-handed polarised light, one
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can derive a relationship between the difference in absorption and difference in molar extinction
coefficient (Eq. 2.52).
δA = AL −AR = εLCl − εRCl = (εL − εR)Cl = δεCl (2.52)
The Beer-Lambert Law (Eq. 2.51) can also be expressed in terms of a natural logarithm
(Eq. 2.53), which includes the cross section of light absorption by a single particle σ and the
density of absorbing particles N . It should be noted that the absorption coefficients (α = ε C
and α
′
= σ N ) are different, but can be converted using α
′
= αln(10).
A = ln(IoL/IL) = σNl (2.53)
It would be logical to report CD data in terms of δε (allowing for samples of differing concen-
tration and path length to be compared directly) as modern instruments are capable of measuring
small δA. However, another method of expression relies on the ellipticity, θ (Eq. 2.54), which is
derived from the minor (b) and major (a) axis of the resultant elliptically polarised light (Fig. 2.4).
Furthermore, these two quantities (i.e. δA and θ) are linked by a simple numerical relationship,








Figure 2.4: Diagrammatic representation of the elliptically polarised light, revealing the major
axis, a, the minor axis, b, and the ellipticity, θ.
Spectra recorded in the near-UV and visible region are commonly expressed in terms of
protein molarity, however in far-UV CD of polypeptides and proteins it is common to use the
mean residue concentration. This is obtained by dividing the concentration in mass terms (i.e.
27
2.2. EXPERIMENTAL TECHNIQUES
mg.ml−1) by the mean residue weight (MRW), Mmrw, which is the molecular mass divided by
N − 1 (where N is the number of amino acids in the peptide chain). Far-UV CD spectra are
therefore often expressed in terms of the “mean residue ellipticity” [θ]mrw (Eq. 2.55) which is
quoted in units of deg.cm2.dmol−1, and is related to the observed ellipticity (θ), the path length





Furthermore, one can express the concentration in terms of mol.l−1 (CM ), and remove the
dependence of Mmrw from the equation; the molecular mass is factored into the number of moles
(g/MW ), therefore one need only consider the number of amino acids, N (Eq. 2.56).
[θ]mrw ∝
θ
CM .l.(N − 1)
(2.56)
However as mentioned above, CD spectra may be expressed in terms of absorbance. Here
the units relate to the “difference in molar absorbance” δε and are expressed as cm−1.M−1.
Like the observable quantities δA and θ, these two units δε and [θ]mrw are linked by a simple
numerical relationship [θ]mrw = 3298δε at all wavelengths [1, 39, 40]. At this point it should be
noted that henceforth all reference to the “mean residue ellipticity” will omit the ‘mrw’ subscript
(i.e. [θ]mrw ↔ [θ]).
2.2.1.3 Identifying Secondary Structure
The α-helix, β-sheet and random coil structures each give rise to a characteristic shape & mag-
nitude of CD spectrum (Fig. 2.5). The α-helix displays large CD bands with negative ellipticity
at 222 & 208nm and a CD band with positive ellipticity at 192nm. Similarly to the α-helix,
the 310-helix displays CD bands with negative ellipticity at 222 & 207nm (the former being a
shoulder), with a weak positive band near 195nm. The ratio of [θ]222 / [θ]207 is found to be
much weaker than that of the α-helix. Overall the CD spectrum of the 310 is different but NOT
dramatically from those of α-helices.
The left-handed polyproline helix, pPII, gives a CD profile that is very similar to that of an



























Figure 2.5: Example of far-UV CD spectra for an α-helix (green), β-sheet (blue) and random
coil (red). Revealing the associated electronic transitions of the absorption bands: the exciton
coupling of π → π∗ results in two bands polarised perpendicular to, or along the helix axis
(parallel) [1]
200nm, while the pPII helix is characterised by a weaker positive band at about 217nm. This
positive band is found to shift in position to 225nm when the peptide is rich in proline.
β-sheets exhibit a broad negative band near 217nm and a large CD band with positive ellipt-
icity near 195nm. The exact position of these two bands and their ratio are found to be more
variable than those of the α-helix. This may be due to β-sheets being able to adopt a parallel
or anti-parallel (or mixed) arrangement. Their ability to be twisted may also contribute to the
variability in the bands features. In the case of β-turns, there is no CD spectrum that is char-
acteristic of this structure. Type II β-turns exhibit a weak CD band with negative ellipticity at
220-230nm, with a stronger positive band between 200-210nm. Type I & III β-turns on the other
hand give CD spectrum which are qualitatively similar to that of an α-helix. The distinction is in
the two longer λ bands of negative ellipticity, with the amplitude of these bands for turns being
approximately half of their α-helix counterparts. In addition the positive band near 190nm is 14
to 13 of the magnitude of an α-helix [1, 41–45].
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2.2.1.4 Origin of bands
The OCN peptide bonding system consists of the single C-O and C-N σ bonds and a delocalised
π bonding system (Fig. 2.6a) comprised of the px atomic orbitals and contains two electrons
from the nitrogen, one from the oxygen and one from the carbon. Within the peptide bond
two electronic transitions may occur. The first is the π → π∗ transition from within this π
bonding system. The oxygen atom also posses two nonbonding electrons in the atomic py orbital


















Figure 2.6: Molecular orbital energy level diagram from p-orbitals; illustrating end-on p-orbital
overlap resulting in σp orbitals and side-on p-orbital overlap resulting in πp orbitals. (b) The
three p-orbitals of oxygen are located along the x, y, and z axis.
The n→ π∗ transition is of lower energy and manifests as absorption at longer wavelengths
than the π → π∗ transition (Fig. 2.5). In the case of the α-helix, π → π∗ transition is split
into two transitions as a result of ‘exciton coupling’ [1]. This occurs when one has two identical
chromophores, one excited and the other not. Resonance of the excitation could occur between
the two chromophores, and at any given time, one would be unclear as to which was in the
excited state. This exchange results in two states, one of higher energy, and one of lower energy
in regards to the two isolated (non-interacting) chromophores.
2.2.1.5 CD as a quantitative technique
Due to CD being a quantitative technique, it is highly regarded in following denaturation of
proteins. CD obeys Beer’s Law (Eq. 2.51) and therefore the spectrum of each component in a
solution is directly proportional to its concentration. The total CD spectrum is essentially a sum
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A further consequence is that a change in the CD spectrum due to addition of a denaturant
or heat, is directly proportional to the concentration of native & denatured forms. As such,
following these changes as a function of temperature or denaturant is a very convenient and easy
way of obtaining information on the thermodynamics of folding.
2.2.2 Fourier Transform Infrared Spectroscopy
Fourier transform infrared (FTIR) spectroscopy has been widely used as a basis for secondary
structure analysis [46]. The torsional angles, which determine the spatial orientation of the
peptide backbone, ultimately affect the vibration modes of the peptide bond [47] - known as the
amide modes. The understanding of these amide modes stems from early work on the simplest
model compound which includes the amide group, N -methyl acetamide (NMA) [48]. From this,
three classical amide modes have been identified. The amide I band is primarily the stretch of
the C=O bond [7] and can be found in the 1610-1700 cm−1 region depending on the solvent.
As it depends on the secondary structure of the backbone and is hardly affected by the nature
of the side-chain, it is the most commonly investigated band in structural analysis [49]. Amide
II, found in the 1530-1580 cm−1 region [50], is regarded as the out of phase combination of the
N-H in plane bend and the C-N stretch [7, 51], and is considered less structurally sensitive than
amide I. Finally, the amide III mode is the in phase combination of the N-H in plane bend and
C-N stretch, and normally appears in the 1200-1340 cm−1 region [50].
Overall information on the secondary structure of peptides can be derived from analysis of
the amide I band which is strong in IR [52]. In solution, the frequency of the C=O stretch
is sensitive to hydrogen bonding characteristic conformation forms [53]. However, this band




2.2.2.1 Identifying Secondary Structure
In IR analysis, experimental studies show that α-helical conformations are characterised by IR
absorptions in the 1650-1658 cm−1 range [54]. However, studies have drawn attention to proteins
which absorb in this region yet exhibit no α-helical structure [55–57]; large looped structures
have been recorded to present bands around 1655 cm−1 [56, 57]. Another complication in the
assignment of α-helices is the small number of proteins which absorb below 1650 cm−1, yet
are known to be predominately α-helical [58, 59]; one example is the homopolypeptide poly-L-
lysine, which absorbs at 1638 cm−1.
Other helical forms such as the 310-helix are also difficult to assign on the basis of IR ab-
sorption. Synthetic α-aminobutyric acid-containing peptides, known to form 310-helices, have
been shown to characterised by strong amide I bands at 1662-1663 cm−1 [60]. Whereas a band
centred near 1640 cm−1 has been assigned to the repeating i, i + 3 hydrogen bonds of a 310-
helix [61, 62]. The type III β-turn, regarded as the building block of a 310-helix, has also been
predicted to absorb in this region [60]. In fact FTIR studies conducted on i, i + 3 hydrogen
bonds in both linear and cyclic peptides, suggest that all three of the main β-turn subtypes (i.e. I,
II, III) present characteristic absorptions near or below this region. Bands occurring in the high
frequency amide I region (>1660 cm−1) have also been associated with turns [63].
IR absorption in the 1620-1640 cm−1 region corresponds to pleated β-sheets [52, 53]. An
antiparallel β-sheet structure is characterised by a strong band ∼1632 cm−1 irrespective of the
medium in which the spectrum is recorded, and a (weaker) high wavenumber component located
at 1690 cm−1 in H2O or 1675 cm−1 in D2O [7]. It is often claimed that a distinction can be made
between antiparallel and parallel sheets due to the theoretical prediction that an infinite parallel
sheet should lack the higher wavenumber component [64]. Experimentally however, there is no
evidence for this claim and similar spectra are expected for finite β-sheets [64–67]. Therefore
contrary to results suggested by theoretical calculations, a distinction between antiparallel and
parallel sheets does not appear possible on the basis of the amide I band [65, 66]. The β-hairpin
bands are seen to differ in two aspects from ordinary antiparallel β-sheets, with a low wavenum-
ber absorption at 1620 cm−1 and a higher wavenumber absorption that does not vary between
H2O and D2O [68]. Finally, absorption in the region 1640-1648 cm−1 is commonly assigned to
backbone structures which are unordered or aperiodic [53].
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2.2.3 Dynamic Light Scattering
Dynamic Light Scattering (DLS) is a useful technique which measures the Brownian motion
of a particle and relates this to the particles size. Brownian motion itself refers to the random
movement of a particle caused by collisions with the surrounding solvent molecules. These
collisions result in smaller particles (with less inertia) being propelled further and faster than
larger particles. The velocity of this Brownian motion is defined by the translational diffusion






The size that is actually computed is the hydrodynamic diameter, d(H), and refers to how
the particle diffuses within a liquid. This value equates to the diameter of a sphere which has the
same translational diffusion coefficient as the particle. It should be noted that as the viscosity, η,
of a liquid relates to its temperature, T , DLS requires that one accurately knows the temperature
and that it must be stable, otherwise convection currents in the sample will result in inaccurate
results due to non-random movements.
The speed at which the particles are diffusing is evaluated by measuring the rate at which
the intensity of scattered light fluctuates. Theoretically, if one was to use a laser to illuminate a
cuvette filled with stationary particles, one would observe (via a frosted glass screen) a classical
speckle pattern consisting of patches of bright light and dark areas. These speckles arise from
the scattering of the propagated waves of light by the particles (Fig. 2.7). The bright patches are
caused by light waves arriving with the same phase at the detector and constructively interfering,
whereas the dark areas are due to phase additions that result in destructive interference. In this
theoretical example, as the particles are stationary, the sizes and positions of the speckle pattern
will also be stationary. For a system undergoing Brownian motion, the corresponding speckle
pattern will be in constant motion with the rate of fluctuations in the intensity being dependent
on the size of the particles.
A digital correlator is then used to measure the degree of similarity between the intensity sig-




Figure 2.7: The observed signal is dependent on the phase addition of the scattered light, (a)
decreased intensity is a result of two beams interfere and cancel each other, (b) while increased
intensity results if two beams interfere and enhance each other.
values would be very similar (strongly correlated). However as one compares values at greater
separations (i.e. t+ 2δt etc.) this correlation would begin to reduce due to the random nature of
Brownian motion (Fig. 2.8a). Assigning perfect correlation as being 1 and no correlation as 0,
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Figure 2.8: (a) The intensity of scattered light may fluctuate as a function of time. (b) Following
the correlation with respect to time, one would expect the correlation of larger particles to decay
The rate at which this correlation decays is linked to the size of the particles. As smal-
ler particles move more rapidly due to Brownian motion, their intensities will also fluctuate
more rapidly, resulting in their corresponding correlation functions decaying faster than larger
particles.
2.2.4 Fluorescence Spectroscopy
Fluorescence is one of the two categories of luminescence, which is defined as the emission of
light from any substance; the other category is termed phosphorescence, and is distinguished
from fluorescence in terms of the nature of the excited state from which the light is emitted from
(fluorescence, singlet; phosphorescence, triplet). The major difference between the two forms of
luminescence, is that fluorescence occurs between two singlet states, an allowed transition, while
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phosphorescence occurs between a triplet and singlet state, a forbidden transition (Fig. 2.9). This










Figure 2.9: A typical Jablonski diagram, highlighting the difference in fluorescence and phos-
phorescence. The singlet ground, first and second excited states are denoted S0, S1 and S2
respectively, while the first triplet state is denoted T1.
Typically, emission from fluorophores occurs at longer wavelengths than those of absorption,
due to a variety of dynamic process that transpire after light absorption (Fig. 2.10). For example,
when a fluorophore is excited to the first singlet state (S1), it is usually to an excited vibrational
level within S1, and the excess vibrational energy is rapidly lost to the solvent. Additionally, if
the fluorophore is excited to the second singlet state (S2), internal conversion results in it rapidly
decaying to S1 within 10−12s. Within the excited state (µE) the fluorophore generally has a
larger dipole moment than the ground state (µG), thus the solvent dipoles can reorient around
µE and lower the energy of the excited state; the greater the polarity of the solvent, the greater
the effect. Naturally, non-polar molecules (e.g. aromatic hydrocarbons) exhibit less sensitivity
to solvent polarity than polar fluorophores [69].
Among biopolymers, proteins are unique in that they display intrinsic fluorescence; proteins
may contain three amino acids which are all fluorescent - phenylalanine, tyrosine, and trypto-
phan. As these residues are typically rare in proteins, it allows one to interpret the spectral data.
Tryptophan itself is highly sensitive to its environment, with changes in its emission spectra res-
ulting from conformational transitions, subunit association, denaturation or substrate binding.
















Figure 2.10: Jablonski diagram revealing the effects of solvent relaxation.
onment, the absorption and emission spectra of tryptophans typically overlap and it is difficult to
separate the spectral contributions of each residue [70].
An important feature for this research is that the tryptophan emission is dependent on the
structure of the protein. Within an apolar environment, one would expect the tryptophan emission
to be blue-shifted due to the aforementioned solvent relaxation [69, 71]. As the tryptophan
experiences hydrogen bonding, the emission shifts towards longer wavelengths (Fig. 2.11). This
is analogous to the tryptophans becoming solvent exposed, and denaturation of proteins results in
similar emission spectra. Similarly, if the emission spectra is blue-shifted, then one may deduce








Figure 2.11: Effect of the tryptophan environment on the emission spectra.
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The structure of certain peptides can be regarded as being comprised of an ensemble of flex-
ible conformations, characterised by a rugged energy landscape with shallow minima. Such a
peptide should be sensitive to changes in the environment (i.e. solvent), which may favour the
equilibrium of structures towards a particular population (or fractional population). It is well
documented that the conformation of proteins and peptides are greatly influenced by interac-
tions with different solvent environments [72–74] and a solvent can override the propensity for
a secondary structure.
Membrane surfaces have been shown to induce a partial denaturation of proteins resulting in
a non-native state [75, 76]. This effect has been proposed to be due to a cumulative effect of the
negative charges of a membrane [77] and a decrease in dielectric constant near the membrane
surface [78–80]. The conformational changes experienced by a membrane active peptide under
such solvent influences have been shown to result in structure similar to that observed upon
interaction with membranes [72, 73].
The effect a membrane has on a protein’s structure is dependent partly on the location of
the protein relative to the membrane, due to various environmental conditions that it may exper-
ience [81]. These include diffuse layers where the dielectric constant can be either considered
well approximated by aqueous conditions (at far distances) or is considerably reduced (at inter-
mediate regions of closer approach); and the interfacial contact regime where the membrane is
in contact or in very close proximity to the protein.
3.2 System chosen
A major problem in combating HIV is that the virus has evolved numerous and sophisticated
immune-evasion strategies, many of which rely on multiple mutations and sequence variabil-
ity [82]. The Membrane Proximal Region (MPR) of the HIV-1 fusogenic subunit (gp41) is
found to be a highly conserved sequence, and therefore an attractive focus for new therapies. Of
the few broadly neutralising monoclonal antibodies (mAb) which have been isolated [83], three
target gp41 (2F5, Z13 & 4E10) [84, 85] with epitopes localised in the same continuous MPR;
this region encompasses amino acids 660-683 (numbering based on HIV-1 HxB2 [86]) and also
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includes the C-terminal residues relevant for the anti HIV-1 fusion inhibitor T-20 (Fig. 3.1a).
Figure 3.1: (a) The full sequence of the membrane proximal region (MPR) gp41660−683 high-
lighting the epitopes for two broadly neutralising antibodies, 2F5 (blue) and 4E10 (red). The
C-terminal sequence is also shown to illustrate the amino acids in common with the peptide EL-
LELDKWASLWN, the object of this study. (b) The Structure of the peptide ELDKWASLWN-
WFDITNWLWYIK was solved by NMR in the presence of DPC micelles. The conformation
adopted is of a kinked α-helix. Blue: amino acids in α-helix, Red: 310-helix.
Approximately half of the residues in this region are hydrophobic with five of these being
tryptophan [87]. Mutations in this region (in particular the Trp residues) have been shown to
decrease the fusogenicity and inhibit viral entry, suggesting that these residues are critical for the
function of this domain [88]. However attempts to elicit a neutralising immune response from the
membrane-proximal region, and especially the hexapeptide epitope ELDKWA (gp41662−667) [2]
of the human monoclonal antibody (mAb) 2F5, have not succeeded [89, 90]. This has prompted
several studies to determine the structure of this sequence as well as to establish whether or not
additional residues outside of the ‘core’ hexapeptide are required for successful binding to the
2F5 mAb [2]. It has also been reported the 2F5 epitope must contain the sequence gp41659−671,
where the additional residues enhance the binding affinity by a factor of 103. It is this sequence
that we focus on in this study.
Previous solution studies of gp41659−671 have led to conflicting findings regarding conform-
ational preference [2, 91]. Nuclear Magnetic Resonance data implied that this peptide has a
strong conformational bias toward the rare 310-helix in water. Conversely, a greater variety of
local motifs in this peptide has been revealed by UV resonance Raman scattering [92] and inde-
pendent circular dichroism data [2, 93] revealed no strong helical bias under aqueous conditions.
However, parallel tempering molecular dynamics simulations using the CHARMM empirical
potential were strongly biased toward helical motifs in water accounting for the experimental
39
3.2. SYSTEM CHOSEN
data only at unphysically high temperatures [93].
Structural data has shown that the sequence gp41662−683 forms a kinked helix in liposomes
with a hinge centred on gp41673−674 (Fig. 3.1b) [94, 95], which is in contrast to previous res-
ults pertaining to the shorter sequence gp41665−683 which revealed a straight α-helix [96]. The
functional role of these two different conformations has been proposed and linked to mAb neut-
ralising activity; suggesting that the interconversion between the two conformations is an im-
portant aspect of the fusion process. Furthermore, it has been proposed that the capping residue
Asn671 acts as a switch in this interconversion between the kinked conformation and the longer
α-helix [97]. These studies have also demonstrated that both the nature of the lipid and the
pH were important factors in the structure of the P1 peptide (residues 649-683), located in the
conserved MPR of gp41 [94]. At neutral pH, the N-terminal charged residues of this sequence
adopt a disordered structure, while the Trp-rich domain folds into a helix in order to interact with
DPC micelles. Under acidic conditions, the Glu-rich region of the P1 peptide also folds into this
helical conformation.
We propose that if the hinge gp41673−674 is indeed functionally important, then the sequence
gp41659−671 should exhibit an independent capability to interact with a membrane surface. It is
also proposed that the two Trp residues are able to fold independently in order to interact with
the membrane surface. This autonomous interaction with the surface of a membrane is supported
by an investigation into interactions of dipeptides with SDS micelles which probed the effect of
neighbouring amino acids on the energetics of the interactions [98], concluding that the presence
of either lysine or leucine preceding a Trp residue greatly favoured the Trp-micelle interaction.
As both of these amino acids are present in the sequence gp41659−671 (ELLELDKWASLWN),
this therefore implies that this peptide should posses a strong affinity for binding. Finally, as
these Trp residues may be assigned positions i and i + 4 relative to one another, it is logical to
assume that these fold into an α-helix.
Here we examine the secondary structure of gp41659−671 using a combination of computer
simulation and experimental measurements under various solvent conditions. These are chosen
in order to mimic the distinct physical and chemical environments that this sequence may be
exposed to during the viral fusion process. The aim of which is to uncover aspects of structural
control and membrane binding of the peptide by chemical and physical processes accessible in
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the extracellular environment.
3.3 Materials & Methods
3.3.1 Materials
The amino acid sequence, ELLELDKWASLWN, was purchased from Cambridge Peptides with
a stated final purity of 100%. The peptide stock was prepared by dissolving the peptide powder
directly in 20mM buffer solution when applicable. For samples in pure water, the solubilisation
of the peptide was helped through additions of 2µl of 1M NaOH. In order to check for complete
dissolution, the absorbance at 350 nm was monitored. The concentration of the stock solutions
were determined spectrophotometrically using the calculated extinction coefficient at 280 nm of
14000 M−1 cm−1 [91] due to the presence of two tryptophan residues in the peptide sequence.
The peptide stock solutions were used to prepare working solutions of various concentra-
tions of Trifluoroethanol (10%, 20%, 30% v/v), Methanol (50% v/v), Sodium Dodecyl Sulphate
(3mM, 4mM, 5mM, 6mM, 9mM, 12mM), and Acetonitrile (50% v/v). Water and 0.2M buffer
solutions were used to ensure the overall buffer concentration remained 20mM. The concentra-
tion of each sample was checked spectrophotometrically prior to any experiments being carried
out, using the same extinction coefficient used to determine the concentration of the stock solu-
tion.
3.3.2 Circular Dichroism (CD) measurements
Far-UV CD spectra were recorded on a Jasco J-810 spectropolarimeter (Japan Spectroscopic
Co., Tokyo) fitted with a Peltier unit for temperature control. The concentration of peptide in
solution was 0.04mM. The spectra are the average of three accumulations in step mode (data
pitch of 1 nm, response time of 8s, bandwidth of 1 nm) acquired in rectangular cuvettes of
0.1 cm path length (unless otherwise stated) at 25◦C. For every sample, an appropriate solvent
spectrum was recorded under identical conditions and subtracted from the corresponding sample
spectrum. The data collected was expressed in molar ellipticity (deg.cm2.dmol−1) in order for a
direct comparison with CD spectra reported to date [2, 91].
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3.3.3 Dynamic Light Scattering measurements
DLS was used to confirm whether the concentrations of the surfactants were above or below the
critical micelle concentration (cmc). The DLS measurements were performed using a Zetasizer
Nano (Malvern) and disposable clear plastic cuvettes at 25◦C. For each run, three accumula-
tions were performed to ensure consistent results. Data was subsequently analysed using the
manufacturer’s Dispersion Technology Software (DTS version 5.10).
In order to ensure subsequent interpretation of the CD spectra was handled correctly, it was
necessary to confirm which of the concentrations of SDS lay above and below the cmc. DLS was
performed on the solutions of various concentrations of SDS in 20mM sodium phosphate (i.e.
without gp41659−671) to determine where they lay relative to the cmc of the surfactant (Fig. 3.2a).
Furthermore, in order to verify that the solutions of gp41659−671 and SDS under the different pH
conditions tested lay above the cmc, DLS measurements performed on the samples (Fig. 3.2b)
revealed that all samples lay above the cmc.
Figure 3.2: (a) Correlograms of solutions at different SDS concentrations. (b) Correlogram of a
solution of 7mM SDS in 20mM PB at different pH: demonstrating that under all conditions they
were above the cmc.
The nature of the correlograms belonging to the various concentrations of SDS would in-
dicate the presence of polydisperse aggregates, as evident by the multiple exponential decays
(Fig. 3.2a). Analysis of the hydrodynamic radius for the samples at different concentrations of
SDS revealed the emergence of micelles of 4.187 - 4.85nm above concentrations of 4mM; the
length of an SDS monomer is approximately 17Å. Traces of larger aggregates (100-200nm) were
also detected utilising the manufacturers software; the intensity of the 4nm species was found to
become the most prominent of the two, as the concentration of SDS increased.
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Analysis of the samples of gp41 in 7mM SDS revealed average hydrodynamic radii of
118.3nm, 192.8nm and 266.8nm for the solutions near pH 7, 10 and 3 respectively; decorrel-
ation times of 0.193ms, 0.304ms, and 0.369ms, derived from the correlograms, corresponded to
sizes of 24.2nm, 38.1nm and 46.2nm. This suggested the presence of larger aggregates poten-
tially comprised of a mixture of SDS and peptide.
3.3.4 Fluorescence Spectroscopy
Tryptophan fluorescence was measured with a LS55 (Perkin Elmer Instruments, Massachusetts,
USA) at 25◦C using a 1cm quartz cuvette (Hellma GmbH, Germany) and 0.0647 mg ml−1 pro-
tein solution. To selectively excite the tryptophan an excitation wavelength of 295 nm (2.5nm
excitation slit) was used. The spectra were acquired from 300 to 400 nm (emission slit 6nm) and
subtracted with the corresponding buffer blank.
3.3.5 Computational Methods
Three starting configurations based on motifs reported by Barbato et al. [2] and Biron et al. [91]
have previously been investigated using classical atomistic molecular dynamics [93]. One mo-
tif that was reported by Barbato, yet not investigated, was that of the unordered conformation.
Furthermore, as the results of the previous study suggested that the CHARMM force field over
emphasised the helical content in pure water, it was imperative to investigate the effect of em-
ploying different force fields for this system. A unit cell was set up, which comprised one gp41
molecule (Fig. 3.3), 1853 water molecules and 2 sodium counter ions in order to ensure charge
neutrality. The molecules were arrayed on a cubic lattice with random molecular orientations in
a cubic box of length 38.2Å. The water molecules were represented by the rigid, non-polarisable
3-site TIP3P empirical force field. The unit cell was replicated three-fold with the peptide being
described by either the CHARMM22 [31], AMBER-ff03 [36, 37] or AMBER-ff99SB [35] force
fields in each of the replicas, while the PINY simulation package [99] was employed to perform
the simulations.
The systems were equilibrated at 300K in the canonical ensemble for 150ps with a time-
step of 0.5fs to anneal out unphysical contacts. The system was then run for 150ps with a time
step of 0.5fs in the isothermal-isobaric ensemble to allow for spatial relaxation. The system was
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then run for a further 150ps in the canonical ensemble with a time-step of 1fs being employed,
before a production run of 15ns using a time-step of 2.5fs from which all data was collected.
Periodic boundary conditions were employed and long-range interactions were evaluated via
Ewald summation.
Figure 3.3: Initial starting configuration used in simulations, as reported by Barbato et al. [2]
In order to analyse the structure of the peptide using Molecular Dynamics simulations, we
have made use of Ramachandran plots and bond probability distribution functions, as used by
Samuelson et al. [100]. The former allows for the assignment of secondary structure motifs
based on dihedral angles, while providing a clear illustration of the conformational space ex-
plored during the course of the simulation. The later on the other hand allows for the probability
distribution of selected atomic contacts as a function of inter-atomic separation to be assessed.
These distribution functions arise from the connectivities between residues i and i + n where
n=3, 4 or 5 for 310-, α- and π-helices respectively, and examination of such functions allows us





3.4.1 Structure under aqueous conditions
3.4.1.1 Structure obtained experimentally
Due to contrasting results obtained in literature [2, 91], far-UV CD spectra of 0.04mM gp41659−671
in various buffers (water, 20mM ammonium acetate, 20mM sodium phosphate) were recorded.
The buffers were chosen to match those employed in these past studies, in order to determine
if the choice of buffer ultimately affected the secondary structure of gp41659−671. No discern-
ible structural change was observed between the conditions tested (Fig. 3.4), confirming that
the environment of the buffer was not responsible for these reported discrepancies. The overall
shape of the spectra were identical to those reported previously by Barbato et al. [2], and were
consistent with an aperiodic structure. This was interpreted from the location of the large band
of negative ellipticity centred around 197 nm, both helical and β-sheet secondary structures are
known to give rise to bands of positive ellipticity in this region. These two secondary struc-
tures also give large bands of negative ellipticity, however they are red shifted (relative to the
location of our band) to 208 nm (plus 222 nm shoulder) and 217 nm respectively, thus ruling
these structures out as a dominant secondary structure motif. CD spectra indicative of type II
β-turns exhibit a weak band of negative ellipticity at 220-230 nm and a stronger positive band
between 200-210 nm, whereas type 1 & III β-turns are known to give CD spectrum which are
qualitatively similar to that of an α-helix. As these features were also not present in the spectra
collected, these structures could also be ruled out as a dominant secondary structure motif.
It should be noted however that these structures should not be ruled out entirely. Barbato et
al. [2] reported four conformations that collectively should be present in any feasible solution of
the secondary structure. Theses conformations were that of an inverse γ- and type I β-turn, a
helix with φ, ψ values intermediate between an α-and 310-helix, and finally an aperiodic strand.
Additionally, reported molecular dynamics simulations of gp41659−671 [101] revealed the sec-
ondary structure of the peptide varied significantly over the course of the simulation. Both of
these studies suggest a dynamic equilibrium between different secondary structural elements
with no dominant structure emerging.






















Figure 3.4: Far-UV CD spectra of 0.04mM gp41659−671 in Acetate buffer pH 7.57, phosphate
buffer pH 6.93 and H2O pH 7.7.
of gp41659−671 did not vary greatly at high temperatures when compared to those under ambient
conditions. This indicated only a small change in the conformational population and pointed
towards the structure of gp41659−671 being consistent with a flexible conformational ensemble.
It is well documented that under conditions thermodynamically favouring the native structure,
protein structures are not static but in fact fluctuate on a rugged energy landscape that exhibit
many local energy minima [102–104]. The CD spectra reported here are certainly consistent
with a rugged energy landscape characterised by shallow minima. The individual amino acid
residues along the sequence could adopt, transiently, φ and ψ angles typical of secondary struc-
ture elements, or there could be an equilibrium between different conformers at a chain level.
It has previously been proposed that this flexibility was important for the physiological func-
tion of this part of gp41 [2]. When an ensemble of conformers is present whether at residue
or polypeptide chain level, one would expect the peptide to be sensitive to changes in the en-
vironment (i.e. solvent), which may favour the equilibrium of structures towards a particular
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population (or fractional population). It is also possible that different elements of secondary
structures, present at the sequence level, retain different degrees of stability relative to paramet-
ers such as solvent, temperature and pH. It is therefore of interest to investigate whether particular
conformations can be promoted over other competing structures by altering such parameters.
3.4.1.2 Comparison to Simulation
Previous work has focused on investigating the conformational landscape of gp41659−671 and the
stability of previously reported structural motifs [93], by means of MD simulations employing
disparate starting configurations; an α-helix, a type I β-turn, and an inverse γ-turn. This study
made use of replica exchange (parallel tempering) in order to improve sampling of the rugged
energy landscapes, a feat not easily achievable by conventional molecular dynamics simulations.
Having identified the type I β-turn as being an unstable solution motif, attention was switched
to the two remaining energetically competitive motifs. Furthermore, in order to investigate the
competition between these two structures (i.e. α-helix and inverse γ-turn), an array of replicas
was constructed in which the starting configurations rotated (e.g. ABABAB...) thus eliminating
any bias introduced by the starting configuration. The structures encountered at 300K were pre-
dominantly helical (interestingly the initial structure at this temperature was the turn), and were
in contrast to the flexible ensemble predicted experimentally (Fig. 3.4). In fact, the simulations
were only found to be consistent with the data acquired by CD at temperatures in excess of 800K,
at which the peptide was predicted to exhibit increased flexibility and disordered structure. In
comparison to other MD studies [101, 105], the results obtained by means of replica exchange
suggested that the CHARMM22 force field excessively stabilised helical structures at the ex-
pense of other structural elements. The force field therefore introduced an "effective temperature
shift", in which an ensemble of secondary structure elements at residue level was only achievable
at artificially high temperatures.
3.4.1.3 Need for New Force Field
In order to probe the chemical physics associated with structural variation near a membrane sur-
face, it is desired to examine the secondary structure of gp41659−671 in a mixed-solvent using
long-time averaged molecular dynamics simulations. Unfortunately, the previous simulations
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utilising the CHARMM22 force-field revealed that CHARMM22 over-stabilised the helical con-
tent when compared to experimental findings regarding the secondary structure of the peptide.
A recent and thorough study suggested that classical force-fields in general over-express hel-
ical content by excessively stabilising helical content at the expense of other secondary structure
motifs [32]. Furthermore, this study suggested that classical force fields may differ widely in
the regions of dihedral space sampled. Before one can investigate the changes in secondary
structure of gp41659−671 in a mixed-solvent, it is necessary to find a force-field that yields a
better agreement with the results obtained by far-UV CD. To that end, three separate force-fields
were investigated in conjunction with a previously untested starting configuration reported by
Barbato et al. [2] (i.e. unordered conformation). CHARMM22 was used in order to draw com-
parisons with other work using this force-field, but with disparate starting configurations. The
additional two force fields were different versions of the AMBER force field, AMBER-ff03 and
AMBER-ff99SB; both developed from the AMBER-ff99 force field in order to improve the bal-
ance between helical and extended regions of peptide and protein backbones via modifications
to the φ and ψ backbone torsions.
Before analysing the secondary structure in detail, it should be noted that for the purposes
of this work all references to the epitope will be in regards to the historic sequence gp41662−667
(i.e. ELDKWA) rather than the extended sequence proposed by Barbato et al. [2].
Visualisation of the peptide after the initial equilibration revealed a structural change hav-
ing occurred in each of the simulations (Fig. 3.5). Surprisingly, the two AMBER force fields
appeared to display the greater helical content over the epitope.
Analysis of the backbone torsional angles over the initial 1ns for each of the simulations
(Fig. 3.6) clearly showed that the epitope ELDKWA of the peptide was dominated by a helical
secondary structure. In the case of the CHARMM22 model, it was clear that over the course
of the initial 1ns, part of the epitope had additional secondary structure out with that of a helix.
This was identified as belonging to the Asp664 residue. However the Ramachandran plots of the
two AMBER force-fields seemed to indicate that the secondary structures of the amino acids out
with the epitope were more stable over this initial 1ns, as the spread of the angles corresponding
to each amino acid were more localised and not as diffuse.
Visualisation of the peptide after 10ns revealed further structural changes to the peptide in
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Figure 3.5: Secondary Structure of gp41 after equilibration: (a) CHARMM, (b) AMBER-ff03,
(c) AMBER-ff99SB.
the simulations (Fig. 3.7). The simulation using the CHARMM22 force field had folded into
an α-helix, spanning essentially the entire length of the peptide chain. The simulation employ-
ing the AMBER-ff03 force-field however clearly revealed that only the epitope displayed an
α-helical motif, with residues lying out with the epitope adopting a more frayed-like structure.
This structure was very similar to that observed after equilibration, indicating that this arrange-
ment of different secondary structures along the peptide chain may be a stable arrangement
for the AMBER-ff03 system. Visualisation of the simulation employing the AMBER-ff99SB
force-field revealed an α-helical structure that extended beyond the epitope region yet not fully
encompassing the whole peptide sequence.
Analysis of the backbone torsional angles over the last 5ns of each simulation (Fig. 3.8)
revealed that in the system employing the CHARMM22 force field, the main feature of the
Ramachandran plot of the epitope was a compact peak located within the right-handed α-helical
region of dihedral space, with only residue Trp670 presenting a peak outside of this region (loc-
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Figure 3.6: Ramachandran plots of the epitope (left) and full sequence (right) over the initial
1ns: CHARMM (top), AMBER-ff03 (middle), AMBER-ff99SB (bottom)
ated within the left-handed α-helical region). Under the AMBER-ff03 parameterisation, the
main feature was also a compact peak located within the right-handed α-helical region, with the
peak located within the β-sheet region arising from the torsional angles of the Leu661 and Leu669
residues, and the other peak arising from the Trp670 residue. Finally in the system defined by the
AMBER-ff99SB force field, like the other two simulations, the main feature was a compact peak
located within the right-handed α-helical region of dihedral space. The other two peaks out with
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Figure 3.7: Secondary Structure of gp41 after 10ns: (a) CHARMM, (b) AMBER-ff03, (c)
AMBER-ff99SB.
this α-helical region have been attributed to residues Leu669 and Trp670 for the peaks residing
within β-sheet region and left-handed α-helical region respectively.
Bond probability plots offered a means to characterise the nature of the helical structure in
more depth. Analysis of the bond probability distributions over the epitope for i, i + 3 bonds
corresponding to the Hydrogen-bonding in a 310-helix revealed that in the CHARMM22 model,
residues Glu662-Trp666 displayed peaks in the range 2.455 - 2.847Å (Fig. 3.9). This suggested
that these residues possessed some 310 content, however only residue Lys665 possessed a peak
at a distance less than an assumed Hydrogen-bonding threshold of 2.5Å; 1.8-2.5Å is regarded
as a typical H-O distance for a hydrogen bond [106]. Analysis of the AMBER-ff03 model
revealed peaks in the range 2.146 - 2.657Å for residues Leu661-Trp666 and Ser668, with residues
Glu662-Asp664 lying slightly above the 2.5Å threshold (Fig. 3.10). The position of these bond
probability distributions suggested that these residues had some 310 content over the course of the
last 5ns. The bond probability distributions for the AMBER-ff99SB model revealed peaks in the
range 2.253 - 2.657Å for residues Leu660-Trp666 and Ser668, with residues Leu661, Leu663 and
Asp664 lying slightly above the assigned 2.5Å threshold. In fact, only residue Ala667 displayed
a peak considerably out of range of this threshold (Fig. 3.11). As with the AMBER-ff03 model,
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Figure 3.8: Ramachandran plots of the epitope (left) and full sequence (right) over last 5ns of
simulation: CHARMM (top), AMBER-ff03 (middle), AMBER-ff99SB (bottom)
the bond probability distributions for i, i + 3 bonding in the AMBER-ff99SB suggested that
residues Leu661-Trp666 possessed some 310 content; the difference being that in the case of the
AMBER-ff99SB model, residue Leu660 also seemed to possess some 310 content.
The bond probability distributions over the epitope for the i, i+4 bonds which correspond to
the Hydrogen-bonding in an α-helix, revealed that in the CHARMM22 model residues Glu662-




































Figure 3.9: Bond distribution over last 5ns of simulation using CHARMM force-field: (a) i,i+3
bonding, (b) i,i+4, (c) i,i+5
tope, residues Leu660 and Leu661 displayed peaks in the range 2.051 - 2.146Å. Clearly all of these
residues possessed peaks in their bond distributions at distances less than the 2.5Å threshold [106],
suggesting that these residues possessed a strong affinity for participating in α-helices. The
AMBER-ff03 model resulted in bond probability distributions with peaks in the range 2.051-
2.265Å for residues Leu661-Asp664. Once again as these peaks were all at distances below
the 2.5Å cut-off, this suggested that these residues had a significant α-helical content. The
final model AMBER-ff99SB revealed peaks in the bond probability distributions in the range
2.051 - 2.253Å for residues Leu660-Asp664, with residue Lys665 giving a peak centred around
2.764Å (Fig. 3.11). These values clearly suggested that residues Leu660-Asp664 in particular had
a strong α-helical content.
Finally, evaluation of the bond probability distributions for i, i + 5 bonds corresponding to
the Hydrogen-bonding in a π-helix revealed that there was no π-helical content in any of the
three simulations (Fig. 3.9, 3.10, 3.11). This was inferred from the lack of successive peaks











































Figure 3.10: Bond distribution over last 5ns of simulation using AMBER-ff03 force-field: (a)
i,i+3 bonding, (b) i,i+4, (c) i,i+5
On the basis of the above results one could deduce that in the system using the CHARMM22
force-field, the peptide gp41659−671 folded into a helical structure spanning at least residues
Leu660-Leu669, with the Glu659 residue transiently extending this helix. This helical structure
comprised primarily an α-helix however the rare 310-helix did appear to contribute to the struc-
ture of the peptide to some degree on the basis of bond probability distribution analysis. This
conclusion was supported by the torsional angles of the amino acids in question; Leu660-Leu669
all had torsional angles within the right-handed α-helical region of dihedral space; and the bond
probability distribution functions displayed clear i, i+4 and potential i, i+3 Hydrogen-bonding.
In order to highlight the formation and subsequent stabilisation of this helical structure, one can
analyse the secondary structure of each residue as a function of time utilising the STRIDE sec-
ondary structure assignment algorithms [107] (Fig. 3.12). In the case of the CHARMM22 model,
the structure of gp41659−671 became dominated by an α-helical structure spanning residues
Leu660 to Leu669 (residue Glu659 also participated in this helix for considerable periods).









































Figure 3.11: Bond distribution over last 5ns of simulation using AMBER-ff99SB force-field: (a)
i,i+3 bonding, (b) i,i+4, (c) i,i+5
was that of a helical motif spanning residues Glu662-Ser668. As with the CHARMM22 system,
this helix comprised primarily an α-helix with potential 310 content. This was inferred from the
torsional angles of these residues all lying within the α-helical region of dihedral space, whereas
the torsional angles of residues Leu661 and Leu669 fell within the region of dihedral space usually
attributed to β-strands therefore excluding them from belonging to this helix. The results of
the bond probability distribution analysis also supported this hypothesis, showing clear α (and
potential 310) helical Hydrogen-bonding for the residues in question; i, i + 4 peaks appeared
below 2.5Å for residues Glu662-Asp664 indicating Hydrogen-bonding up to and including residue
Ser668. Analysis of the secondary structure of each residue as a function of time using the
STRIDE algorithm supported the interpretation of a helix spanning only residues Glu662-Ser668.
This helix was dominated by an α-helix, yet the residues appeared to transiently adopt 310- and
turn-like structure (cf. CHARMM model which was entirely α-helical). Out with this sequence,
residues Glu659-Leu661 have been assigned a stable turn-like structure, and residues Leu669-
Asn671 have been assigned an aperiodic structure.
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Figure 3.12: Secondary structure of each residue as a function of time: CHARMM (top),
AMBER-ff03 (middle), AMBER-ff99SB (bottom). Pink corresponds to α-helix, blue is 310-
helix, green is turn and white corresponds to unordered.
Finally, the secondary structure of gp41659−671 from AMBER-ff99SB was also that of a
helical motif, spanning residues Leu660-Ser668. As with the other two models, this helix was
dominated by an α-helix with the rare 310-helix contributing to the secondary structure of the
peptide to some degree on the basis of the bond probability distribution analysis for this sys-
tem. This was supported by the presence of i, i + 4 bonds up to a value of i corresponding
to residue Asp664, indicating a Hydrogen-bonding arrangement consistent with an α-helix up
to and including residue Ser668. The torsional angles of the residues showed a successive pop-
ulation in the right-handed α-helical region of dihedral space for residues Leu660-Ser668 also
supporting this interpretation. Subsequent analysis of the secondary structure as a function of
time using STRIDE also supported this interpretation, having revealed a predominantly α-helical
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structure spanning these residues (Fig. 3.12) with the residues out with this sequence adopting an
unordered structure. As with the AMBER-ff03 model, the residues comprising this helical struc-
ture also appeared to transiently adopt 310-like structure and for a considerable period appeared
to form a stable 310-helix spanning the entire length of this helical region.
In summary, the simulations indicated that the structure of gp41659−671 reported by Barbato
et al. comprising of no dominant secondary structure, was not a stable motif. In each of the three
simulations the epitope of the peptide folded into a helical conformation consisting of a mixture
of α (major) and the rare 310-helices (minor), with the degree of mixing being dependent on
the force-field. In each of the three simulations, while the flexibility of the peptide outside of
the epitope was force field dependent, the second Trp residue was not assigned an α-helical
conformation, confirming that the two Trp residues did not fold into this co-operatively under
aqueous conditions. Of the three force-fields used in this study, the CHARMM parameterisation
was clearly the most biased towards a helical structure and this finding was certainly consistent
with the previous in depth study of classical force-fields [32]. Additionally it would appear
that the simulation utilising the AMBER-ff03 force-field gave the best agreement with results
obtained experimentally, in that the model showed the greatest content of secondary structure
over and above that of a helical motif and suggested an ensemble of conformers at the residue
level; the far-UV CD spectra were consistent with a rugged energy landscape indicative of a
flexible conformational ensemble. The AMBER-ff03 model also demonstrated that regardless
of the absence of i, i + 4 hydrogen bonding between the two Trp residues, these residues were
positioned in order to facilitate simultaneous interaction with a membrane surface (Fig. 3.13).
The lack of an α-helical structure spanning these residues may be attributed to this structure
being representative of that under aqueous conditions, and as this peptide is membrane-active
then this folding may only transpire in close proximity to a membrane surface.
However the results of all three simulations still indicated that these force-fields over em-
phasised the helical content in pure water when compared to results obtained experimentally.
In order to enhance the configurational sampling of these systems, parallel tempering (replica
exchange) simulations should be conducted utilising the two AMBER force-fields.
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Figure 3.13: (a) Bond distribution between Trp666 and Trp670 over the last 5ns of each simulation.
(b) Proposed interaction of the Trp residues with the membrane surface. The secondary structure
predicted by AMBER-ff03 reveals that they are orientated in a way to facilitate binding with a
membrane surface. Insert: Side-view reveals that these Trp residues are not perfectly aligned,
potentially indicating that further folding may occur on a membrane surface.
3.4.2 Structural variations due to lower dielectric constant
In order to investigate the effect of the microenvironment that the peptide could experience in the
proximity of the cell membrane, TFE titrations were performed on the peptide solution. The hy-
drophilic solvent TFE is widely known to often induce α-helical structure in short peptides [108–
110], yet some groups have reported stable β-strands in TFE [111–113]. TFE therefore appears
to stabilise the secondary structure for which the amino acid sequence has a propensity [114].
It is also believed to provide a mimic of the microenvironment close to a membrane surface by
lowering the solvent dielectric constant [78]. A concentration of 30% TFE (v/v) was chosen as
the maximum value as this has been reported to mimic the membrane environment more closely
than 100% [115].
In the CD experiments carried out, the ensemble of peptide conformations changed upon
addition of TFE in such a way that there was a shift in the conformer population towards higher
percentages of helical structures. This was indicated by the formation of a band of positive
ellipticity centred around 190 nm, the shift of the negative peak from 199 nm to 205 nm and
the appearance of a small shoulder at around 220 nm (Fig. 3.14). The α-helix is known to
display large CD bands with negative ellipticity at 222 & 208nm and a CD band with positive
ellipticity at 192nm [1, 41–44]. The exact position of the band with negative ellipticity centred






























Figure 3.14: Changes in the far-UV CD spectra of 0.04 mM peptide as a function of % of TFE.
Line: no TFE; dash: 10% TFE; dash and dots: 20% TFE; dots: 30% TFE. The cuvette pathlength
used was 0.2 cm.
protein [116]. Similarly to the α-helix, the 310-helix displays CD bands with negative ellipticity
at 222 & 207nm (the former being a shoulder), with a weak positive band near 195nm. The ratio
of [θ]222 / [θ]207 is found to be much weaker than that of the α-helix. An important factor to
consider therefore was this ratio over the range of concentrations of TFE, while the % helical
content could be followed in a similar fashion (Eq. 3.1). This % was based on the assumption
that a value of -33,000 deg.cm2.dmol−1 is taken for 100% helix content [117].
%Helicity = 100× [θ]222
33000
(3.1)
As evident from these values (Fig. 3.15), there was a clear increase in helical content as the
TFE concentration was raised. The ratio of the [θ]222 / [θ]207 values seemed to indicate a structure
intermediate between an α- and 310-helix, however this value did increase with the increasing
concentration of TFE suggesting the α-helical structure became more dominant.
Mixed water-alcohol solvents have been reported to model a decrease in dielectric constant
effectively, with the effect of various alcohols on a peptide’s secondary structure reportedly de-
pending entirely on the average dielectric constant of the solution rather than the individual prop-
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Figure 3.15: Helical content (solid line) and ratio of [θ222]/[θ207] (dotted line) of 0.04mM
gp41659−671 over various concentrations of TFE.
erties of the alcohols [118, 119]. Having exploited the fluorinated alcohol trifluoroethanol (TFE),
it was therefore of interest to expose any differences between fluorinated and non-fluorinated al-
cohols. Additionally, organic co-solvents are known to promote intramolecular hydrogen bond-
ing through the removal of water molecules in the proximity of the solute (encompassing the
solute in a hydrophobic ‘matrix’) and by lowering the dielectric constant. It was therefore also
of interest to compare the effect of a solvent with comparable dielectric constant, yet which
lacked hydrogen bonding donors. To that end CD spectra of 0.04mM gp41659−671 in 20mM
Sodium Phosphate were recorded in the presence of either methanol (50% v/v) or acetonitrile
(50% v/v); chosen as they had similar dielectric constants to one another and have both been
used previously as mimics for membranes [78, 80, 81, 120].
The changes in the CD spectra (Fig. 3.16) were qualitatively similar to those previously
observed for TFE, with the ensemble of peptide conformations shifting towards a higher helical
content. This was indicated by a red shift in the position of the band of negative ellipticity from
199 to 202 nm, coupled with an increase in the intensity of a negative shoulder centred around
220 nm and the emergence of a positive band around 190 nm. As Trp residues are known to
be capable of contributing to the far-UV CD spectra, Fluorescence spectra were recorded in
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order to investigate potential changes in the microenvironment of the Trp side chains (Fig. 3.17).
N-acetyl tryptophan amide (NATA) was used as a model compound for a completely exposed
Trp molecule; such a control method is necessary when comparing spectra of different solvent
conditions due to such spectra being extremely sensitive to changes in the environment. Upon
addition of each solvent, the changes observed for the peptide were identical to those observed
for the NATA control (Fig. 3.17) indicating that the tryptophans were solvent exposed. These
results were compatible with an increase in helical population with both Trp residues favourably
orientated to interact with a membrane (Fig. 3.13).
Figure 3.16: Far-UV CD spectra of 0.04mM gp41659−671 in 20mM sodium phosphate buffer pH
6.83 (Solid line), in 20mM sodium phosphate buffer and 50% Methanol (Dashed line) and in
20mM sodium phosphate buffer and 50% Acetonitrile (Dotted line).
The mixture of 50% methanol (v/v) resulted in a helical composition of 13%, which was half
of the value obtained for 30% TFE (Fig. 3.15). This may have been due in part to the differences
in the dielectric constant values for these two solvents (with the net dielectric constant of the
mixed solvent being lower in the case of TFE) and/or to the differences in stabilisation of sec-
ondary structure elements by fluorinated solvents [121]. A helical content of 15.9% was obtained
for the mixture of 50% acetonitrile (v/v). As acetonitrile and methanol have a similar dielectric
constant, this small increase in helical fraction may have been evidence of the solvents lack of
hydrogen bond donors further promoting the formation of intramolecular hydrogen bonds.
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Figure 3.17: Changes to the intrinsic Trp fluorescence of the gp41 peptide and 10µM NATA
control due to the presence of (a) 50% Methanol and (b) 50% Acetonitrile.
The solvents used in this mixed-solvent study were all less polar and had a lower dielectric
constant than water. As the dielectric constant has a linear relationship to the number of hydrogen
bonds in solution, both of these factors reduce the total number of hydrogen bonds between
solvent and peptide. This appeared to promote the formation of intramolecular hydrogen bonding
within the peptide, promoting the helical conformation in each of the solvents studied. As these
mixed solvents can mimic the extended regions of a membrane [81], it is therefore natural to
conclude that the secondary structure of the membrane proximal peptide gp41659−671 is more
ordered in its native state near a membrane surface than under simple aqueous conditions. These
results pertaining to the lowering of dielectric constant, appeared to be in greater agreement
with the results of the MD simulations than those obtained under aqueous conditions. This
may be evidence of the force fields over-expressing the helical content in pure water potentially
due to an inability to correctly handle the intermolecular and intramolecular competition for
hydrogen bonding. The AMBER-ff03 model may in reality represent the secondary structure
of this sequence in an environment with a lower dielectric constant than that of water, with
the helical conformation spanning residues Glu662-Ser668 being representative of the increase in
helical composition observed in the CD spectra (Fig. 3.16).
3.4.3 Mimicry via micelles
Here the cumulative partial denaturation effects of a membrane surface were replicated; that of
the negative charges of a membrane [77] and the decrease in dielectric constant near the mem-
brane surface [78–80]. Far-UV CD spectra of 0.04mM gp41659−671 in 20mM sodium phosphate
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buffer were recorded in the presence of varying concentrations of Sodium Dodecyl Sulphate
(SDS). Micellar SDS provides an anionic membrane-mimicking environment [122] and has been
used extensively to study membrane peptides [123–127]. The simplicity of an SDS micelle (as
opposed to liposomes or vesicles) makes it an ideal starting point to study the secondary structure
of the membrane-proximal gp41659−671 and to elucidate the interactions between the peptide and
membrane interfaces [98].
In the CD experiments carried out, the ensemble of the peptide conformation changed upon
addition of SDS with a shift in the population towards higher percentages of helical structures
(Fig. 3.18). This was indicated by a red shift in the band of negative ellipticity, the formation
of a positive band around 190 nm and the emergence of a shoulder centred around 227-228 nm.
This latter band appeared at higher wavelengths when compared to the classical 220 nm position
of the α-helix, suggesting a major contribution to the CD spectra from the Trp residues (known
to give rise to bands in this region [128]). As this band has so far only appeared in the presence
of SDS, this may be evidence of the two Trp residues folding into the proposed helical structure
in order to directly interact with the micelle surface. Fluorescence spectra of gp41659−671 in the
presence of micelles revealed that the microenvironment of the Trp residues was indeed altered
(Fig. 3.19a), with the shift towards lower wavelengths being indicative of the microenvironment
of the Trp residues becoming less polar [71]. As this difference between the NATA control and
the peptide was only found in the presence of micellar SDS (Fig. 3.19b), it implied membrane-
mediated folding of the peptide upon the interaction of the tryptophan residues with the micelle.
The first step of the interaction between Trp-rich antimicrobial peptides and membranes is
an electrostatic association between these positively charged peptides and the negatively charged
micelles [129]. As the sequence gp41659−671 carried an overall charge of -2 (localised towards
the N-terminus of the peptide) at neutral pH, it was important to investigate the electrostatic
interactions between this peptide and the negatively charged head groups of SDS via variations
in the pH of the sample. Far-UV CD spectra of gp41659−671 in 20mM sodium phosphate and
7mM SDS under neutral, acidic and basic conditions were subsequently recorded (Fig. 3.20).
Under acidic conditions, SDS-induced α-helical folding appeared to be further enhanced.
This was evident through the increased intensity in the band of positive ellipticity and the appear-
ance of an additional negative shoulder near 220nm; no such increase was detected in the CD
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Figure 3.18: Changes in the far-UV CD spectra of 0.04 mM peptide in 20mM Phosphate buffer
due to increasing concentrations of SDS at 25◦C. Above the cmc all changes are completed.
Figure 3.19: (a) Intrinsic Trp fluorescence of the gp41 peptide in the presence of different con-
centrations of SDS below (3mM) and above (6, 9, 12 mM) the cmc. (b) Intrinsic Trp fluorescence
of 10µM NATA in the presence of different concentrations of SDS.
spectra of 0.04mM gp41659−671 in 20mM sodium phosphate in the absence of SDS (Fig. 3.21).
However under basic conditions this SDS-induced folding was weakened, as the major negative
band was blue shifted and accompanied by a decrease in the intensity of the positive band centred
around 190nm.
This structural sensitivity due to pH was only manifested in the presence of SDS micelles; the
presence of micelles for all pH values was confirmed using dynamic light scattering (Fig. 3.2b).




























Figure 3.20: Changes in the far-UV CD spectra of 0.04 mM peptide in 20mM Phosphate buffer





















Figure 3.21: Changes in the far-UV CD spectra of 0.04 mM peptide in 20mM Phosphate buffer
at pH 6.83 (solid line) and pH 2.14 (dashed line).
interaction between the negatively charged head groups of SDS and the charged residues of
gp41659−671. As mentioned above, under neutral conditions it appeared that the Trp residues
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(positioned at i and i+4) folded into an α-helix in order to interact with the membrane surface. A
strong electrostatic interaction between the Glu662 and Lys665 residues (potentially resulting in a
competing i, i+3 electrostatic intra-helical interaction) would also be present; such an interaction
was supported by all three of the MD simulations which revealed potential 310 hydrogen bonding
between these residues (Fig. 3.22).
Figure 3.22: Bond distribution between Glu662 and Lys665 over the last 5ns of each simulation.
As the two Trp residues bind to the surface of the micelle, the positively charged Lys residue
would be attracted to the negatively charged surface and may potentially act as an ‘anchor’ for
this helix. There would subsequently be a strong electrostatic repulsion between the anionic
head groups of SDS and the Glu662 residue, destabilising this 310-helix. Coupled with the strong
electrostatic repulsion between the anionic SDS head groups and Asp664, this would result in
the N-terminal part of gp41659−671 adopting a more frayed-like structure directed away from
the micelle surface. Under acidic conditions, the carboxylic acid groups of the Glu and Asp
residues would be protonated, therefore removing the electrostatic repulsion between the neg-
atively charged groups of the peptide and micelle. This protonation subsequently results in the
co-operative folding of ELLELD into a helical structure with the sequence spanning the two Trp
residues. Finally under extreme basic conditions, deprotonation of the Lys residue also removes
the i, i + 3 electrostatic interaction and the electrostatic repulsion between the anionic species
increasing and affecting the ability of the two Trp residues to successfully bind to the micelle.
This is certainly consistent with the results obtained for the full MPR sequence [94], and sug-




Interestingly, an independent study investigating pH dependence on the secondary structure
of a peptide (both under aqueous and micellar SDS environments) found that while the aqueous
structure was highly dependent on the pH of the system, the secondary structure promoted by the
micelle did not vary greatly under the pH conditions tested [130]. Such a result was claimed to
be expected due to the interaction with SDS potentially imposing constraints on any structural ef-
fects caused by variations in the pH. By contrast, we found appreciable pH tuneability suggesting
that gp41659−671 is structurally flexible even in close proximity to a membrane surface.
3.5 Conclusions
The structural properties of the HIV peptide gp41659−671 have been studied using mixed solvents,
anionic micelles and MD simulations in order to mimic the distinct local environments relevant
to viral fusion. The results revealed gp41659−671 presented an independent capability to interact
with a membrane surface, with different segmental secondary structures being adopted during the
fusion process. The bias towards helical folding could be tuned by pH variation to the extent that
the membrane proximal peptide showed no defined fold type at basic pH and that it was helical
near physiological and lower pH environments. This was in contrast to results obtained in the
absence of membrane mimicking SDS, which revealed no such control of helical folding by pH
under aqueous conditions. The pronounced sensitivity to standard empirical potentials was also
explored and it was concluded that AMBER-ff03 provided a reasonably accurate description of
the solution state structures and provided a marked improvement over the previously employed
CHARMM force field, which substantially overestimated the helical population. On the basis
of this force field study, it would be interesting to determine if the AMBER-ff03 force field




Membrane binding: Structure variations of
gp41532−544:659−671 in the hemifusion phase.
4.1. RATIONALE
4.1 Rationale
In the previous chapter, the flexibility of the membrane proximal region (MPR) of the HIV-
1 gp41 envelope was investigated by focusing on a very short MPR fragment, gp41659−671.
The flexibility of this region is believed to be relevant to its biological function, therefore it is
important to consider what role gp41 fills in the infection process of HIV.
A critical step in this infection process is the gp41-mediated fusion between the viral en-
velope and the cellular membrane, which is driven by a sequence of conformational changes
in the gp41 ectodomain (i.e. the domain that extends into the extracellular space and initiates
contact with the surface of the host cell). Current evidence suggests that the protein initiates
host membrane binding through a pre-hairpin intermediate, serving as a bridge between the two
membranes. In this pre-fusion phase, three gp41 monomers are held together in parallel by a
trimeric coiled-coil domain formed by the N-terminal heptad repeat 1 (HR1) regions; a heptad
repeat consists of a repeating pattern of seven amino acids. It is this phase which is attractive for
therapeutic intervention as the relatively long conformational exposure of the structure renders
it rate-limiting [131]. As such, primary anti-HIV strategies constitute peptides and neutralising
antibodies targeting HR1 in order to inhibit the helical transition of the C-terminal heptad re-
peat 2 (HR2) region and the refolding of the pre-hairpin into a core structure designated the
six-helical bundle (6HB). This transition catalyses the fusion process by forcing the viral and
cell membranes into close proximity with one another, resulting in hemifusion or stalk interme-
diates. The formation of these mixed lipidic structures suggests that two membrane proximal
regions, the C-terminal membrane proximal external region (MPER) and the N-terminal fusion
peptide proximal region (FPPR), may have a significant and potential regulatory role in the fu-
sion process. These two regions link the 6HB to the cell and viral membrane-inserted domains,
termed the fusion peptide (FP) and transmembrane region (TMR) respectively (Fig. 4.1), and are
believed to be involved in the lipid-mixing phase.
It is reasonable to hypothesise that the two domains that are aligned within the 6HB should
contain peptide sequences which exhibit mutual interactions dependent upon their membrane
environments [132, 133]. Before fusion, these stretches are in close proximity within the en-
velope spike (Env) and share the viral membrane environment; within the envelope spike, the
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Figure 4.1: Schematic representation of gp41 regions in the 6HB, revealing the peptide sequences
of interest.
gp41 ectodomain is wrapped by the gp120 trimer. These stretches then separate during the pre-
fusion phase, before coming together again in a different environment (including the host cell
membrane) upon the formation of the 6HB [132, 133].
The conserved primary structure of MPER sequences has prompted suggestions that the
MPER exhibits autonomous interactions with membrane interfaces, with recent investigation
demonstrating the membrane insertion of the MPER within the gp41 trimer [3]. The crystal
structure of gp41 includes both proximal regions, and implies that these regions may arrange into
an ordered (and possibly aligned) assembly beyond the core thereby contributing to the fusion
reaction. Furthermore, the hydrophobic residues of the MPER have been observed to be binding
determinants in the interactions with the FPPR [133], which would appear to be supported by
the investigation into gp41659−671 in the previous chapter; the results of which suggested that
the Trp666 and Trp670 residues were important in MPER-membrane interactions, and the stretch
was capable of self-regulated membrane binding in response to pH and potentially (due to the
involved electrostatics) to the membrane composition itself. It is therefore of interest to probe
whether this membrane activity could be co-regulated with a matching FPPR stretch.
A series of studies have been aimed at the elucidation of the structure-activity relationships
of the fusion inhibitor DP178 (or T20) peptide, which spans the gp41643−678 stretch comprising
the HR2 and a portion of the MPER [134, 135]. Interestingly, it would appear that it is the
MPER portion of this peptide which determines not only the membrane interactions of T20, but
also its inhibitory potency [94, 135–138]. T20 is known to inhibit membrane fusion at a post-
lipid mixing phase, yet lacks the coiled-coil binding residues of HR1 which are believed to be
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necessary for preventing HIV-1 entry. Furthermore, T20’s inhibitory activity directly correlates
with its ability to bind at membrane surfaces [139] and with its enhanced interactions with the
6HB incorporating the gp41530−544 FPPR region [136], which is consistent with recent studies
suggesting T20 strongly binds to the gp41532−546 region [137]. In total, this data would imply
there is a specific membrane-bound inhibitory stretch for T20 within the FPPR, and on the basis
of the presented stretches, it would appear to be the gp41532−544 region.
4.2 MPER-FPPR stretch pair selection
Having previously investigated the conformational preferences of the sequence gp41659−671 in
Chapter 3, it stands to reason that this region would define the choice of stretch pair. The
gp41659−671 sequence itself, which spans the N-terminal portion of the MPER and part of the
HR2, has been identified as the epitope for the mAB 2F5 believed to block MPER-FPPR in-
teractions in the hemifusion phase [133, 134, 140, 141]. Furthermore, this sequence has been
comprehensively studied under a variety of conditions including solution, micellar and phosphol-
ipid environments [2, 86, 91, 94, 97, 138, 141]. Within the crystal structure of gp41, gp41659−671
was found to be aligned with gp41532−544 (Fig. 4.2), which was regarded as the prime choice
for the FPPR stretch. Both the gp41659−671 and gp41532−544 stretches are terminal extensions
of their corresponding HR regions, and it is theorised that the degree to which they fold into a
helical structure is regulated by the 6HB.
As with gp41659−671 and the FP (gp41512−528), the FPPR stretch was expected to be con-
formationally polymorphic and display environmental sensitivity [142, 143]. Studies utilising
the N- and C-terminal fragments of the FP-FPPR sequence (gp41512−541) have suggested that
the FP and FPPR interact independently from one another with membranes at various steps dur-
ing the fusion process [134, 144]. Therefore it was of considerable interest to probe the folding of
the C-terminal portion of the FP-FPPR (i.e. gp41532−544), both individually and in combination
with the “complementary” gp41659−671. Such an investigation was hoped to reveal the extent
to which the interplay between the two sequences could be modulated by changes in membrane
model environments.
The gp41532−544 peptide is a highly conserved motif across all isolates of HIV-1,HIV-2 and
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Figure 4.2: Crystal structure of 6HB [3], revealing close proximity of gp41532−544 (Green) and
gp41659−671 (Blue).
SIV and carries a general sequence HTLTV, where H (gp41535) is hydrophobic and predom-
inantly Leu or Ile [133, 145], and in some instances Met (e.g. B-HXB2R) [3]. This motif is
regarded as being prone to β-sheet formation, suggesting conformational bias upon membrane
binding.
4.3 Model environment
In order to examine the interactions between the proximal regions during the fusion process,
it was therefore important to study such systems within a membrane environment. Previous
lipid studies of the gp41-mediated HIV fusion involved specific gp41 regions and focused on in-
vestigating conformation-stabilising interactions [146, 147]. Additional studies have concerned
the impact of lipids on mAbs targeting gp41: interactions involving the mAb 4E10 were found
to extend beyond those with the MPER epitopes and relied upon binding with the viral mem-
brane [148–150], while the binding of the mAb 2F5 was reported to be stabilised by an extra
docking site in the membrane [150–152]. As this investigation contained herein focused on the
interaction interplay upon membrane binding, the reciprocal response of the two stretches were
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investigated under different membrane environments. As the stretches are located in proximity
to the viral (gp41659−671) and host cell (gp41532−544) membranes during the pre-hairpin phase,
zwitterionic and anionic phospholipid vesicles (mimicking mammalian and viral membranes re-
spectively) were chosen to emulate the lipid environments during the pre-fusion and hemifusion
phases.
4.4 Materials & Methods
4.4.1 Synthesis of peptides and membranes
Peptide synthesis was performed by the National Physical Laboratory (NPL) on a Liberty sys-
tem (CEM Corporation). The peptides were assembled on a rink amide MBHA resin (100 µM
scale) using standard solid-phase N-(9-fluorenyl)methoxycarbonyl (Fmoc) -based protocols with
HCTU/DIPEA as coupling reagents. Synthesised peptides were purified by RP-HPLC following
post-synthetic deprotection and work-up. The final constructs were identified by MALDI-ToF
mass-spectrometry with α-cyano-4-hydroxycinnamic acid as the matrix.
Dilauryl phosphatidylcholine (DLPC) and its mixtures with dilauryl phosphatidylglycerol
(DLPG) (Avanti Polar Lipids) were used by the National Physical Laboratory (NPL) to pre-
pare zwitterionic and anionic membranes respectively using previously published protocols [153,
154]. Unilamellar vesicles of DLPC and DLPC-DLPG (3:1 molar ratio) were prepared by dis-
solving dry lipids in chloroform/methanol (2:1 v/v) followed by evaporating the solvents and
hydrating the residue to 10 mg ml−1 total lipid concentration in 10 mM phosphate buffer, pH
7.4. The suspension was then extensively vortexed, sonicated (30◦C), filtered (up to twenty
times, polycarbonate filter, 0.1 µm) to give a clear solution, and analysed (100 nm) by photon
correlation spectroscopy.
4.4.2 UV-visible spectroscopy
The concentrations of the peptide solutions were determined spectrophotometrically using the
calculated extinction coefficients at 214 nm for gp41532−544 (ε214 = 11852 M−1 cm−1) and 280
nm for gp41659−671 (ε280 = 14000 M−1 cm−1) - calculated from established techniques [155]
and used previously [91, 156].
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4.4.3 Circular Dichroism (CD) measurements
Far-UV CD spectra were recorded on a Jasco J-810 spectropolarimeter (Japan Spectroscopic
Co., Tokyo) fitted with a Peltier unit for temperature control. The spectra were the average
of three accumulations in step mode (data pitch of 1 nm, response time of 8s, bandwidth of 1
nm) acquired in rectangular cuvettes of 0.1 cm path length (unless otherwise stated) at 25◦C.
For every sample, an appropriate solvent spectrum was recorded under identical conditions and
subtracted from the corresponding sample spectrum. The data collected was expressed in molar
ellipticity (deg.cm2.dmol−1) and spectra recorded in the presence of synthetic membranes were
for the lipid/peptide ratio of 40:1 (1.6mM lipid).
CD spectra with an extended range of wavelengths were acquired at Diamond Light Source
(Beam-line 23) using a synchrotron radiation CD spectropolarimeter. CD spectra for individual
peptides and their equimolar mixtures were acquired at 0.2 mM (total peptide concentration)
using a quartz cuvette with 0.02 cm path length at the stated lipid/peptide ratios and solvent
conditions. Experimental mixtures were compared with spectra derived from linear combination





All measurements performed at Diamond were taken in mdeg and for individual peptides,
converted to mean residue ellipticity, [θ]. Spectra for gp41532−544:659−671 were not converted in
order to provide a clear comparison with the linearly combined individual spectra.
4.4.4 Fluorescence Spectroscopy
Tryptophan fluorescence was measured with a LS55 (Perkin Elmer Instruments, Massachusetts,
USA) at 25◦C using a 1cm quartz cuvette (Hellma GmbH, Germany) and 0.04mM protein solu-
tion. To selectively excite the tryptophan an excitation wavelength of 295 nm (2.5nm excitation
slit) was used. The spectra were acquired from 300 to 400 nm (emission slit 6nm) and subtracted




Two unit cells were set up, each comprising of one gp41532−544 molecule with zwitterionic
termini, 1853 water molecules and 1 chloride counter ion in order to ensure charge neutral-
ity. The starting configurations of gp41532−544 were based on the crystal structure of the 6HB
(Fig. 4.2) and on the unordered configuration reported by Barbato et al. [2] and employed pre-
viously for gp41659−671 [156]. The latter was achieved through mutation of the gp41659−671
sequence through inbuilt features of the Visual Molecular Dynamics (VMD) software [157]. A
further unit cell was set up, which comprised one gp41532−544 molecule and one gp41659−671
molecule (both with zwitterionic termini and based on the unordered configuration) in an anti-
parallel arrangement, 1853 water molecules and 1 sodium counter ion in order to ensure charge
neutrality.
In each simulation, the molecules were arrayed on a cubic lattice with random molecular
orientations in a cubic box of length 38.2Å. The rigid, non-polarisable, three-site TIP3P em-
pirical force field was used to describe the water molecules, the AMBER-ff03 force field was
employed to describe the peptides, while the PINY simulation package was employed to per-
form the simulations [99]. The system was equilibrated at 300K in the canonical ensemble for
150ps with a time-step of 0.5fs to anneal out unphysical contacts. The system was then run for
150ps with a time step of 0.5fs in the isothermal-isobaric ensemble to allow for spatial relaxa-
tion. The system was then run for a further 150ps in the canonical ensemble with a time-step
of 1fs being employed, before a production run of 15ns using a time-step of 2.5fs from which
all data was collected. Periodic boundary conditions were employed and long-range interactions
were evaluated via Ewald summation.
4.5 Results
4.5.1 GP41532−544
Before moving onto the gp41 peptides in the presence of membrane mimetics, it was imperative
to study the structural properties of gp41532−544. To that end, structural investigation of the FPPR
gp41532−544 was conducted under identical conditions to those used for the MPER counterpart
gp41659−671, chosen in order to mimic the distinct physical and chemical environments that
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this sequence may be exposed to during the viral fusion process; under aqueous and mixed
solvent conditions mimicking the diffuse layers of varying dielectric constant, and with surfactant
solutions mimicking the interfacial contact regime.
Under aqueous conditions, gp41532−544 did not fold into a dominant secondary structure with
the shape of the recorded far-UV CD spectra indicating an unordered confirmation (Fig. 4.3) and,
as with the far-UV CD spectra of gp41659−671, was consistent with a flexible conformational
ensemble. As such an ensemble could be characterised by an equilibrium between different
conformers at a chain level or individual amino acid residues along the sequence adopting, tran-
siently, φ and ψ angles typical of different secondary structural elements, it was important to






















Figure 4.3: Far-UV CD spectra of 0.04mM gp41532−544 in 10mM phosphate buffer.
Visualisation of the simulation of the initial helical gp41532−544, revealed that the structure
had not varied significantly from its initial configuration (Fig. 4.4a), and was defined by a slightly
curved helix. Analysis of the secondary structure of each residue revealed that the simulation
predicted a stable α-helical motif spanning the residues Ala532-Arg542, and transient 310-helical
structure over the Ala541-Gln543 residues (Fig. 4.5). This was supported by the backbone tor-
sional angles for the peptide over the last 5ns of the simulation, which presented a compact peak
within the right-handed α-helical region of dihedral space (Fig. 4.4b).
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Figure 4.4: (a) Structure after 15ns of initially ‘helical’ simulation of gp41532−544, revealing
continuance of helical motif. (b) Ramachandran plot of the simulation over the last 5ns.
Figure 4.5: Secondary structure of each residue of the initially ‘helical’ gp41532−544 as a function
of time. Pink corresponds to α-helix, blue is 310- helix, green is turn and white corresponds to
unordered.
This simulation therefore appeared to suggest that the helical conformation was indeed a
stable structural motif for this peptide, however such secondary structure was not found experi-
mentally under aqueous conditions. As highlighted in Section 3.4.1.3, it has been suggested that
classical force fields over express helical content and that different force fields may differ widely
in the regions of dihedral space sampled [32]. Furthermore, from the previous investigation
into starting structure bias introduced in Section 3.4.1.2, CHARMM22 appeared to introduce an
“effective temperature shift” and trap the simulation within a helical well on the energy land-
scape [93]. The simulation of gp41532−544 starting from the helical conformation may therefore
have experienced the same obstacle, in that the AMBER-ff03 force field was not capable of fully
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sampling the energy landscape. However in the investigation of gp41659−671 in Chapter 3, the
AMBER-ff03 force field was found to yield a significant improvement over the CHARMM22
parameterisation, therefore it was important to consider simulating the peptide from a different
starting structure.
In preparation for simulating a dimeric system consisting of gp41532−544:659−671, it was de-
cided to simulate gp41532−544 starting from the same initial configuration as used previously for
gp41659−671 - the unordered structure reported by Barbato et a. [2]. Firstly, this would allow for
a direct like-for-like comparison between the two peptide simulations, ensuring that differences
in the simulated structures were a result of the influence that the primary amino-acid sequence
had on the folded conformations and not as a result of a bias introduced by the starting structure.
Secondly, it would allow for the structures predicted from an initially unordered dimeric system,
to be compared directly to the individual monomeric counterparts, therefore revealing whether
the presence of one peptide influenced the conformational space sampled by the other.
The simulation of the initially unordered gp41532−544 monomer revealed the secondary struc-
ture of the peptide to be comprised of two helical regions, with a kink localised on the Thr538
residue which appeared to act as a hinge between these two regions (Fig. 4.6a). This was con-
firmed by analysis of the backbone torsional angles over the last 5ns of the simulation (Fig. 4.6b)
which revealed that the main feature of the Ramachandran plot was a compact peak located with
the right-handed α-helical region of dihedral space, with only the Thr538 residue presenting a
peak outwith this region (located within the left-handed α-helical region).
!"#$ !%#$
Figure 4.6: (a) Structure after 15ns of initially ‘unordered’ simulation of gp41532−544, revealing
kinked helix. (b) Ramachandran plot of the simulation over the last 5ns, identifying Thr538 as
the only amino acid outside right-handed α-helical region.
In order to probe the stability of the two helical regions over the course of the simulation,
the STRIDE secondary structure algorithm was employed to follow the secondary structure of
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each residue with respect to time (Fig. 4.7). This revealed that the structure after the equilib-
ration phase was dominated by a mixture of turn-like and 310-helix motifs. Within 1ns of the
simulation, the structure over the sequence Ala532-Leu537 was dominated by an α-helical motif
which persisted over the remainder of the 15ns simulation. The C-terminal was found to be more
dynamic, displaying a mixture of turn, 310-, and α-helical content. While this region was ini-
tially dominated by turn-like motifs, the sequence Val539-Gln543 was found to adopt a primarily
310-helical structure as the simulation progressed. In comparison to the simulation starting from
the initial helical conformation, both parameterisations predict the peptide to adopt a predom-
inantly helical structure (a structure not observed experimentally) characterised by an α-helical
N-terminus and a C-terminal defined by a mixture of turn, α- and 310-helix (the exact ratio being
dependent on the initial configuration).
Figure 4.7: Secondary structure of each residue of the initially ‘unordered’ gp41532−544 as a
function of time. Pink corresponds to α-helix, blue is 310- helix, green is turn and white corres-
ponds to unordered.
Having started from the same initial structure as the simulation of gp41659−671 (Fig. 3.3), it
was therefore reassuring that the simulation predicted different conformations than those found
in the previous model and did not fold into the same structure regardless of the major differences
in primary sequence. Furthermore, as the simulation of gp41659−671 predicted a rigid helix over
Glu662-Ser668, the dynamic nature of the C-terminal of gp41532−544 would indicate that this
FPPR peptide should exhibit a better conformational responsiveness than it’s MPER counterpart.
With a view to probing the various structural motifs that gp41532−544 could explore, it was
important to study the system under conditions mimicking the environmental changes implicated
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in the fusion process, e.g. dielectric constant fluctuations and interfacial interactions [81, 152].
As such, it was decided to subject this peptide to the same organic solvents and surfactant-
containing buffers previously used in conjunction with gp41659−671, i.e. TFE, SDS, acetonitrile,
and methanol.
As with the MPER gp41659−671, titration of gp41532−544 with TFE resulted in a shift in the
conformer population towards higher percentages of helical structures (Fig. 4.8a). This was in-
dicated by the formation of a band of positive ellipticity centred around 190 nm, the shift of the
negative peak from 197 nm to 206 nm and the appearance of a small shoulder at around 224
nm. The stabilisation of such a motif was not unexpected as the simulation predicted a pre-
dilection for a helical conformation, and TFE is known to stabilise the secondary structure for
which the amino-acid sequence has a propensity [114]. Other mixed-solvent conditions (50%
Methanol and 50% Acetonitrile, v/v) similarly resulted in the ensemble of peptide conforma-
tions shifting towards a higher helical content (Fig. 4.8b), with the changes in the CD spectra
being qualitatively similar to those observed in TFE. The promotion of intramolecular hydrogen
bonding within the peptide, resulting in the gp41532−544 folding into a helical conformation, was
no doubt a result of the lower dielectric constant of these solvents. Due to these mixed solvents
being mimetics of the extended regions of a membrane [81], it can be concluded that similarly
to its MPER counterpart, the secondary structure of the FPPR gp41532−544 is more ordered in its















































10mM PB, 50% MeOH
10mM PB, 50% AcCN
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Figure 4.8: Far-UV CD spectra of 0.04mM gp41532−544 in 10mM phosphate buffer (red) and (a)
20% (green) & 60% (blue) TFE, and (b) 50% Methanol (green) & 50% Acetonitrile (blue).
In Section 3.4.3, the cumulative partial denaturation effects of a membrane surface were in-
vestigated utilising micellar SDS, providing an anionic membrane-mimicking environment. As
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the FPPR stretch should be located near the host cell membrane, it would be more appropriate
to investigate the structural changes in a zwitterionic (mammalian) membrane-mimicking en-
vironment rather than SDS. However, it was important to be consistent in the samples used for
conformational sampling, while at the same time it was interesting to probe electrostatic im-
plications; variations in the pH were exploited to probe the electrostatic interactions between
gp41659−671 and the negatively charged head groups of SDS, therefore it was of considerable
interest to probe such interactions with the positively charged species gp41532−544.
Far-UV CD spectra of gp41532−544 were recorded in the presence of both non-micellar and
micellar SDS (Fig. 4.9). The spectra revealed a concentration-dependent folding in micellar SDS
(12mM), with the peptide folding into a helical structure at concentrations of 40 µM, while it was
found to adopt a β-structure at higher concentrations of 240 µM; concurrently, at non-micellar
concentrations (3 mM), gp41532−544 folded into a β-sheet structure at both concentrations. This
was inferred from the formation of a band of positive ellipticity at 195nm plus a negative band
between 215-220nm, and a positive band centred at 190nm plus two bands of negative ellipticity
at 205nm & 220nm, for the β-sheet and α-helical structures respectively. Such a concentration-
dependence polymorphism was not observed in the gp41659−671 peptide, suggesting that the














































Figure 4.9: Far-UV CD spectra of (a) 0.04mM and (b) 0.24mM gp41532−544 in 10mM phosphate
buffer (red), 3mM (green) and 12mM (blue).
With regards to gp41659−671, the stabilisation of a helical conformation in organic solvents
was attributed to the solvent locking the peptide within a hydrophobic matrix of intramolecular
hydrogen bonds (Section 3.4.2). In the case of gp41532−544, it would appear that such a confirm-
ation could be compromised by non-specific charge interactions between the positively charged
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gp41532−544 and the anionic SDS monomers (i.e. at concentrations below cmc). At concen-
trations above the cmc, SDS micelles provide an extensive surface support (resembling a bulk
organic phase), and by lowering the local dielectric constant, reduces hydrogen bonding between
the micellar surfaces and peptide favouring structures that are stabilised intramolecularly (i.e.
helices). The concentration dependence would appear to indicate that upon increasing peptide
concentration, peptide-SDS electrostatic interactions recover β-sheet conformations, predomin-
antly stabilised by peptide-peptide and peptide-solvent intermolecular hydrogen bonding.
4.5.2 Monomers at membrane environments
In order to asses the ability of the host-cell lipid environment to induce folding, both gp41532−544
and gp41659−671 were investigated in the presence of zwitterionic membranes. None of the
acquired far-UV CD spectra displayed any appreciable secondary structure at either neutral or
acidic pH levels (Fig. 4.10). The lack of folding in the gp41532−544 stretch was inline with the
current fusion models which describe the FP as inserting into the cellular membrane without







































Figure 4.10: Far-UV CD spectra of (a) 0.2mM gp41659−671 and (b) 0.2mM gp41532−544, in the
presence of 1.6mM zwitterionic membranes and 10mM PB (red) or H2O, pH 3 (green).
The native environment of gp41659−671 in both the pre-fusion and hemifusion phases was
subsequently emulated utilising anionic vesicles; in both phases, the gp41659−671 stretch is in
the proximity of the viral membrane where it has been reported to remain unfolded [158, 159].
No folding was observed in the recorded far-UV CD spectra of gp41659−671 in anionic mem-
branes, irrespective of peptide concentration or pH (Fig. 4.11a). The partial structuring of this
stretch in SDS micelles was a result of pH-induced conformational locking of the gp41666−670
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Trp span, therefore changes in the microenvironment of the span were probed using intrinsic
fluorescence in order to probe whether the locking was a pre-requisite for the hydrophobic in-
teractions with the anionic membrane. As there were no observed shifts in the fluorescence
spectra for gp41659−671 with and without lipids (Fig. 4.11b), this indicated that there were neg-
ligible changes in the microenvironment and there were no folding-related interactions of the
stretch. This was supported by linear dichroism (LD) measurements conducted on this peptide
in the presence of anionic vesicles [160], which suggested that the peptide adopted an unfolded











































Figure 4.11: (a) Far-UV CD spectra of 0.19mM gp41659−671 in the presence of 1.6mM anionic
membranes and 10mM PB, pH 7.5 (red) or H2O, pH 3 (green). (b) Normalised Trp fluorescence
of 0.04mM gp41659−671 (red) and in the presence of anionic membranes (blue).
In contrast to the observations made in neutral membranes, far-UV CD spectra of gp41532−544
in anionic vesicles were characteristic of a β-sheet structure. This folding was not found to be
dependent on the concentration of the protein (Fig. 4.12a) as was observed for the peptide in the
presence of micellar SDS (Fig. 4.9). However, such folding was found to be pH-dependent, with
a transition to a random coil being observed upon lowering the pH (Fig. 4.12b). As this res-
ulted in charge quenching of the anionic membrane, such a transition implied that electrostatic
interactions were decisive for the membrane-mediated folding of gp41532−544.
Far-UV CD spectra of increasing amounts of the membrane solution (Fig. 4.13) revealed
that the folding was complete at a ratio of 10:1, at which point gp41532−544 was essentially
100% membrane-bound. The folding of a β-sheet structure was supported by LD measurements
conducted on this peptide in the presence of anionic vesicles, with the spectra indicating a β-sheet




































Figure 4.12: Far-UV CD spectra of (a) 0.04mM gp41532−544 (red) & 0.4mM gp41532−544
(green), and, (b) 0.24mM gp41532−544 in 10mM phosphate buffer, pH 7.5 (red) or H2O, pH
3 (green) - all in the presence of 1.6mM anionic membranes.































Figure 4.13: Far-UV CD spectra of 0.04mM gp41532−544 in the presence of increasing concen-
trations of anionic membranes.
The stability of gp41532−544 and gp41659−671 was investigated by following the thermal
transitions of these peptides in the presence of anionic membranes. As was expected, far-UV
CD spectra of gp41659−671 in such an environment were characteristic of unfolded structures
over several temperatures (Fig. 4.14a). However, far-UV CD spectra of gp41532−544 and anionic
vesicles suggested a stabilisation of the β-structure at temperatures in excess of 40◦C; charac-
terised by an increase in intensity for the band of positivity ellipticity at 196 nm, and a shift in
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the negative band to 218 nm (Fig. 4.14b). This was attributed to extended surface contacts as a
result of increased lipid migration, which is in agreement with the temperature-dependent lipid
motion from a solid (gel) phase at 20◦C through a rippled phase at >40◦C, into a fluidic phase
at 60◦C [161]. A caveat of such lipid migration, is that an increase in lipid diffusion must be
matched with a sufficient peptide concentration in order to provide ample coverage and binding.
This is exemplified by gp41532−544 at lower concentrations, which underwent thermal unfolding
(Fig. 4.14c). As it is suggested that the fluidic phase is the best mimetic of biological membranes,
it stands to reason that the observed increase in folding supports a cooperative and responsive



















































































Figure 4.14: Far-UV CD spectra of (a) 0.04mM gp41659−671 , (b) 0.037mM gp41532−544 and (c)
0.008mM gp41532−544, in the presence of 1.6mM anionic membranes over a range of temperat-
ures.
4.5.3 Dimer System
In order to investigate whether the gp41532−544 and gp41659−671 sequences fold cooperatively
with one another, far-UV CD spectra of an equimolar mixture of gp41532−544:659−671 in 10mM
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PB were recorded. Utilising the quantitative nature of CD, this spectra was directly compared
to a ‘theoretical’ linear combination of the individual monomeric spectra for gp41532−544 and
gp41659−671 (Eq. 4.1). Such a comparison would highlight any structural variation resulting
from the cooperative folding of the dimeric system. However, as was expected, no appreciable
structuring was observed under aqueous conditions, with the shape of both spectra being repres-
entative of an unordered confirmation (Fig. 4.15a). Furthermore, such a comparison was exten-
ded to include the equimolar mixture of gp41532−544:659−671 in 10mM PB and either 20% TFE,
50% Acetonitrile, or 12mM SDS (Fig. 4.15b-d). In each condition tested, the linear combination
of the monomeric spectra was revealed to be essentially identical to the far-UV CD spectra re-
corded for the equimolar mixture. This not only supported the finding that these sequences did
not fold cooperatively in the absence of membranes, but also revealed that induced pre-folding
(arising from the solvents used; Acetonitrile, TFE, and SDS) was not sufficient to promote the























































Figure 4.15: Far-UV CD spectra of equimolar gp41532−544:659−671 (red) compared to the linear
combination of the monomeric spectra (green) in (a) 10mM phosphate buffer, (b) 50% Acetoni-
trile, (c) 12mM SDS, and (d) 20% TFE.
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Having simulated the individual monomers from a predominantly unordered confirmation,
it was therefore of interest to investigate whether the final structures observed for these simula-
tions would be reproduced in a dimeric system, or whether the presence of one stretch of amino
acids would perturb the final structure of the other. The starting point for the dimer simulation of
gp41532−544:659−671 was therefore an anti-parallel arrangement of the unstructured stretches of
gp41532−544 and gp41659−671 used in the corresponding monomer simulations. Analysis of the
simulation utilising the STRIDE secondary structure algorithm (Fig. 4.16) revealed that, interest-
ingly, the secondary structure features of the monomeric gp41532−544 and gp41659−671 appeared
to be retained in the dimeric gp41532−544:659−671; gp41532−544 was still defined by two helical
regions spanning amino-acids Ala532-Leu537 and Val539-Gln543, while gp41659−671 was charac-
terised by a helix between Glu662-Ser668. This thereby appeared to support the results obtained
experimentally and suggested that under aqueous conditions, the individual stretches did not fold
cooperatively.
Figure 4.16: Secondary structure of each residue of the dimeric gp41532−544:659−671 as a function
of time. Pink corresponds to α-helix, blue is 310- helix, green is turn and white corresponds
to unordered. Simulation does not reveal any major changes to the main secondary structural
features.
As the dimeric system under solvent conditions did not reveal any notable interactions between
the two stretches, it was important to probe if these systems influenced one another in a lipidic
environment. In comparing the far-UV CD spectra of gp41532−544:659−671 in the presence of
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1.6mM DLPC liposomes and 10mM PB, to the linear combination of the non-interacting indi-
vidual monomers under identical conditions (Fig. 4.17), it was apparent that the dimeric system
did not display an appreciable secondary structure and revealed no interactions at zwitterionic
membrane surfaces. Synergetic interactions between the FPPR and MPER regions, both implic-
ated in the fusion process [133, 162], would likely transpire in mixed lipid environments as they
are brought together upon formation of the 6HB. Therefore, one would expect an appreciable co-
operative folding between gp41532−544 and gp41659−671 in the presence of anionic membranes.
From the monomeric stretches, it was apparent that the activity of gp41659−671 (which remained
unfolded in the anionic environment) would be determined by the responsive membrane binding



































Figure 4.17: Far-UV CD spectra of dimeric 0.04mM gp41532−544:659−671 (red) compared to
the linear combination of the monomeric spectra (green) in the presence of 1.6mM zwitterionic
membranes and 10mM phosphate buffer, pH 7. Inset: in the presence of 1.6mM zwitterionic
membranes and H2O, pH 3.
The equimolar mixture of gp41532−544 and gp41659−671 (gp41532−544:659−671) was titrated
with anionic membranes. Far-UV CD spectra revealed a series of conformation responses in
the mixture as a function of increasing peptide-lipid rations. At a ratio of 1:4 (corresponding
to a peptide and lipid concentration of 0.04mM and 0.16mM respectively) a transition to a hel-
ical motif was observed, indicated by the emergence of a band of positive ellipticity at 190nm
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and two negative bands at 202nm and 217nm (Fig. 4.18b). Upon increasing the lipid concen-
tration to 0.9mM, resulting in a ratio of approximately 1:20, the recorded CD spectra suggested
a conformational shift towards β-type conformers (Fig. 4.18c); however, the positive peak near
190nm is usually characteristic of helical structure. These spectra were subsequently compared
to the linearly combined spectra of the monomeric data at appropriate concentrations, which as-
sumed that there were no perturbations to the structure upon mixing; obtained from titrating the
individual peptides with anionic membranes. As there were no differences between the linear
combination and acquired spectra of the dimeric gp41532−544:659−671 system in lipid-free media,
it would appear that any potential binding interplay between the two stretches ensues as a result















































Figure 4.18: Far-UV CD spectra of 0.04mM gp41532−544:659−671 (red) compared to the linear
combination of the monomeric spectra (green) in the presence of (a) 10mM phosphate buffer (b)
0.16mM anionic membranes, and (c) 0.9mM anionic membranes.
Within the 6HB, both stretches fold into α-helices as terminal parts of their correspond-
ing heptad repeat regions, and can therefore be expected to exhibit preferential helical fold-
ing. However as observed in Section 4.5.2, this was not true for the monomeric systems in the
presence of either lipidic system (i.e. DLPC or DLPC/DLPG), or for the dimeric mixture of
gp41532−544:659−671 in the absence of such membranes; in fact, gp41532−544 was found to adopt
β-sheet membrane-induced conformations, whereas gp41659−671 was not found to bind to mem-
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branes in a folding-dependent manner. It would therefore appear that the dimer would only able
to emulate the native tertiary contacts of the regions in the 6HB while in the presence of anionic
membranes.
Fluorescence spectra of gp41532−544:659−671 were recorded for any changes in intrinsic fluor-
escence as compared with the results for gp41659−671. As no changes were observed, this sug-
gested that the gp41666−670 Trp span did not interact with the membranes the way it did in SDS
micelles (Fig. 4.19): the span may preferentially interact within gp41532−544:659−671. In support
of this, LD measurements conducted on the gp41532−544:659−671 dimer system suggested that
the tryptophans were not involved in the dimers interactions with the membrane [160]. Further-
more, the LD results suggested the dimer system exhibited multiple binding modes consisting of
a predominantly perpendicular orientation of helices to the membrane surface, and residual β-
structure parallel to the surface. As the collected LD data could not rule out that one stretch was
orientated parallel to the membrane surface, whilst the other was perpendicular, it was important




















Figure 4.19: Fluorescence spectra of 0.02mM gp41659−671 (red) and 0.04mM
gp41532−544:659−671 (blue) in 10mM PB and in the presence of 1.6mM anionic liposomes.
As mentioned in Section 4.4.5, the starting point for the simulation of gp41532−544:659−671
was an anti-parallel arrangement of the unstructured stretches of gp41532−544 and gp41659−671.
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Following an equilibration phase, visualisation of the simulation revealed that the anti-parallel
arrangement of the monomers was maintained within the first 5ns (Fig.. 4.20a), whereafter the
peptides arranged in a perpendicular fashion, with the C-terminal of gp41659−671 orientated to-
wards gp41532−544 (Fig.. 4.20b). This transition appeared to be driven by the residues Leu535,
Trp666, Leu669, and Trp670, forming a network of hydrogen bonds within a hydrophobic in-
terface; during the transition, the residues Leu535 and Trp670 appeared to form the dominating
interaction (Fig.. 4.20c).
As the simulation evolved up to 10ns (of the 15ns production run), the Trp666 residue relo-
cated from the hydrophobic core at the expense of stabilising interactions with Leu663 (Fig. 4.21a)
before then folding back into the hydrophobic core. In the latter stages of the simulation, the
two α-helical regions of gp41532−544 and gp41659−671 appeared to be aligned in parallel be-
fore drifting apart by 12.5ns into the simulation (Fig.. 4.21b), with Trp666 and Trp670 forming
close contacts with Leu663 and Leu669 respectively. The simulation of the dimer predicts that
gp41532−544:659−671 is indeed a highly dynamic structure with an intrinsic ability to rearrange.
Different structural arrangements of the pair appear to be controlled by hydrophobic inter- and
intra-peptide interactions, which are primarily mediated by the Trp residues of gp41659−671.
Complementarily, the kinked helix of gp41532−544 can provide conformational flexibility neces-
sary to meet geometric requirements of membrane rearrangements implicated in phase trans-
itions.
4.6 Conclusions
The membrane proximal regions of gp41 have been shown to interact cooperatively, exclusively
in membrane-bound environments. Specifically, the binding interplay between the two highly
conserved peptide stretches gp41532−544 and gp41659−671 (of FPPR and MPER, respectively)
resulted in the formation of helical structure in the presence of anionic membranes; neither of
the individual monomers in the presence of anionic or zwitterionic membranes displayed such
structural propensity. Furthermore, these peptides have been shown to fold into helices without
the presence of the HR1 and HR2 stretches. This autonomy suggests that gp41532−544:659−671





Figure 4.20: Visualisation of the dimeric gp41532−544:659−671 simulation. (a) after the equilibra-
tion phase revealing that the initial anti-parallel arrangement was retained. (b) after 5ns revealing
the stretches in a perpendicular arrangement. (c) a hydrophobic interface (orange) comprising
Leu535, Trp666, Leu669, and Trp670. Inset: a complete molecular surface (blue) with the interface
in the centre.
mixing phase and therefore implies that it may possess a regulatory function [156, 163]. As
isolated gp41659−671 was found to posses negligible membrane interaction while gp41532−544
was found to display distinct folding-mediated binding [160], it is reasonable to assume that it




Figure 4.21: Snapshot of the dimeric gp41532−544:659−671 simulation. (a) Trp666 residue leav-
ing the hydrophobic interface (orange) to interact with Leu663 (red). (b) α-helical regions of
gp41532−544 and gp41659−671 aligned in parallel.
hemifusion phase [107, 164, 165].
The results of this study suggest that in the Env, MPER and FPPR are co-aligned without the
ability to fold or assemble. In the pre-fusion phase, MPER displays negligible interacts with the
viral membrane, while the FPPR does not interact with the cell membrane at all. However, in the
hemifusion phase (characterised by the changed lipid environment), the interactions of the FPPR








The glycoprotein human chorionic gonadotropin (hCG), is a hetero-dimer consisting of an α-
chain in non-covalent association with a β-chain (Fig. 5.1). Essential in pregnancy and detect-
able within a few days of fertilisation, hCG has become one of the most frequently assayed
hormones, and simple, one-step, antibody-based measurements of hCG are now standard in
pregnancy testing. At this early stage of pregnancy, the trophoblast cells of the pre-implantation
embryo produce a hyperglycosylated form of the hormone, which drives embryonic implantation
in the uterine wall [166]. Once successful implantation has been achieved, hCG production is
controlled by syncytiotrophoblast cells of the placenta, and its continued action is required to
promote and maintain the secretion of progesterone from the corpus luteum, which is essential
in maintaining the pregnancy. In other applications, therapeutically, injected hCG is the key to
in-vitro fertilisation, where it is used to trigger ovulation and, in males, it is used to promote
testosterone production.
Figure 5.1: Crystal structure of hCG [4], hCGβ66−80 is circled.
The role of hCG as a tumour marker in a variety of cancers is of great clinical signific-
ance [167, 168], and quantitative, specific hCG tests are important in the diagnosis and manage-
ment of hCG-secreting cancers [169]. However the design criteria of hCG cancer assays differ
from those required for pregnancy tests. Specifically, different sensitivity ranges are involved
and, for oncology applications, the antibodies used must be able to detect various modified forms
of hCG with equal affinity [170]. The role of hCG assays in the diagnosis and management of
malignant trophoblastic disease (choriocarcinoma) is one of the great success stories of onco-
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logy [171, 172]; it is the ideal tumour marker - always present when choriocarcinoma cells exist,
and in quantities directly related to the number of those cells. The correct use of hCG assays
in combination with appropriate therapy has led to a survival rate approaching 100% in this
otherwise aggressive cancer.
All hCG diagnostic tests are carried out as immunoassays, based on specific antibodies that
are able to distinguish hCG from three other, closely related, members of the glycoprotein hor-
mone family (luteinizing hormone, LH; follicle-stimulating hormone, FSH; and thyroid stimu-
lating hormone, TSH) [173]. The α-chains of these four hormones are identical, and are each
comprised of 92 amino acids. The β-chains however are hormone specific and determine the
particular activity of each hormone [174], but exhibit significant sequence homology between
all four β-chains, with LH having 86%, TSH 46% and FSH 36% commonality with the first 114
amino acids of hCG [175]. Both the α- and β-chains are composed as three loops held in place
by a “cysteine knot” of three disulphide bonds [4, 176]. Due to this distinctive molecular archi-
tecture, the glycoprotein hormones are classified within the cysteine knot growth factor (CKGF)
family of proteins, even though they perform as hormones, rather than growth factors.
These similarities in sequence and structure, especially within the quartet of the glycoprotein
protein hormones (hCG, LH, TSH, FSH), make stringent demands of antibody specificity when
immunoassays are used to distinguish between the different molecules. To ensure high fidelity
in hCG detection and quantification, rigorous antibody characterisation and selection is essential
and, for this reason, much attention has been paid to hCG immunochemistry in terms of de-
fining epitope structure and relating antibody binding specificity to structural differences in the
various isoforms of hCG. The diagnostic value of any hCG immunoassay depends totally on the
properties of the antibody around which the assay is built. Previous analysis of the hCG epitope
structure [177], focused on the assignment of epitopes to the 3D structure of hCG, together with
a clear linkage to identified monoclonal antibodies.
However, a wide range of hCG variants exist differing both in glycosylation state and frag-
ment size. While hCG can exist as the normal α/β hetero-dimer, as individual subunits, or even
as α/α homo-dimers. The most frequently encountered fragments are from the β subunit, in
the form of nicked hCG β-subunit (hCGβn), hCG β-core fragment and hCGβ lacking the C-
terminal peptide (-CTPhCGβ) [167, 178, 179]. This heterogeneity poses a major obstacle to the
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development of a quantitative universal immunoassay for hCG [180], especially as many hCG
epitopes depend on the molecule being intact and/or in its native conformation [175]. An assay
architecture built around a single epitope site is preferred, as a two-site assay (double antibody
sandwich) could result in more false negative results due to the doubled risk of one of the ne-
cessary epitopes being absent in a hCG variant [181]. However, the performance of a single site
assay depends on the identity and nature of the chosen epitope, and it is crucial that it is present,
intact and correctly folded in every hCG variant encountered.
It is against this background that the β3-loop of hCGβ66−80 (Fig. 5.1) has been identified
as a potentially ideal epitope on which to base universal, single-site hCG assays. This loop is
present in all known variants of hCG, and we postulate that it might have its own, self-contained
secondary structural features that are retained, regardless of the conformation or fragmentation
state of the rest of the molecule. It is suggested here that this local structure provides the basis
for antibodies against this epitope to bind with similar affinity to any known hCG variant, as long
as the relevant linear sequence remains accessible.
5.2 Experimental
5.2.1 Peptide Synthesis
Peptides were synthesised by Mologic Ltd. with N-(9-fluorenyl)methoxycarbonyl (Fmoc) -
chemistry on TGA resin (Merck Chemicals) using a Liberty Microwave Synthesiser (CEM).
Completed peptide resins were cleaved in 95% TFA (Rathburn), 2.5% water and 2.5% trisopro-
pylsilane (Sigma) for two hours and recovered TFA liquors were dried by rotary evaporation and
precipitated in cold tert-butyl methyl ether (Sigma) to afford a white solid. Freeze dried crude
peptides were purified using a Dionex Ultimate 3000 HPLC system with an Onyx C18 column
(Phenomenex) and a mobile phase gradient of 5% acetonitrile/water (0.1% TFA) to 100% acet-
onitrile (0.1% TFA) over 8 minutes. Pure peptide fractions were reduced by rotary evaporation
and freeze dried from 50% acetonitrile. Purified peptides were analysed using a C18 kinetix
column (phenomenex). Integrated peak areas typically indicated purity of 95% or above. Pep-




A range of peptide arrays were synthesised by Mologic Ltd. on polypropylene 455 well PEPSCAN
cards using standard Fmoc-chemistry. Initially, to determine which linear sequential epitopes
were recognised by various antibody preparations, a library of overlapping 12-mer peptides rep-
resenting the entire sequence of hCGβ was created [182]; the first well was endowed with an
array of identical immobilised peptides consisting of amino acids 1-12, the second well carried
peptides consisting of amino acids 2-13, the third 3-14 etc. In conjunction with further libraries
constructed with longer peptides (up to 20-mer), these libraries were used to determine which
host species (mouse, rabbit, or sheep) were able to produce antibodies that recognised the linear
sequence of the β3-loop. From these findings a panel of candidate monoclonal antibodies with
binding specificity for the β3-region were selected. These monoclonal antibodies were prepared
by hybridoma techniques in the laboratories of Bioventix Ltd., Farnham UK. Subsequently, once
the recognition of the correct sequential epitope (hCGβ66−80) had been confirmed, a positional
scanning library incorporating all single natural amino acid changes across the peptide sequence
SIRLPGCPRGVNPVV (of hCGβ66−80) was used. After deprotection with TFA and scavengers,
the cards were washed extensively with an excess of H2O and sonicated in disrupt-buffer con-
taining 1% SDS / 0.1% β-mercaptoethanol in PBS (pH 7.2) at 70◦C for 30 minutes, followed by
sonication in H2O for another 45 minutes. The binding of antibody to each peptide was tested in
a PEPSCAN-based ELISA. The polypropylene cards containing the covalently linked peptides
were incubated with primary antibody 8G5 (obtained from sheep) diluted in blocking solution,
4% horse serum, 5% ovalbumin (w/v) in PBS / 1% Tween. After the wells had been washed, the
peptides were incubated with a 1/1000 dilution of secondary antibody peroxidase conjugate for
one hour at 25◦C to detect and quantify the binding of 8G5 antibodies. After a further washing
step, the peroxidase substrate 2,2’-azino-di-3-ethylbenzthiazoline sulfonate (ABTS) and 2µl of
3% H2O2 were added. Colour development was then measured by means of a charge coupled
device (CCD) - camera and an image processing system, after a one-hour incubation [183].
5.2.3 Sample preparation
The peptides were dissolved directly in 10mM Phosphate buffer solution (pH 6.8), with a final
concentration of 0.11 mM (0.177 mg ml−1). The peptides stock concentration was confirmed by
98
5.2. EXPERIMENTAL
UV-vis spectroscopy using a calculated extinction coefficient of ε214 = 21807 M−1 cm−1 [155].
For the samples with the fluorinated alcohol HFIP, water and 0.2 M buffer solutions were used
to ensure the overall buffer concentration remained 10 mM.
5.2.4 Circular dichroism (CD) measurements
Far-UV CD spectra were recorded on a Jasco J-810 spectropolarimeter (Japan Spectroscopic
Co., Tokyo) fitted with a Peltier unit for temperature control. The spectra are the average of
three accumulations in step mode (data pitch of 1 nm, response time of 8s, bandwidth of 1
nm) acquired in rectangular cuvettes of 0.1 cm path length (Hellma GmbH, Germany) at 20◦C.
For every sample, an appropriate solvent spectrum was recorded under identical conditions and
subtracted from the corresponding sample spectrum. The data collected was expressed in molar
ellipticity (M−1 cm−1).
5.2.5 Fourier Transform Infrared (FTIR) Spectroscopy
FTIR - attenuated total reflectance (FTIR-ATR) spectra were collected using a Tensor-37 FTIR
spectrophotometer (Bruker Optics) equipped with a thermostated BioATR II unit and a liquid
nitrogen cooled photovoltaic mercury cadmium tellurium (MCT) detector. The spectra were
analysed using the OPUS software (Bruker Optics). Five acquisitions (128 scans, 4 cm−1 resol-
ution) were done at different peptide concentrations. The contribution from atmospheric gasses
was eliminated using an algorithm provided by the OPUS software. The contribution of liquid
water was subtracted from the peptide spectrum using the combination band of water, centred at
2125 cm−1, by flattening the region from 1906 to 1740 cm−1.
FTIR spectra of synthetic peptides should be analysed carefully due to the possibility of
trifluoroacetic acid (TFA) being present as an impurity in the sample, resulting from the RP-
HPLC purification step. It is important to consider TFA, as it is known to absorb in the Amide
I region at 1673-1680 cm−1 and can result in an overestimation of certain secondary structural
elements (e.g. turns). In order to compensate for this, the TFA contribution is subtracted if the
spectrum of a synthetic peptide presents a peak centred around 1200 cm−1 [184].
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Peptide Sequence Counter ions Notes





Table 5.1: Peptide sequences and counter ions used in unit cells.
5.2.6 Computational Method
An array of peptides was generated by performing point mutations on the structure of hCGβ66−80
obtained from 1HRP.pdb (Fig. 5.2), varying only the coordinates of the side chain and not the
backbone. From these, unit cells were set up, which comprised a peptide sequence, 1853 water
molecules and counter ions in order to ensure charge neutrality (Tab. 5.1). The molecules were
arrayed on a cubic lattice with random molecular orientations in a cubic box of length 38.2Å.
The rigid, non-polarisable, 3-site TIP3P empirical force field was used to describe the water
molecules, the peptide was described by the CHARMM22 force field [31], while the PINY
simulation package [99] was employed to perform the simulations.




The systems were equilibrated at 300K in the canonical ensemble for 350ps with a time-
step of 0.5fs to anneal out unphysical contacts. The system was then run for 300ps with a time
step of 0.5fs in the isothermal-isobaric ensemble to allow for spatial relaxation. The system was
then run for a further 150ps in the canonical ensemble with a time-step of 1fs being employed,
before a production run of 15ns using a time-step of 2.5fs from which all data was collected.




Of the three species tested, only sheep were found to produce antibodies to the β3-loop, with
the loop appearing to constitute an immunodominant epitope. The sequence of the β3-loop is
highly conserved with hCGβ66−80 and LHβ86−100 differing by only one amino acid; asparagine
(N) in hCG cf. aspartate (D) in LH (Fig. 5.3a). Utilising a particular sheep monoclonal antibody
designated 8G5, point mutations in peptide arrays were introduced in the sequence SIRLPGC-
PRGVNPVV (hCGβ66−80), to determine whether substitution of the asparagine (Asn77) residue
(Fig. 5.3b) had an impact on the antigen-antibody binding.
Mologic Ltd. found that this single amino acid difference between LH and hCG conferred a
substantial specificity bias to the antigen-antibody interaction (Fig. 5.3), in favour of hCG with
all five of the monoclonal antibodies binding to this region. Careful calibration of the LH cross-
reactivity (with intact LHβ and hCGβ) revealed this to be 2.5% for 8G5 (additional antibodies
were tested, and this cross-reactivity was found to range between about 0.27% and 2.5%). Sub-
stitution involving histidine (H) was the only other mutation found to retain significant binding.
In view of the potential usefulness of this particular epitope-antibody combination, we ex-
plored the structure of the β3 epitope recognised so strongly by the ovine immune system by
means of a combination of experimental techniques and computer simulation in the free pep-
tide. By this means we sought to determine if there are structural differences between these two
peptides; such structural variations may be evidence of an inability of the LHβ version of the
epitope to bind successfully with the paratope. Additional point mutations were investigated,
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Figure 5.3: (a) Primary structures of hCGβ66−80 (upper) and LHβ86−100 (lower). (b) Binding
results from a small subset of the Pepscan positional substitution library, in which there is a
systematic substitution of position 77, occupied by asparagine in hCGβ. Note that there is neg-
ligible binding to the peptide occupying the position third from the bottom, which equates to the
sequence in LH. In the sequence containing histidine at position 77, the binding is ∼60% that of
the hCGβ binding.
involving substitution of a proline (Pro78) residue [185]. The results revealed that binding to the
monoclonal antibody 8G5 was lost.
5.3.2 Secondary structure of hCG
5.3.2.1 Structure predicted by simulations
In the crystal structure of hCGβ, hCGβ66−80 is defined by two turns with β-sheet structure over
the N- and C-termini of the peptide (Fig. 5.2). A molecular dynamics simulation was performed
to reveal the native structure of hCGβ66−80 under aqueous conditions (Fig. 5.4), in order to




Figure 5.4: Secondary structure of hCGβ66−80 after 15ns.
The secondary structure of each residue as a function of time was analysed utilising the
STRIDE secondary structure assignment algorithms [107] (Fig. 5.5). From this, it was clear that
the simulation predicted a stable turn motif spanning the residues Pro73-Val76, as evident from
it persisting over the course of the 15ns simulation. The analysis conducted utilising STRIDE
also revealed that the turn structure spanning residues Leu69-Cys72 was not as stable, with the
sequence becoming more unordered by 5ns into the simulation; STRIDE did predict the turn
structure to return sporadically. Furthermore, evidence of β-sheet character in the full protein
(present as an initial condition in the free peptide between Arg68 and Val79) was found to anneal
away very quickly. This aspect of the full protein was therefore not retained in the isolated
peptide.
A turn can be defined as the close approach (< 7Å) of two Cα and it does not necessar-
ily have to have a well formed hydrogen bond. To that end, the separation of all Cα involved
in γ-turns, β-turns, α-turns, and π-turns (separated by 2, 3, 4 and 5 peptide bonds respect-




Figure 5.5: Secondary structure of each residue of hCGβ66−80 as a function of time. Green
corresponds to turn, white is unordered and gold is β-strand. Simulation predicts a stable turn
over Pro73-Val76, whereas a second turn spanning Leu69-Cys72 was found to be only a transient
feature.
a clear indication of a β-turn spanning residues Pro73-Val76 (Fig. 5.6) as was predicted by the
STRIDE algorithms, with the entirety of the Cα separation distribution falling below the assumed
7Å threshold. Furthermore, bond probability distribution analysis revealed strong evidence of a
β-turn stabilising hydrogen bond between the backbone carbonyl group of Pro73 and the back-
bone amine group of Val76, with the peak at a distance less than the assumed Hydrogen-bonding
threshold of 2.5Å [106].
The potential presence of a β-turn motif spanning residues Leu69-Cys72 was also partially
confirmed by the separation of the Cα of Leu69 and Cys72 (Fig. 5.7a). While the peak was
positioned above the assumed 7Å threshold, a notable portion of the distribution was found
to lie below this cut-off. This appeared to support the findings of the STRIDE algorithm, by
revealing that a β-turn structure spanning these residues may appear to some degree over the
course of the last 5ns of the simulation; STRIDE revealed sporadic appearances of this motif
over this same time period (Fig. 5.5). However analysis of the bond probability distribution
involving the backbone carbonyl group of Leu69 and the backbone amine group of Cys72 revealed
a peak at 3.66Å (Fig. 5.7a), well above the assumed 2.5Å cut-off. This therefore ruled out the
















Figure 5.6: Solid (red line), separation of Cα in Pro73 and Val76. Dashed (green line), separation
between backbone carbonyl (Pro73) and amine (Val76) groups.
was only detected sporadically. Similarly, while the Cα belonging to residues Asn77 and Val80
were found to be separated at a distance below the 7Å cut-off (Fig. 5.7b), the separation between
the backbone carbonyl and amine groups (3.86Å) was too great to support the presence of a
stabilising hydrogen bond.
Figure 5.7: Solid (red line), separation of Cα. Dashed (green line), separation between backbone
carbonyl and amine. (a) Leu69-Cys72, (b) Asn77-Val80.
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Every pair of potential Cα involved in γ-turns presented a peak below the 7Å threshold
(Fig. 5.8a) therefore it was necessary to evaluate the bond probability distributions of the back-
bone carbonyl group of residue i and the backbone amine group of residue i+ 2 (Fig. 5.8b). For
every pair of residues evaluated, the separation of the two atoms was found to be greater than
the assumed 2.5Å threshold therefore precluding the existence of stable γ-turns in the structure
of hCG β66−80. Analysis of the separation of Cα involved in α-turns (Fig. 5.9a) resulted in only
one pairing (Cys72-Val76) presenting a peak below the assumed 7Å cut-off (6.27Å), however
bond probability analysis of potential hydrogen bonds ruled out the existence of a stable α-turn
between these residues due to the corresponding peak falling at a separation of 5.36Å (Fig. 5.9b).
Figure 5.8: (a) Separation of Cα involved in γ-turns in hCGβ66−80, (b) Bond probability distri-
bution analysis for potential hydrogen bonds.
Figure 5.9: (a) Separation of Cα involved in α-turns in hCGβ66−80, (b) Solid (red line), sep-
aration of Cα in Cys72 and Val76. Dashed (green line), separation between backbone carbonyl
(Cys72) and amine (Val76) groups.
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Finally analysis of the separation of Cα involved in π-turns resulted in negative results for
all possible permutations with no evidence of such motifs existing in the secondary structure of

















Figure 5.10: (a) Separation of Cα involved in π-turns in hCGβ66−80.
The simulation therefore led to a model of the free peptide in which a single stable turn
coexisted with other transient structures; more open and less structured that the sequence in the
full β-chain. Direct experimental confirmation of such a dynamic situation would be challenging,
yet it was important to establish whether the simulations captured the general secondary structure
of the free peptide.
5.3.2.2 Spectroscopic analysis
The measured FTIR spectra of hCGβ66−80 was found to exhibit a very broad Amide I band,
indicative of the co-existence of different conformations in solution (Fig. 5.11). Over the replica
measurements, the second derivative spectra revealed bands consistent with the presence of a
fractional population of turns in solution [63]. The position of the Amide II band (maximum
at 1551 cm−1) also suggested that β-turns were present as the band was positioned at a higher
frequency when compared to other structural elements [186].
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Figure 5.11: FTIR-attenuated total reflectance blank-subtracted and TFA-corrected spectrum of
hCGβ66−80 (black) displaying the Amide I (maximum at 1633 cm−1) and Amide II (maximum
at 1551 cm−1) regions, and the second derivative spectrum (red) displaying the peak positions of
the different components.
Evidence for turns in CD data is more ambiguous; a turn can give variable signatures in
CD with bands of positive or negative ellipticity at wavelengths of approximately 200nm. In
particular, type II β-turns should exhibit a weak CD band with negative ellipticity at 220-230nm,
with a stronger positive band between 200-210nm. Type I β-turns on the other hand give CD
spectra which are qualitatively similar to that of an α-helix; characterised by a band of positive
ellipticity near 190nm and two bands of negative ellipticity at longer wavelengths [45]. In order
to confirm if a turn structure was indeed present in the secondary structure of this peptide, far-UV
CD spectra of hCGβ66−80 were recorded (Fig. 5.12). As evident from the recorded CD spectra,
none of the typical signatures of a turn structure were present, and the single CD band with
negative ellipticity near 200nm was more indicative of a disordered structure. This suggested
that the turn was not a stable secondary structure element for this peptide in an aqueous buffer,
or if the turn was present it was part of an ensemble of open conformations.
To examine whether the conformational bias of the ensemble could be altered to enhance the
population of a particular fold type, experiments were performed in fluorinated alcohol HFIP-
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Figure 5.12: Far-UV CD spectrum of 0.11mM hCG β66−80.
water mixtures. Fluorinated co-solvents exclude water from the peptide’s environment, favouring
the formation of intramolecular hydrogen bonds. Therefore, if a hydrogen bond was responsible
for the stabilisation of a particular conformation, a change in solvent conditions would cause a
shift in the fractional population of conformers which would be observed in a CD spectra due
to the quantitative nature of CD. Far-UV CD spectra of hCGβ66−80 in 50% HFIP (v/v) were
recorded (Fig. 5.12). The presence of the Pro residues in the sequence of hCGβ66−80 would
be expected to strongly disfavour the formation of a helical motif (Tab. A.4). Coupled with the
structural preferences predicted by MD, this observed change in the spectrum could be indicative
of the stabilisation of a turn motif.
On the basis of these spectra, it was concluded that the secondary structure of hCGβ66−80
was comprised of an ensemble of open structures and turn motifs and that the simulated config-
urations (Fig. 5.4) were consistent with the experimental measurements.
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5.3.3 Secondary structure comparison between LH and hCG
5.3.3.1 Spectroscopic analysis
Experimentally, the FTIR spectra of LHβ86−100 (Fig. 5.13) was found to be similar to that ob-
served in hCGβ66−80 (Fig. 5.11). Namely a broad Amide I band was found which indicated the
co-existence of different conformations in solution, and the second derivative spectra was con-
sistent with fractional populations of turns [63]. The position of the Amide II band (maximum
at 1553 cm−1) also suggested that β-turns were present [186].
Figure 5.13: FTIR-attenuated total reflectance blank-subtracted and TFA-corrected spectrum of
LHβ86−100 (black), and the second derivative spectrum (red) displaying the peak positions of the
different components.
The recorded far-UV CD spectra of LHβ86−100 (Fig. 5.14) also revealed a predominantly
disordered structure. There were however detectable differences between the hCGβ66−80 and
LHβ86−100 spectra (∼220nm) which implied that the single point mutation had influenced the
conformational equilibrium. Far-UV CD spectra of LHβ86−100 in 50% HFIP (v/v) also sug-
gested the stabilisation of a turn motif (Fig. 5.14), although potentially to a lesser degree than
observed for hCGβ66−80. The weaker shoulder of negative ellipticity at 220-230nm may be due
to LHβ86−100 presenting weaker intensity than hCGβ66−80 at these wavelengths in aqueous buf-
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fer. This may be indicative of hCGβ66−80 being comprised of more stable turn motifs than the
LHβ86−100 mutant under such conditions.
Figure 5.14: Far-UV CD spectrum of 0.11mM LHβ86−100.
Unsurprisingly, the main structural features of the LHβ86−100 and hCGβ66−80 peptides were
found to be similar, with each peptide comprised of an ensemble of open structures and turn mo-
tifs. The experimental data, however, also revealed evidence of subtle differences arising from
the point mutation. Unfortunately, precise secondary structure interpretation was beyond the res-
olution of the techniques employed. As the MD simulations and experiments of hCGβ66−80 were
within the resolution limits of the measurements, further emphasis was placed on a secondary
structure comparison based on the simulation evidence.
5.3.3.2 Simulation
Molecular dynamics simulations were performed on the sequence emulating that found in the
LHβ3 sub-unit, in order to investigate whether the mAb 8G5 molecular recognition mechanism
and selectivity between hCG and LH was due to a structural variation induced by the single
amino acid mutation. As with the simulation involving the hCG molecule, the secondary struc-
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ture of each residue as a function of time was analysed utilising the STRIDE secondary structure
assignment algorithms [107] (Fig. 5.15). The obvious major difference between the secondary
structure of hCGβ66−80 and LHβ88−100 was the increase in the span of the turn motif, which ap-
peared to have extended to include residues Asp97 and Pro98. Furthermore, evidence of β-sheet
character between residues Arg88 and Val99 was found to anneal away more quickly than in hCG
(Arg68 and Val79). However, it did return sporadically during the initial 3ns of the simulation.
Figure 5.15: Secondary structure of each residue of LHβ86−100 as a function of time. Green
corresponds to turn, white is unordered and gold is β-strand. Simulation predicts a stable turn
over Pro93-Val96, with the span extending to include Asp97 and Pro98. A second turn spanning
Leu89-Cys92 was found to be less stable.
The separation of all Cα involved in γ-turns, β-turns, α-turns, and π-turns (separated by 2,
3, 4 and 5 peptide bonds respectively) were calculated over the last 5ns of the simulation. As
with the hCG simulation, there was a clear indication of a β-turn spanning residues Pro93-Val96
(Fig. 5.16), with the peak of the Cα separation distribution being positioned at 5.365Å. This was
supported by bond probability distribution analysis which revealed a β-turn stabilising hydrogen
bond between the backbone carbonyl group of Pro93 and the backbone amine group of Val96, as
evident through the peak positioned at 2.146Å.
Additional Cα pairs which presented a peak below the assumed 7Å threshold were those

















Figure 5.16: Solid (red line), separation of Cα in Pro93 and Val96. Dashed (green line), separation
between backbone carbonyl (Pro93) and amine (Val96) groups.
bond probability analysis revealed that only the Asp97-Val100 pair coincided with a stabilising































Figure 5.17: (a) Separation of Cα involved in β-turns (b) Solid (red line), separation of Cα
in Asp97 and Val100. Dashed (green line), separation between backbone carbonyl (Asp97) and
amine (Val100) groups.
Visualisation of the secondary structure (Fig. 5.18) revealed that the sequence Pro93-Val100
appeared to be comprised of sequential β-turns forming a ‘S-bend’ like motif. The peaks falling
below 7Å for the Cα pairs of Arg94-Asp97 and Gly95-Pro98 must therefore be due to these
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sequences forming part of this structure, rather than forming their own β-turn; interestingly, the
Cα belonging to Val96 and Val99 were found to be separated by a distance greater than 8Å.
Figure 5.18: Visualisation of ‘S-bend’ like motif over Pro93-Val100 in LHβ86−100.
As in the structure of hCG β66−80, every pair of Cα potentially forming γ-turns were found to
have a separation less than the 7Å threshold and it was necessary to evaluate the bond probability
distributions of the backbone carbonyl group of residue i and the backbone amine group of
residue i + 2 (Fig. 5.19). And as in the hCGβ66−80 model, every pair of residues presented a
negative result with the separation of the two atoms being found to be greater than the assumed
2.5Å threshold; ruling out the existence of stable γ-turns in the structure of LHβ86−100.
Figure 5.19: (a) Separation of Cα involved in γ-turns in LHβ86−100, (b) Bond probability distri-
bution analysis for potential hydrogen bonds.
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The only pairs of Cα involved in potential α-turns to present peaks below the assumed
7Å threshold were those found in Cys92-Val96 and Pro93-Asp97 (Fig. 5.20a), however only the
Pro93-Asp97 pairing corresponded to a potential stabilising hydrogen bond (Fig. 5.20b). How-
ever due to the strong evidence of two β-turns spanning this sequence, the presence of an α-turn
was unlikely. Finally, pairs of Cα involved in potential π-turns were evaluated. The pairs, Cys92-
Asp97 and Gly95-Val100 were found to present peaks below 7Å, while Ile87-Cys92 presented
a peak with considerable intensity under this threshold (Fig. 5.21a). Bond probability analysis
however revealed that none of the pairings coincided with evidence of stabilising hydrogen bonds
(Fig. 5.21b), suggesting that such structures were in reality not present in the structure.
Figure 5.20: (a) Separation of Cα involved in α-turns in LHβ86−100, (b) Bond probability distri-
bution analysis for potential hydrogen bonds.
Figure 5.21: (a) Separation of Cα involved in π-turns in LHβ86−100, (b) Bond probability distri-
bution analysis for potential hydrogen bonds.
As the β-turn structure spanning residues Pro-Arg-Gly-Val appeared to be a common fea-
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ture shared between hCGβ66−80 (Fig. 5.22a) and LHβ86−100 (Fig. 5.22b), it was important to
determine if both turns were of the same type.
!"#$ !%#$
Figure 5.22: Visualisation of the turn motif spanning residues PRGV in (a) hCG, Pro73-Val76,
and (b) LH, Pro93-Val96, revealing the stabilising hydrogen-bond between the backbone carbonyl
group of the Pro residue and the backbone amine group of the Val residue
5.3.3.3 Finer details - turn
A turn can be classified by its backbone dihedral angles (Table. A.3); in the case of a β-turn, one
focuses on the dihedral angles of the two central amino acids. The Ramachandran angles of the
amino acids belonging to the sequence Pro73-Val76 in hCGβ66−80 were calculated over the last
5ns of the simulation (Fig. 5.23). The two central amino acids were found to have Ramachandran
angles (φ, ψ) equalling approximately -75◦, -30◦ (Arg) and -85◦, -10◦ (Gly). Based on these
angles, the closest structure would therefore be the type I β-turn which is defined by the two
central amino acids presenting Ramachandran angles of -60◦, -30◦ and -90◦, 0◦ respectively.
Over the last 5ns of the LHβ86−100 simulation, the torsional angles of Pro93-Val96 (Fig. 5.24),
however, revealed that the two central amino acids presented unique Ramachandran angles
equalling approximately -60◦, -120◦ (Arg) and 90◦, 0◦ (Gly). This indicated a type II β-turn
(known to present Ramachandran angles of -60◦, 120◦ and 80◦, 0◦ respectively) as opposed to




Figure 5.23: Ramachandran angles of sequence PRGV in hCGβ66−80 over the last 5ns. The
torsional angles of the two central amino acids, Arg74 and Gly75, indicate a type I β-turn.
The amino acids which comprise the proposed second β-turn (i.e. Asp97-Val100) however
were found to present Ramachandran angles which indicated a type I β-turn (data not shown).
5.3.3.4 Finer details - clasp
Visualisation of the crystallographic structure of the hCGβ sub-unit (Fig. 5.25), reveals a hydro-
gen bond between the carbonyl group of the Asn77 side-chain and the backbone amine group of
Val79 (Fig. 5.26a). It is known that asparagine can form hydrogen bonds with the polypeptide
back bone, for example at the start or end of an α-helix or in turn motifs in β-sheets, and such
a hydrogen bond could stabilise a hairpin loop whereby the peptide is “zipped" together at each
end.
The accommodation of a substitution involving histidine can be rationalised by a similar
orientation also allowing for this hydrogen bond (Fig. 5.26b). It is also believed that although
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Figure 5.24: Ramachandran angles of sequence PRGV in LHβ86−100 over the last 5ns. The
torsional angles of the two central amino acids, Arg94 and Gly95, indicate a type II β-turn.
Figure 5.25: Crystallographic structure of hCGβ66−80 as obtained from 1HRP.pdb [4], revealing













































Figure 5.26: Proposed H-bonding geometry in (a) hCGβ66−80, (b) His77 mutant. (c) Asp77
mutant depicting the proposed “clasp" being only present in the protonated form of Asp.
aspartate (native on LH) is very similar to asparagine (native in hCG), such a stabilising hydrogen
bond would only be present if Asp were protonated (Fig. 5.26c). This seemed surprising, as one
would have expected the deprotonated carboxylate anion to be a prime hydrogen bond acceptor.
However due to the deprotonation, the oxygens and carbon of the carboxylate anion would be
partially sp and sp2 hybridised, respectively. This would lead to the formation of two partially
double bonded C-O bonds, which could be spatially locked in an orientation disfavouring such
an interaction.
In order to determine if such a hydrogen-bond was potentially present in the free peptide
hCGβ66−80 during the course of the simulation, the bond probability distribution for these atoms
was evaluated over the entirety and, separately, the last 5ns of the simulation (Fig. 5.27). Analysis
of these distributions revealed that irrespective of the chosen time frame, two peaks were present
and located at 2.158Å and 5.852Å. This indicated that while such a hydrogen-bond was present
during the course of the simulation due to the presence of the peak below the 2.5Å threshold, such
an arrangement was not stable over the entirety of the run and for considerable periods of times
the separation of the atoms was too great to accommodate this proposed hydrogen bond. Overall















Figure 5.27: Bond probability analysis of the safety catch in hCGβ66−80, coupled with visual-
isations of the structure corresponding to each peak. Solid (red) line: over full 15ns, Dashed
(green) line: over last 5ns.
From the simulation of LH β86−100, bond probability analysis was performed on each of the
two carboxylate oxygens of the Asp97 side-chain (Fig. 5.26c); henceforth referred to as O−A and
O−B; and the backbone amine group of Val99. The bond probability analysis over the entirety
of the simulation reveal a peak positioned at 5.662Å for the pairing involving O−A (Fig. 5.28a)
and peak at 5.365Å, with a shoulder at 3.357Å for the O−B pair (Fig. 5.28b). Bond probability
analysis over the last 5ns of the simulation reveals that these separations fluctuate to a greater
degree, with the O−A pairing presenting a double peak at 5.662Å and 4.367Å (Fig. 5.28a), while
the O−B pairing results in a peak at 5.365Å accompanied by two (more pronounced) shoulders at
4.319Å and 3.405Å (Fig. 5.28b).
Regardless of whether one focused on the last 5ns of the simulation or the simulation as a
whole, neither carboxylate oxygen was found to present a peak below the assumed 2.5Å threshold.
This therefore appeared to support the hypothesis that the stabilising hydrogen bond was not fa-
voured in the presence of the deprotonated Asp97 residue. The lack of hydrogen bond clasp,
coupled with the difference in turn type spanning the residues Pro-Arg-Gly-Val, would suggest































Figure 5.28: Separation of Asp97 carboxylate oxygen (a) O−A, (b) O
−
B , and hydrogen of the
backbone amine group of Val99. Solid (red) line: over full 15ns, Dashed (green) line: over last
5ns.
8G5 with the different β sub-units of hCG and LH.
5.3.4 Other mutations
In order to investigate whether these fine structural differences were indeed important in ration-
alising the 8G5 discrimination between hCG and LH, it was important to determine if these fea-
tures were shared by other peptide systems. From the results of the point mutations (Fig. 5.3b),
only the substitution involving histidine was found to retain significant binding to the monoclonal
antibody and it was believed that such a substitution would result in an orientation accepting of
a hydrogen bond. It was therefore of interest to probe if such a structural feature was indeed
present in the structure of this peptide (SIRLPGCPRGVHPVV) and if the type I β-turn motif
was a shared feature between this system and hCGβ66−80 - potentially explaining the retained
binding to the mAb 8G5. To that end, a molecular dynamics simulation was performed on the
sequence SIRLPGCPRGVHPVV.
As with the previous simulations, the secondary structure of each residue as a function of time
was analysed utilising the STRIDE secondary structure assignment algorithms [107] (Fig. 5.29).
The obvious major differences between the secondary structures was in the stability of the turn
motif spanning residues Leu-Pro-Gly-Cys and in the β-sheet character between residues Arg and
Val, with both structural motifs being more stable over the course of the 15ns simulation.
The Ramachandran angles of the amino acids belonging to the sequence Pro-Arg-Gly-Val
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Figure 5.29: Secondary structure of each residue of the histidine mutant as a function of time.
Green corresponds to turn, white is unordered and gold is β-strand.
were calculated over the last 5ns of the simulation (Fig. 5.30). The two central amino acids were
found to have torsional angles (φ, ψ) equalling approximately -75◦, -30◦ (Arg) and -85◦, -10◦
(Gly), indicating a type I β-turn.
As in the hCGβ66−80 model, analysis of the bond probability distributions (Fig. 5.31) re-
vealed the presence of two peaks - the location of one peak was found to be invariable irrespect-
ive of the chosen time frame (2.36Å), while the other varied to a minute degree (3.84-3.95Å).
These peaks indicated that the hydrogen bond was indeed present during the course of the simu-
lation due to the presence of the peak below the 2.5Å threshold. The presence of the hydrogen
bond and type I β-turn in this system, would appear to support the notion that the ability of 8G5
to discriminate between the β sub-units of hCG and LH was due to a well defined structural
difference between the two peptides.
In order to determine if the structure of the LHβ86−100 peptide was shared by other mutants
(i.e. a type II β-turn), molecular dynamics simulations were performed on sequences which
presented a lack in ability to successfully bind to the mAb 8G5. Analysis of the model represent-
ative of the sequence SIRLPGCPRGVLPVV revealed the peptide to present a type II β-turn over
the Pro-Arg-Gly-Val sequence, as evident from the Ramachandran angles of these residues over
the last 5ns of the simulation (Fig. 5.32). Furthermore, as with the model involving the histidine
substitution, STRIDE predicted an increased stability in the turn motif spanning residues Leu-
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Figure 5.30: Ramachandran angles of sequence PRGV in the histidine mutant over the last 5ns.
The torsional angles of the two central amino acids, Arg and Gly, indicate a type I β-turn.
Pro-Gly-Cys and in the β-sheet character between residues Arg and Val (Fig. 5.33); however as
these features were not found to be stable in either hCGβ66−80 or LHβ86−100, it was unlikely
that they were important in rationalising the observed difference in binding affinity between these
two antigens.
Another model investigated was representative of the sequence SIRLPGCPRGVGPVV. The
structure of which was found to differ substantially from the other peptide sequences, with the
model displaying 310-helical structure over the sequence RGVGPV (Fig. 5.34); this was con-
firmed by analysis of the torsional angles of Pro-Arg-Gly-Val, which revealed considerable in-
tensity within the helical region of dihedral space (Fig. 5.35). As both peptide sequences (i.e.
SIRLPGCPRGVLPVV and SIRLPGCPRGVGPVV) were found to be lack the ability to suc-
cessfully bind to 8G5, the models would suggest that any deviation from the structure shared by
hCGβ66−80 and the histidine mutant, would result in significant loss in binding; both SIRLP-
GCPRGVLPVV and SIRLPGCPRGVGPVV should lack the ability to form a hydrogen bond












 0  2  4  6  8  10
r (Å)
Figure 5.31: Bond probability analysis of the safety catch in the histidine mutant. Solid (red)
line: over full 15ns, Dashed (green) line: over last 5ns.
An interesting question therefore was whether the presence of this hydrogen bond between
the side chain of the reside located at position 77 and the backbone of Val79 (based on amino-acid
numbering in hCGβ66−80) stabilised a particular turn type over Pro-Arg-Gly-Val? Or, wether
the residue at position 77 influenced the particular turn type, allowing for a spatial geometry
accepting of such a hydrogen bond?
5.3.5 Protonation of Aspartate
In Section 5.3.3.4, it was hypothesised that the clasp between the side chain of Asp97 and
the backbone amine group of Val99 would only be feasible if the Asp residue was protonated
(Fig. 5.26c). Therefore it was of interest to investigate if such an interaction was possible and
if the clasp had any bearing on the geometry of the turn experienced over the sequence Pro-
Arg-Gly-Val. To that end, a simulation was set up in which one of the oxygen atoms (O−A) was
protonated. This was akin to simulating the peptide under acidic conditions as the pKa (Eq. 5.1)
of the aspartic acid side chain is 3.90 (Tab. A.1); Ka is the acid dissociation constant (Eq. 5.2).
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Figure 5.32: Ramachandran angles of sequence PRGV in the leucine mutant over the last 5ns.
The torsional angles of the two central amino acids, Arg and Gly, indicate a type II β-turn.
Figure 5.33: Secondary structure of each residue of the leucine mutant as a function of time.
Green corresponds to turn, white is unordered and gold is β-strand.
From the Henderson-Hasselbalch equation (Eq. 5.3), a 50:50 ratio of deprotonated and proton-
ated side-chains occurs at a pH value of 3.90, while a pH value of 1.90 equates to a ratio of 100:1
in favour of the protonated state (Eq. 5.4). Under such acidic conditions, one would expect the
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Figure 5.34: Secondary structure of each residue of the glycine mutant as a function of time.
Green corresponds to turn, white is unordered and gold is β-strand.
Figure 5.35: Ramachandran angles of sequence PRGV in glycine mutant over the last 5ns. The
torsional angles, located within the helical region of dihedral space, support the 310-helical struc-
ture.
carboxylic acid group of the Val termini to also be partially protonated; therefore it is important
to state that the conditions tested in the simulation reflect only a theoretical model.
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pKa = −log10Ka (5.1)
Ka = ([A
−][H+]/[HA]) (5.2)
pH = pKa + log([A
−]/[HA]) (5.3)
([A−]/[HA]) = 10(pH−pKa) (5.4)
Analysis of the bond probability distribution for the carbonyl group of the protonated aspartic
acid and backbone amine group of valine (Fig. 5.36) revealed that, over the last 5ns, only a
single peak positioned at 5.958Å was present. Furthermore, over the full 15ns (and first 10ns),
only minute traces were detectable below the assumed 2.5Å threshold of a hydrogen bond. This
would suggest that the initial hypothesis (i.e. the protonated aspartic acid would be accepting of













Figure 5.36: Bond probability analysis of the safety catch in the protonated aspartic acid mutant.
Solid (red) line: over full 15ns, Dashed (green) line: over last 5ns, Dotted (blue) line: over initial
10ns.
As the simulation of this protonated form also predicted a stable turn over the sequence
Pro-Arg-Gly-Val, for completeness, the Ramachandran angles were evaluated over the last 5ns
of the simulation (Fig. 5.37). Interestingly the two central amino acids were found to have
torsional angles equalling approximately -65◦, -45◦ (Arg) and -80◦, -20◦ (Gly). This is in stark
contrast to those obtained for the deprotonated form of LHβ86−100 (Fig. 5.24), indicating that
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the protonated form adopts a type I (or type III) β-turn as opposed to the type II β-turn found in
the native LHβ86−100.























Figure 5.37: Ramachandran angles of sequence PRGV in protonated aspartic acid mutant over
the last 5ns. The torsional angles of the two central amino acids, Arg and Gly, indicate a type I
β-turn.
Such a result was surprising, as it was initially believed that the protonation would only af-
fect the ability to form a hydrogen bond (which it did not) and would not have any impact on
the structure immediately preceding the residue (which it did). In addition, the protonated model
revealed that the two structural features (i.e. hydrogen bond and turn type) were not directly
linked; the presence of a type I β-turn did not have to be accompanied by the hydrogen bond
clasp. This therefore indicated that the presence of a particular turn type did not automatically
allow for the spatial geometry accepting of such a clasp, and also suggested that the hydrogen
bond clasp was not necessary for the stabilisation of a particular turn type. Whether the pres-





The monoclonal antibody 8G5 is found to be able to discriminate between peptides representat-
ive of the β3 loops of hCGβ and LHβ, which are distinguishable by only a single amino acid
mutation. Structural analysis of these peptides utilising molecular dynamics simulations reveals
that while both sequences are characterised by a β-turn spanning the residues Pro-Arg-Gly-Val,
the type of β-turn varies. In comparison to the results obtained experimentally, the secondary
structures are consistent with an ensemble of open structures and turn motifs. The simulations
of these peptides also reveal the presence of a proposed hydrogen bond clasp, present only in
hCGβ66−80. As this feature is present in the crystallographic structure of the hCGβ sub-unit, it
would suggest that such a feature is important in the stabilisation of a particular turn type and
thus the molecular recognition mechanism with the mAb 8G5.
129
6
Aggregation: Gas-phase transthyretin oligomers
6.1. INTRODUCTION
6.1 Introduction
Self-assembly is regarded as a powerful approach for fabricating supramolecular architectures.
In order for it to occur, it requires that the individual components be complementary to one
another in shape. Furthermore, it is driven by the presence of numerous (individually) weak
non-covalent interactions (e.g. hydrophobic interactions, electrostatic interactions and hydro-
gen bonds) [14]. Of the intermolecular forces, hydrophobic interactions are perhaps the most
common driving force for the self-assembly of molecules in water, while electrostatic forces act
on the largest length scale. Nature itself utilises self-assembly in order to generate larger, well-
defined structures from building blocks such as DNA and peptides, which have themselves been
the basis in building synthetic nano-structures [187, 188]. A number of applications have been
suggested for materials prepared by the self-assembly of peptides, for example as scaffolding for
tissue repair [189, 190], hydrogels and drug delivery vehicles [191]. As such, recent work in the
field has concentrated on using the self-assembly of small peptides to generate new materials.
In addition, there has been significant research into the self-assembly of peptides in an effort to
understand the formation of amyloid fibrils; small peptide fragments of larger proteins prone to
such amyloid formation have been extensively used as models for the proteins themselves.
Amyloid fibrils are constructed from proteins that have converted from their soluble native
structure to insoluble fibrils which form either systemically or within specific organs such as the
brain or liver. Many human and animal disorders such as Alzheimer’s, Parkinson’s, Creutzfeldt-
Jakob, bovine spongiform encephalopathy, kuru, and type II diabetes are associated with the
formation of these amyloid fibres [23, 24, 192–194]. Amyloid fibrils are not the native conform-
ation of the protein, but would appear to be a thermodynamically favourable alternative structure
that is formed spontaneously. Furthermore, numerous proteins and peptides that are not con-
nected to any known disease have been shown to form amyloid fibrils in vitro [192, 194–197],
indicating that the ability to form such fibrils may be an inherent property of peptides [195].
Interestingly, proteins lacking structural or functional similarities have been found to self-
assemble into amyloid fibrils which display similar chemical and physical properties [198]. In
amyloid-like structures, the individual polypeptide chains form β-strands that lie perpendicular
to the long axis of the fibre. As indicated by their distinctive X-ray pattern, protofilaments
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consist of a cross-β-sheet structure, with the distance separating adjacent sheets falling between
10-15 Å, while neighbouring polypeptide chains within the sheets are separated by 4.7Å; it is
these structures that subsequently self-assemble to give amyloid fibrils [199]. Other commonly
shared characteristics [192, 194] are that the fibrils are typically long, unbranched and∼100Å in
diameter (as revealed by electron microscopy), and bind to the dye Congo red, resulting in a
green birefringence under polarised light.
6.2 System chosen
Human transthyretin (TTR) is a 55-kDa protein involved in the transport of thyroxine and ret-
inol in plasma, and the native protein is a homotetramer of 127-residue subunits with extensive
β-sheet structure [200]. The wild-type protein, as with many of its fragments and naturally oc-
curring mutants, self-assembles into amyloid fibres in vivo and in vitro which are associated
with diseases including senile systemic amyloidosis (SSA) and familial amyloid polyneuropathy
(FAP) [201, 202]. In addition, two 11-residue peptide fragments derived from the native se-
quence, designated TTR10−20 and TTR105−115 (Fig. 6.1), have been shown to form amyloid
fibrils in vitro [203]. These peptides represent β-strands A and G of the full-length TTR and
are both located at the surface of the thyroxine-binding channel formed by the TTR homotetra-
mer. Due to their ability to form fibrils which exhibit the characteristic ‘cross-β’ x-ray diffrac-
tion pattern [204], these peptides are ideal candidates as model systems in order to investigate
the structure of amyloid fibrils and the mechanism of their formation. This is exemplified by
previous investigation into the structure of TTR105−115 in amyloid fibrils utilising nuclear mag-
netic resonance (NMR) [205, 206], FTIR [207] and molecular dynamics simulations focusing
on the mechanism of fibril formation [208–210]. Time-course mass spectrometry (MS) and ion-
mobility mass spectrometry (IM-MS) have also been used to probe the early aggregation states
of the TTR105−115 peptide [209], and have provided insight into the 3-dimensional geometry
of the various oligomers formed during the initial stages of self-assembly by means of calcu-
lated collision cross-sections. The experimental results were compared to calculated values from
simulations of multimers of charge (n − 1)+ (where n denoted the number of TTR peptides)
which were achieved by incorporating an anionic C-terminal carboxyl to one of the TTR105−115
132
6.3. COMPUTATIONAL METHODS
peptides; an exception was a simulation of the monomeric species which consisted of a cationic














Figure 6.1: (a) Visualisation of the theoretical model of the amyloid structure of TTR105−115,
revealing four stacked antiparallel β-sheets (antiparallel with respect to the peptides within each
sheet and between neighbouring sheets) [5], and (b) illustration of the separation between the Cα
in Leu110, revealing the distance between sheets to be 9Å, while the distance between peptides
within the same sheet is 4.7Å
It was of interest to probe whether gas-phase simulations of neutral TTR105−115 monomers
and oligomers resulted in structures and subsequent collision cross-sections comparable to those
of the charged species. Such an investigation was hoped to reveal whether the charge state
influenced the packing of the oligomers and the energy landscape of the TTR molecule as it
aggregated.
6.3 Computational Methods
Two unit cells were set up, which each comprised one TTR molecule (Fig. 6.2a) with zwit-
terionic termini in a cubic box of length 80.0Å, with the peptide being described by either the
CHARMM22 [31] or AMBER-ff03 [36, 37] force fields. From the theoretical model of the amyl-
oid structure (Fig. 6.1), four antiparallel β-sheets are stacked upon one another; each peptide is
antiparallel with respect to one another within each sheet, and between neighbouring sheets.
While moving onto dimeric and higher order oligomers, it was therefore important to consider
various permutations that such systems could adopt; the dimer could be comprised of two mo-
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lecules from the same sheet, or two from different sheets. Two unit cells were subsequently set
up, which comprised either two TTR molecules from the same sheet (Fig. 6.2b) or two from
neighbouring sheets (Fig. 6.2c) in a cubic box of length 80.0Å. These cells were then replicated
and the peptides were handled by the CHARMM22 [31] or AMBER-ff03 [36, 37] force fields.
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Figure 6.2: Snapshot of the initial structure of the TTR105−115 (a) monomer, (b) intra-sheet dimer
and (c) inter-sheet dimer.
A similar approach was applied to a trimeric system of TTR molecules, with unit cells be-
ing created which consisted of either three molecules from the same sheet (Fig. 6.3a) or from
neighbouring sheets (Fig. 6.3b), while each system was represented by either the CHARMM22
or AMBER-ff03 force field (all within a cubic box of length 80.0Å).
In the case of the tetramer system, in addition to two unit cells comprised of four TTR
molecules from either the same sheet (Fig. 6.4a) or from neighbouring sheets (Fig. 6.4b), a
further unit cell comprised of two intra-sheet dimer systems forming a rectangular cuboid shape
(Fig. 6.4c). As with the other systems, these unit cells were replicated and were handled by either
the CHARM22 or AMBER-ff03 force fields.
Each of the 16 simulations (8 systems, 2 force fields) were equilibrated at 300K in the ca-
nonical ensemble for 650ps with a time-step of 0.5fs to anneal out unphysical contacts. The
system was then run for a further 150ps in the canonical ensemble employing a time-step of 1fs,
before a production run of 5ns using a time-step of 1fs from which all data was collected. Peri-










Figure 6.3: Snapshot of the initial structure of the TTR105−115 (a) intra-sheet trimer and (b)









Figure 6.4: Snapshot of the initial structure of the TTR105−115 (a) intra-sheet, (b) inter-sheet and
(c) ‘cuboid’ tetramer, coupled with peptide designations (i.e. Peptide 1, Peptide 2 etc.).
summation. The PINY simulation package [99] was employed to perform the simulations, while
collision cross-sections were estimated with mobcal using the trajectory method [211]. This
method treats species as a collection of atoms (each represented by a Lennard-Jones and an
ion-induced dipole potential) in order to obtain a scattering angle representative of the angle
between the incoming and departing buffer gas atom trajectory. The averaged collision integral
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is subsequently determined by averaging over all possible collision geometries.
6.4 Results
Due to previous experiments being conducted utilising mass spectroscopy, it was important to
investigate the structure of possible oligomers detected utilising this technique. To that end, a
series of MD simulations of gas phase peptide systems were conducted; the gas phase was chosen
to mimic the vaporised analyte. It should be noted that while mass spectroscopy makes use of
ionised particles, these simulations were conducted on zwitterionic, whole peptides. This was
in aid of comparison with simulations conducted by another group in parallel, which focused on
simulating the ionised gas phase molecules; such a comparison was hoped to probe whether the
structure and size of the ionised peptide was retained in the neutral free peptide.
6.4.1 Monomeric Transthyretin
In order to determine if the structure of a monomer of TTR remained extended in the gas phase,
two simulations were performed utilising the CHARMM22 and AMBER-ff03 force field; the
use of two separate force fields would expose any pronounced sensitivity to standard empirical
potentials. Visualisation of the simulations after 5ns revealed that the initially extended rod-like
appearance of the monomer had collapsed into a compact structure under both parameterisa-
tions (Fig. 6.5). In support of this, analysis of the average end-to-end distance over the last 1ns
(defined as the distance between the N atom of the Tyr105 N-terminus and the C atom of the
Ser115 C-terminus) revealed sharp peaks located at 3.14Å and 2.95Å for the CHARMM22 and
AMBER-ff03 parameterisations respectively. In comparison to MD simulations conducted on
monomeric TTR105−115 in solution, such a distance was found to range from 3Å to 33Å with an
average of 14.2Å [208]. Clearly the gas phase simulations conducted herein resulted in a signi-
ficantly more collapsed geometry; this was not surprising as the system was comprised of only
a single molecule in the gas-phase, and the simulation would lack any stabilising intermolecular
interactions.
To ascertain whether their were subtle differences between the two systems, the secondary




Figure 6.5: Visualisation of the structure of the TTR105−115 monomer after 5ns, under the (a)
CHARMM22 and (b) AMBER-ff03 parameterisation. In relation to the initial structure, the
peptide backbones were found to present RMSD values of 9.244Å and 9.528Å respectively.
structure assignment algorithms [107] (Fig. 6.6, 6.7). From this, it was clear that both simulations
predicted stable turn-like motifs spanning the sequence Tyr105-Leu111 over the course of the 5ns,
with the AMBER-ff03 parameterisation extending this span to include the Ser112 and Pro113
residues; the CHARMM22 force field also displayed turn structure over these residues, however
this was only a transient feature. In addition, the AMBER-ff03 force field revealed additional
secondary structure, with transient appearances of β-sheet character between the Ala108 and
Ser112 residues, and 310-helical structure spanning the sequence Ala109-Leu111.
Figure 6.6: Secondary structure of each residue of TTR105−115 under the CHARMM22 para-
meterisation as a function of time. Green corresponds to turn and white is unordered. Simulation
predicts stable turn motifs over Tyr105-Leu111.
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Figure 6.7: Secondary structure of each residue of TTR105−115 under the AMBER-ff03 paramet-
erisation as a function of time. Green corresponds to turn, white is unordered, blue is 310-helix
and gold is β-strand. Simulation predicts stable turn motifs over Tyr105-Pro113.
With both simulations predicting the monomeric gas phase system to adopt similar secondary
structure and similar end-to-end distances, it was important to determine if the 3-dimensional
structures occupied similar volumes or if one simulation predicted a more compact structure. To
that end, the simulations were used to calculate the cross-sectional area of the peptides (Fig. 6.8).
From the data over 5ns, both the CHARMM22 and AMBER-ff03 parameterisations, predicted
the monomeric TTR peptide to adopt a structure with a similar cross-sectional area; over the last
1ns, CHARMM22 resulted in an average of 273Å2, while AMBER-ff03 resulted in an average of
270Å2; the experimentally obtained value of the collision cross-section of [M+H]+ was found to
be 256Å2 [209]. The only notable difference between the two simulations was that the AMBER-
ff03 force field predicted the monomer to adopt a cross-sectional area of approximately 260Å2
for almost 1ns, indicating a more compact geometry over this time period.
It is therefore reassuring that from the collected data, there did not appear to be any signi-
ficant force-field bias in the handling of the intramolecular interactions of the gas phase TTR,
as evident from both systems predicting similar 3-dimensional architecture. In comparison to
previous simulations conducted on the monomeric TTR [209], all three MD simulations were
found to present near identical collision cross-sections. Furthermore, the AMBER-ff03 simula-




























Figure 6.8: Collision cross-sections of the monomer simulations as a function of time, compared
to the previously reported values of [M+H]+ obtained experimentally and via simulation.
suggesting that the structure measured utilising IM-MS was a compact structure similar in struc-
ture to that of the simulations (Fig. 6.5); the average collision cross-sections over the last 1ns
were found to deviate from the experimental mean by 5.47% and 6.64% for the AMBER-ff03
and CHARMM22 parameterisations respectively.
6.4.2 Dimeric Transthyretin
Due to the predicted structure of TTR consisting of four stacked β-sheets, it was of interest
to probe both a dimeric system from the same sheet (“intra-sheet dimer”) and two peptides
taken from neighbouring sheets (“inter-sheet dimer”). For the purpose of comparing secondary
structure, it was decided to ignore the labels of the peptides in the dimeric system (i.e. Peptide 1
and Peptide 2). This was based on the assumption that as the two identical antiparallel peptides
would be exposed to the same environment, their order of input in defining the simulation would




Visualisation of the intra-sheet dimer system after 5ns revealed that under the CHARMM22
parameterisation, one of the two peptides had adopted a 310-helix , while the other had formed
sequential turns and remained fairly extended resulting in the system forming a ‘β-bulge’-like
structure (Fig. 6.9a). STRIDE revealed that the 310-helix predominantly spanned the sequence
Ala108-Leu111 (Fig. 6.10) as evident from this structure being relatively stable over the course of
the 5ns; however this sequence did appear to transiently adopt an α-helix, and was also sporad-
ically assigned turn-like structure (which extended to include Ile107-Ser112). Analysis utilising
STRIDE also revealed the predominantly turn-like peptide to adopt occasional 310 architecture
over the Ile107-Ala109 and Pro113-Ser115 sequences.
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Figure 6.9: Visualisation of the structure of the TTR105−115 intra-sheet dimer after 5ns, under
the (a) CHARMM22 and (b) AMBER-ff03 parameterisation. In relation to the initial structure,
the peptide backbones were found to present RMSD values of 6.243Å and 6.010Å respectively.
Visualisation of this dimeric system under the AMBER-ff03 parameterisation similarly re-
vealed one peptide to adopt 310-helical structure, while the other had formed an extended struc-
ture (Fig. 6.9b). However, analysis of the secondary structure of each residue as a function of
time exposed notable differences (Fig. 6.11). One peptide from each system was indeed defined
by a 310-helical structure over the last 2ns of the simulations, with the span slightly longer un-
der the AMBER-ff03 force field: Ile107-Leu111 (cf. Ala108-Leu111 under CHARMM22). The
non-helical peptide was found to adopt a predominantly random coil structure over the last 3ns,
140
6.4. RESULTS
Figure 6.10: Secondary structure of each residue of the intra-sheet dimeric TTR105−115 under
the CHARMM parameterisation as a function of time. Green corresponds to turn, white is un-
ordered, blue is 310-helix and pink is α-helix.
wheres under the CHARMM22 parameterisation the non-helical peptide was assigned turn-like
structure; under both parameterisations, the non-helical peptide did remain fairly extended. How-
ever it was in the initial 2ns where the two simulations differed the most. During this time,
the AMBER-ff03 parameterisation predicted the initial β-sheet character to persist, particularly
between the Leu110-Leu111 residues of one peptide and the Ala109-Leu110 residues of the other.
Figure 6.11: Secondary structure of each residue of the intra-sheet dimeric TTR105−115 under
the AMBER-ff03 parameterisation as a function of time. Green corresponds to turn, white is
unordered, blue is 310-helix, pink is α-helix, yellow is β-sheet and gold is β-strand.
141
6.4. RESULTS
Having revealed a sensitivity to standard empirical potentials in intermolecular interactions,
it was interesting to probe how such a sensitivity affected the cross sectional area exhibited by
the peptide systems; from the analysis utilising STRIDE it was safe to assume that the peptide
system had adopted a stable state by 3-4ns under both parameterisations, and it was anticip-
ated by which point the collision cross-section should have reached an equilibrium. While the
CHARMM22 force field resulted in a steady collisional cross-section of 460-470Å2 (Fig. 6.12),
the production run of the AMBER-ff03 system was found to initiate from a significantly larger
geometry (540Å2). Comparing the plotted collisional cross-section and the secondary structure
of each residue over time, a correlation between the loss in β-sheet character (in the AMBER-
ff03 system) and the fall in collision cross-section could be detected. As both systems resulted
in a similar structure and collisional cross-section (466Å2 and 462Å2 for the CHARMM22 and
AMBER-ff03 force fields respectively over the last 2ns), it would appear that the β-bulge struc-


































Figure 6.12: Collision cross-sections of the intra-sheet dimer simulations as a function of time,
compared to the previously reported values of [2M+2H]+ obtained experimentally and the
[2M+H]+ simulation.
Previous simulations of the various oligomers predicted a collision cross-section of 441.1Å2
for the [2M+H]+ species [209], a difference of 5.2% in comparison to the simulations con-
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tained herein (assuming an average 464Å2); these two values corresponded to diameters equat-
ing 21Å and 21.54Å respectively. The recorded data therefore indicated that the simulations of
the neutral dimer, resulted in structures comparable to those reported utilising charged species.
Therefore, introduction of a single H+ did not seem to affect the structure of the system dramat-
ically. However in comparison to the collision cross-sections obtained experimentally, there was
clearly a significant difference between simulation (those contained herein and reported previ-
ously) and experiment. The experimentally recorded cross-section area (380±13Å2) suggested
that the geometry of the species recorded utilising IM-MS was significantly more compact than
what any of the three simulations predicted; the simulations were found to result in a collision
cross-section area 22.1% greater than that obtained experimentally. It should be noted that in
the case of the dimeric system, the previously reported collision cross-sections represented two
different ionic species ([2M+H]+ for simulation cf. [2M+2H]2+ for experiment), which may
indicate that the difference in charge state did indeed affect the structuring of the dimeric sys-
tem; however, the values for the neutral and [2M+H]+ simulations were similar. The increase
in charge would be expected to expand the structure and thereby increase the collision cross-
sectional area as a result of increased electrostatic repulsion. From the data collected herein, the
neutral species were clearly found to result in far larger species than one would have therefore
expected.
6.4.2.2 Inter-sheet dimer
Visualisation of the inter-sheet dimeric system after 5ns revealed the peptides to adopt similar
arrangements as those of their intra-sheet counterparts (Fig. 6.13). Both force fields resulted in
each TTR molecule adopting helical structure: under the AMBER-ff03 parameterisations both
TTR molecules adopted 310-helical structure, while the CHARMM22 force predicted one to
adopt a 310-helix and the other an α-helix.
Analysis of the secondary structure of each residue over the last 2ns revealed that under
both parameterisations (Fig. 6.14, 6.15) the two peptides were predominantly defined by helical
regions spanning the Ala108-Leu111 and Ile107-Leu111 sequences. While the Ile107-Leu111 se-
quence of one peptide was principally anα-helix over the 5ns production run of the CHARMM22




Figure 6.13: Visualisation of the structure of the TTR105−115 inter-sheet dimer after 5ns, under
the (a) CHARMM22 and (b) AMBER-ff03 parameterisation. In relation to the initial structure,
the peptide backbones were found to present RMSD values of 6.831Å and 6.229Å respectively.
the Ile107-Ala109 residues, adopting α-helical content as the simulation evolved. Conversely,
the AMBER-ff03 parameterisation predicted the Ala108-Leu111 sequence of the other peptide to
adopt a stable 310-helix over the simulation, while the STRIDE secondary structure algorithm
assigned this sequence in the CHARMM22 system to be initially turn-like over the initial 2ns
before adopting a mixture of α- and 310-helix.
Figure 6.14: Secondary structure of each residue of the inter-sheet dimeric TTR105−115 under
the CHARMM parameterisation as a function of time. Green corresponds to turn, white is un-
ordered, blue is 310-helix and pink is α-helix.
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Figure 6.15: Secondary structure of each residue of the inter-sheet dimeric TTR105−115 under
the AMBER-ff03 parameterisation as a function of time. Green corresponds to turn, white is
unordered, blue is 310-helix and pink is α-helix.
Both parameterisations resulted in similar collision cross sections over the course of the 5ns
simulation with no observable force field bias (Fig. 6.16). Furthermore, the values of these
were comparable to those achieved by the intra-sheet dimer system over the last 2ns, with the
CHARMM22 and AMBER-ff03 force fields resulting in values of 460Å2 and 458Å2 respect-
ively. This suggested that without the support of initial β-sheet interactions, the dimer system
instantly collapsed into the more compact structure similar in size to that eventually observed
in the intra-sheet dimer. These collision cross sections were found to result in deviations of
approximately 4% and 21% from the previous simulation and experimentally measured values.
6.4.3 Trimeric Transthyretin
As with the dimeric system, two trimer systems of TTR were investigated comprising of either
3 peptides from the same β-sheet (“Intra-sheet trimer”) or 3 from neighbouring sheets (“Inter-
sheet trimer”). In the dimeric system, the peptide labels were ignored due to the symmetry of
the system. While this may hold true for the two outermost peptides in the trimer (i.e. Peptide
1↔ Peptide 3) as both peptides are in close proximity with only one other TTR molecule, the
middle peptide must be treated independently. Therefore for simplification and anticipation of































Figure 6.16: Collision cross-sections of the inter-sheet dimer simulations as a function of time,
compared to the previously reported values of [2M+2H]+ obtained experimentally and the
[2M+H]+ simulation.
denoting their chain (i.e. Pro(1)113, Pro(2)113 or Pro(3)113) in order to compare interactions
between strands. Additionally, a shorthand notation ‘∠a.b’ shall be used to denote the angle
between the end-to-end vectors of peptide ‘a’ and peptide ‘b’ (i.e. ∠1.2, for peptides 1 and 2).
6.4.3.1 Intra-sheet trimer
After 5ns, the CHARMM22 force field predicted the trimeric system to remain fairly extended
exhibiting a slight curve (Fig. 6.17a). Analysis of the end-to-end distances revealed an average
length of 20.3̇Å, while angles of 177.7◦ (∠1.2) and 174.1◦ (∠2.3) were found between these
end-to-end vectors, indicating that the strands remained aligned: assuming 145◦ as a minimum
cut-off for an antiparallel alignment [208]. The model also demonstrated evidence of inter-
molecular hydrogen bonding between the neighbouring strand’s backbones. Evidence of β-sheet
characteristics was also observed between the Leu(1)110 & Leu(2)110 and Pro(1)113 & Ile(2)107
pairings. Visualisation of the AMBER-ff03 system, however, revealed the outermost peptides
had adopted partial 310-helical content while the central TTR molecule had formed a large turn-
like hairpin motif (Fig. 6.17b). The end-to-end distances were found to be smaller than under
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the CHARMM22 parameterisation, resulting in an average 17.93̇Å, however the peptides were
found to remain fairly aligned: 178.2◦ (∠1.2) and 167.5◦ (∠2.3).
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Figure 6.17: Visualisation of the structure of the TTR105−115 intra-sheet trimer after 5ns, under
the (a) CHARMM22 and (b) AMBER-ff03 parameterisation. In relation to the initial structure,
the peptide backbones were found to present RMSD values of 5.399Å and 6.317Å respectively.
Analysis of the secondary structure of each residue in the CHARMM22 system as a function
of time revealed β-sheet character in the Leu(1)110, Pro(1)113, Ile(2)107 and Leu(2)110 residues
over the entire course of the simulation (Fig. 6.18). The Ile(1)107, Pro(2)113 and Leu(3)110
residues were also assigned such structure over the initial 2ns. From the orientations of the pep-
tides (i.e. the antiparallel arrangement), the stable β-sheet interactions must be from the pairings
of Pro(1)113 & Ile(2)107, and Leu(1)110 & Leu(2)110; this was confirmed via visualisation of the
system (Fig. 6.17a). Furthermore, over the initial 2ns, the Ile(1)107 and Pro(2)113 residues were
also found to be aligned with one another in order to facilitate β-sheet interactions. The assign-
ment of β-sheet interactions involving proline residues was a surprising result, as this residue
was known to disrupt both β-sheets and α-helices (Tab. A.4); however prolines may be found
in the edge strands of β-sheets. As the proline residues lacked a hydrogen in the amide group
(Tab. A.1), such β-sheet character must have been as a result of the proline carbonyl group act-
ing as a hydrogen bond acceptor. Finally, the Leu(3)110 residue appeared to interact with the
Leu(2)110 residue, indicating that over the initial 2ns all three Leu110 residues in the trimeric
system were perfectly aligned to form intermolecular interactions stabilising a β-sheet structure.
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Figure 6.18: Secondary structure of each residue of the intra-sheet trimeric TTR105−115 under the
CHARMM parameterisation as a function of time. Green corresponds to turn, white is unordered
and gold is β-strand.
The secondary structure of each residue over the course of the AMBER-ff03 simulation was
also analysed (Fig. 6.19). Interestingly, the Pro(1)113 & Ile(2)107 interaction observed under the
CHARMM22 parameterisation was also found to be stable over the initial 4ns of the AMBER-
ff03 simulation. β-sheet interactions between the Ala(1)108 and Ser(2)112 were also observed
up to 3.5ns into the simulation, which occasionally extended to include the sequences spanning
Ile(1)107-Ala(1)109 and Leu(2)111-Pro(2)113, while there was no observed β-sheet character in
the third peptide at all; over the initial 4ns this third peptide was found to adopt a mixture of ran-
dom coil and turn-like structure (over Ala109-Ser112). Finally, over the course of the last 1ns, the
two outermost peptides (designated Peptide 1 & 3) were assigned 310-helical structure over the
Ala109-Leu111 sequences. The initial stabilisation of β-sheet character and ultimate helix forma-
tion was comparable in both the dimeric and trimeric intra-sheet systems under the AMBER-ff03
parameterisations. In the investigation into force field bias on the predicted secondary structure
of gp41659−671 in Chapter 3, it was the CHARMM22 force field which was found to result in the
greater helical composition. Therefore it was expected that if the peptide did indeed have helical
propensity, of the two force fields employed, it would have been the CHARMM22 system to fold
into such a structure.
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Figure 6.19: Secondary structure of each residue of the intra-sheet trimeric TTR105−115 under
the AMBER-ff03 parameterisation as a function of time. Green corresponds to turn, white is
unordered, gold is β-strand and blue is 310-helix.
In the dimeric system, retained β-sheet character was found to correlate with a higher col-
lision cross section (Fig. 6.12), therefore it was anticipated that there would be a notable differ-
ence in the trimeric system over the last 1ns due to the differing secondary structure assigned
over this period from the different parameterisations. From the calculated collision cross section
of the two simulations, the CHARMM22 system was found to decrease from an average area
of approximately 675Å2 to 600Å2 over a period spanning the 2-3ns interval (Fig. 6.20). This
correlated with the loss of β-sheet character involving the Ile(1)107, Pro(2)113 and Leu(3)110
residues. Having started from a geometry of 680-700Å2, the AMBER-ff03 system was found
to collapse to approximately 640Å2 until 3.5ns into the simulation. At which point, the loss
of β-sheet character between the Ala(1)108 and Ser(2)112 residues coupled with the formation
of 310-helical motifs, reduced the geometry of the trimeric system to 615Å2 over the last 1ns -
effectively matching the size predicted by the CHARMM22 parameterisation (607Å2 over the
same time period). Therefore, while the structures of the last 1ns of each simulation differed, the
overall size of each system appeared to be consistent.
Previous MD simulations of a trimeric system [3M+2H]2+ resulted in a theoretical collision






























Figure 6.20: Collision cross-sections of the intra-sheet trimer simulations as a function of time,
compared to the previously reported values of [3M+2H]2+ obtained experimentally and via
simulation.
found to result in areas approximately 7.05% and 8.47% (CHARMM22 and AMBER-ff03 re-
spectively) larger than their charged counterparts. In comparison to the experimentally obtained
value for the [3M+2H]2+ trimer (509±36Å2), the neutral species were found to deviate by
19.3% and 20.8%, indicating that the species measured experimentally adopted a more com-
pact structure than any of the simulations predicted. The correlation of larger area and β-sheet
character under the AMBER-ff03 and CHARMM22 parameterisations would suggest that such
secondary structural features were not present in the true structure of [3M+2H]2+.
6.4.3.2 Inter-sheet trimer
The CHARMM22 force field was found to result in the trimeric system to be defined by an α-
helix flanked by extended/turn-like peptides (Fig. 6.21a), while under the AMBER-ff03 paramet-
erisation, visualisation of the system revealed the 3 peptides to have collapsed into stacked 310-
helices (Fig. 6.21b). Analysis of the end-to-end distances revealed that the trimer of peptides re-
mained more extended in the AMBER-ff03 system resulting in an average length of 18.6Å com-
pared to the average 13.36Å for CHARMM22; under the CHARMM22 force field, peptide 3
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was found to remain more extended (16.6Å) than the other two peptides (12.2Å & 11.3Å),
however all peptides were found to be significantly shorter than their original starting length of
∼35.7Å and their intra-sheet counterparts. Both force fields were found to result in the peptides
remaining fairly aligned with one another; CHARMM22 resulted in end-to-end vector angles of
174.0◦ (∠1.2) and 162.0◦ (∠2.3), while AMBER-ff03 resulted in angles of 167.8◦ (∠1.2) and
154.3◦ (∠2.3), all above the 145◦ cut-off [208].
!"#$ !%#$
Figure 6.21: Visualisation of the structure of the TTR105−115 inter-sheet trimer after 5ns, under
the (a) CHARMM22 and (b) AMBER-ff03 parameterisation. In relation to the initial structure,
the peptide backbones were found to present RMSD values of 7.425Å and 7.044Å respectively.
The α-helical motif was found to be a very stable motif over the course of the 5ns simula-
tion under the CHARMM22 parameterisation, and was found to consistently span the Thr(1)106-
Leu(1)111 sequence (Fig. 6.22). A 310-helical motif was also assigned transiently to the sequence
Ala(3)109-Leu(3)111, less so as the simulation progressed. Analysis of the secondary structure
of each residue in the AMBER-ff03 system revealed that the 310-helices spanned slightly differ-
ent sequences in each of the peptides: Ile(1)107-Leu(1)110, Thr(2)106-Ala(2)109 and Ala(3)108-
Leu(3)111.
In comparison to the inter-sheet dimer, both systems predicted stable α-helical structure over
the Ile107-Leu111 sequence under the CHARM22 force field, while the AMBER-ff03 handling of
the systems predicted helical content over the Ile107-Leu110 and Ala108-Leu111 sequences. Such
a result may seem unsurprising as the AALL sequence should present a high affinity for helical
formation (Tab. A.4), and without the presence of initial β-sheet structure, TTR molecules may
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Figure 6.22: Secondary structure of each residue of the inter-sheet trimeric TTR105−115 under
the CHARMM parameterisation as a function of time. Green corresponds to turn, white is un-
ordered, pink is α-helix and blue is 310-helix.
fold into such motifs. However as evident in both monomeric simulations (Fig. 6.5), the gas
phase TTR105−115 did not fold into a helix, instead it was found to collapse into a compact
geometry of turn-like secondary structure.
In analysing the collision cross-sections over the course of the 5ns, both simulations revealed
transitions from larger to smaller volumes (Fig. 6.24). The transition of an average area of
approximately 620Å2 to 600Å2 in the AMBER-ff03 simulation after 2ns appeared to coincide
with the assignment of turn motif over the Ser(2)112-Ser(2)115 sequence (Fig. 6.23). However
the transition from 600Å2 to 580Å2 in the CHARMM22 simulation after 3ns did not appear to
coincide with any change in secondary structure. Over the last 1.5ns, the two simulations resulted
in collisional cross-sections of 585Å2 (CHARMM22) and 606Å2 (AMBER-ff03), coinciding
with deviations from the previous simulated value by 3.2% and 6.9%, and deviations from the
experimentally obtained value by 14.9% and 19.1%.
6.4.4 Tetrameric Transthyretin
In the previous dimeric and trimeric systems, two models were investigated which comprised
molecules from either the same sheet or neighbouring sheet (“Intra-sheet” and “Inter-sheet” re-
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Figure 6.23: Secondary structure of each residue of the inter-sheet trimeric TTR105−115 under the
AMBER parameterisation as a function of time. Green corresponds to turn, white is unordered

































Figure 6.24: Collision cross-sections of the inter-sheet trimer simulations as a function of time,
compared to the previously reported values of [3M+2H]2+ obtained experimentally and via
simulation.
spectively). While this was also applicable for the tetrameric system of TTR (as the initial
predicted model consisted of 4 stacked layers of molecules), another possible arrangement of
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TTR molecules was available. This third arrangement consisted of a dimer from one sheet and a
dimer from a neighbouring sheet, henceforth referred to as the ‘cuboid tetramer’.
6.4.4.1 Cuboid tetramer
Under the CHARMM22 parameterisation, the secondary structure of each residue over the
course of the 5ns simulation (Fig. 6.25) revealed strong evidence of β-sheet character (inter-
molecular interactions) between the Ile(1)107 & Pro(2)113 residues (a feature observed over
the initial 2ns of the intra-sheet trimer simulation). These two peptides were found to present
stable 310- and α-helical content over Ala(1)108-Leu(1)110 and Ile(2)107-Leu(2)111 respectively.
While the analysis indicated transient intermolecular β-sheet character between the Leu(3)110
and Ala(4)108 residues, the STRIDE algorithm did not reveal any indications of β-sheet like
character between the two dimeric systems themselves. Visualisation of the tetramer system did
suggest intermolecular backbone hydrogen bonding between the C-terminal of peptide 1, and the
N-terminal of peptide 3 (Fig. 6.26a). Furthermore, the predominantly turn-like peptides 3 and 4
were found to remain extended and analysis of the average end-to-end distance over the last 1ns
for these two peptides revealed both peptides to be defined by sharp peaks centred around 24.6Å.
Figure 6.25: Secondary structure of each residue of the cuboid tetrameric TTR105−115 under
the CHARMM22 parameterisation as a function of time. Green corresponds to turn, white is




Figure 6.26: Visualisation of the structure of the TTR105−115 cuboid tetramer after 5ns, under
the (a) CHARMM22 and (b) AMBER-ff03 parameterisation. In relation to the initial structure,
the peptide backbones were found to present RMSD values of 5.269Å and 6.319Å respectively.
Analysis of the secondary structure of each residue over time from the AMBER-ff03 system
revealed that over the course of the initial 2.5ns of the simulation, the Ala(1)109 and Leu(2)111
residues possessed transient β-strand character (Fig. 6.27). This was coupled with a stable 310-
helical motif spanning the Ala(2)108-Leu(2)110 residues over the course of the entire 5ns simu-
lation; 310-helical character was also occasionally assigned to the Ala(1)109-Leu(1)111 residues.
Furthermore the 310-helical motif spanning the Ile(1)107-Leu(1)110 residues, as captured in the
visualisation of the system (Fig. 6.26b), was not found to be a dominant motif; the ‘Peptide 1’
was instead found to exhibit a flexible conformational ensemble over the later half of the simu-
lation, consisting of a mixture of turn, unordered and aforementioned 310-helical structure. As
under the CHARMM22 parameterisation, STRIDE did not reveal any evidence of intermolecular
interactions between the two dimer systems. The other two peptides (denoted ‘Peptide 3’ and
‘Peptide 4’) were found to exhibit predominantly turn-like motifs, which were found to remain
fairly extended (Fig. 6.26b).
In comparison to the intra-sheet dimeric systems, the simulations of the ‘cuboid’ tetramer
under both parameterisations revealed some similarities in the predicted secondary structure of
‘Peptide 1’ and ‘Peptide 2’. Under the CHARMM22 force field, both systems predicted helical
motifs over the Ala(1)108-Leu(1)110 and Ile(2)107-Leu(2)111 regions; the latter was predomin-
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Figure 6.27: Secondary structure of each residue of the cuboid tetrameric TTR105−115 under
the AMBER-ff03 parameterisation as a function of time. Green corresponds to turn, white is
unordered, pink is α-helix, blue is 310-helix and gold is β-strand.
antly α-helical in both the intra-sheet dimer and cuboid tetramer, while the former was a mixture
of α- and 310-helix. The AMBER-ff03 parameterisation also revealed comparable 310-helical
structure over the Ala(2)108-Leu(2)110 sequence, however while their was some evidence of
helical structure over the Ile(1)107-Leu(1)111, such a motif was not as dominant in the cuboid
tetramer as it was in the intra-sheet dimer.
6.4.4.2 Intra-sheet tetramer
Visualisation of the systems revealed that the 4 peptides remained fairly extended throughout
the course of the simulation and were still relatively antiparallel with respect to one another
(Fig. 6.28). The peptides appeared to have developed a slight twist under the CHARMM22
parameterisation, which was supported by analysis of the angles between the end-to-end vectors:
127.5◦ (∠1.2), 166.1◦ (∠2.3), 176.6◦ (∠1.4), while the angle between the two outermost peptides
was 136.6◦ (∠3.4). In comparison, the AMBER-ff03 system was found to remain more aligned,
with end-to-end vector angles of 172.8◦ (∠1.2), 172.5◦ (∠2.3) and 179.4◦ (∠1.4). After 5ns,
initial β-sheet character between the two central peptides remained intact under the AMBER-
ff03 force field. This suggested that the stability of β-sheet character may increase as a factor of
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the size of intra-sheet oligomer.
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Figure 6.28: Visualisation of the structure of the TTR105−115 intra-sheet tetramer after 5ns, under
the (a) CHARMM22 and (b) AMBER-ff03 parameterisation. In relation to the initial structure,
the peptide backbones were found to present RMSD values of 12.907Å and 13.699Å respect-
ively.
Analysis of the secondary structure of each residue under the CHARMM22 parameterisation
revealed that the observed 310-helical structure in one of the peptides was not a stable motif,
but was only present as a transient feature (Fig. 6.29). The TTR(4) molecule was defined by an
ensemble of turn and helical motifs over the 5ns; α- and 310-helical content was intermittently
assigned to the Ala(4)108-Leu(4)111 and Ala(4)108-Leu(4)110 sequences respectively. Over the
initial 1ns of the simulation, the STRIDE algorithm predicted β-sheet-like intermolecular inter-
actions between the Ile(1)107-Pro(2)113, Leu(2)110-Leu(3)110 and Leu(1)110-Ala(2)108 pairings,
with the latter assigned such character intermittently over the course of the 5ns simulation.
The simulation under the AMBER-ff03 force field revealed strong evidence of intermolecu-
lar interactions between the two central peptides, as evident through the Ile(1)107-Ala(1)108 and
Ser(2)112-Pro(2)113 sequences being assigned β-sheet character throughout the course of the sim-
ulation. This was comparable to the evidence of β-sheet characteristics between the Ala(1)108
and Ser(2)112 residues in the intra-sheet trimer under the same parameterisation (Fig. 6.19) - a
feature present over the course of the initial 3.5ns of that simulation. Furthermore, initial β-sheet
character was also evident over the Leu(1)111-Pro(1)113 and Ile(2)107-Ala(2)109 residues, how-
ever this was lost after 0.5ns. The STRIDE secondary structure algorithm also revealed that the
310-helical structure evident in the visualisation of the tetramer (Fig. 6.28b) was not a dominant
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Figure 6.29: Secondary structure of each residue of the intra-sheet tetrameric TTR105−115 under
the CHARMM22 parameterisation as a function of time. Green corresponds to turn, white is
unordered, pink is α-helix, blue is 310-helix, gold is β-strand and yellow is β-sheet.
structural motif over the course of the simulation, with the Ala(3)108-Leu(3)111 residues only
assigned such structure during the last 200ps.
Figure 6.30: Secondary structure of each residue of the intra-sheet tetrameric TTR105−115 under
the AMBER-ff03 parameterisation as a function of time. Green corresponds to turn, white is
unordered, pink is α-helix, blue is 310-helix, gold is β-strand and yellow is β-sheet.
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In comparing the intra-sheet trimer and tetramer, interestingly the AMBER-ff03 force field
appeared to reveal enhanced stabilisation of β-sheet structure in progressing from a trimeric
system to a tetramer, whereas the CHARMM22 parameterisation showed a notable decrease in
assigned β-sheet characteristics between the two simulations. In relation to this, analysis of the
end-to-end distances revealed that the peptides under the AMBER-ff03 parameterisation were
significantly more extended than their CHARMM22 counterparts; the average peptide lengths
were 25.9Å (AMBER-ff03) and 20.675Å (CHARMM22). The peptides in the AMBER-ff03
intra-sheet tetramer were therefore found to be significantly more extended than in the intra-
sheet trimer which was attributed to the increase in β-sheet character; no significant increase
was detected for the CHARMM22 systems. It should be noted however that both simulations
predicted the peptides in the intra-sheet tetramer to remain fairly aligned with one another, re-
vealing that there were significant intermolecular interactions in order to retain such a geometry.
6.4.4.3 Inter-sheet tetramer
Visualisation of the two inter-sheet tetramers revealed a significant difference in the predicted
structure of the system (Fig. 6.31). While the peptides under the CHARMM22 parameterisation
remained aligned with respect to one another displaying a slight twist (angles between neigh-
bouring peptide end-to-end vectors were found to range from 154.7◦ to 174.8◦), the tetramer
subjected to the AMBER-ff03 force field resulted in two coiled dimers perpendicular to one an-
other: 175.1◦ (∠1.3), 164.8◦ (∠2.4), 62.9◦ (∠1.2). Such a result was unexpected, as this was the
only system to present such a dramatic difference in the tertiary structure from utilising different
force fields. However in comparison to the simulations of the charged species conducted previ-
ously [209], there did appear to be similarities in the structure of the tetramer system reported by
the authors simulated annealing algorithm.
Over the course of the 5ns simulation, the CHARMM22 system was found to be com-
prised of three stable helical structures spanning the Ile(1)107-Leu(1)111, Tyr(4)105-Ala(4)109 and
Thr(3)106-Leu(3)111 sequences consisting of a mixture of α- 310-helical motifs; the Thr(3)106-
Leu(3)111 helix was found to initiate from a 310-like motif spanning Ala(3)109-Leu(3)111, ex-
panding after 2.5ns. While the STRIDE secondary structure assignment algorithm assigned




Figure 6.31: Visualisation of the structure of the TTR105−115 inter-sheet tetramer after 5ns, under
the (a) CHARMM22 and (b) AMBER-ff03 parameterisation. In relation to the initial structure,
the peptide backbones were found to present RMSD values of 7.437Å and 12.086Å respectively.
the tetramer revealed this peptide to remain fairly extended. Furthermore, this peptide was found
to form stable intermolecular interactions with its neighbour ‘Peptide 1’ as evident through the
assignment of β-sheet character between Pro(1)113 and Ile(2)107.
β-sheet character was also evident under the AMBER-ff03 parameterisation, with STRIDE
assigning such structure between the Leu(2)110 and Ser(4)112 residues. The collapse of this
structure was found to coincide with the formation of a helical motif after 3ns: initially a 310-
helix before forming an α-helix spanning Ala(4)108-Leu(4)111. The secondary structure of the
other three peptides was predominantly characterised as unordered and turn-like.
The formation of helical structure under the CHARMM22 parameterisation was not unex-
pected. Both the inter-sheet dimer and trimer revealed that without the presence of initial β-sheet
structure, the TTR molecules displayed significant helical propensity (Fig. 6.14, 6.22). However
the presence of stable β-sheet characteristics between two peptides in both the CHARM22 and
AMBER-ff03 systems was an unforeseen feature, as the none of the previous simulations in-
volving strands from differing layers had revealed such structuring.
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Figure 6.32: Secondary structure of each residue of the inter-sheet tetrameric TTR105−115 un-
der the CHARMM parameterisation as a function of time. Green corresponds to turn, white is
unordered, pink is α-helix, blue is 310-helix and gold is β-strand.
Figure 6.33: Secondary structure of each residue of the inter-sheet tetrameric TTR105−115 under
the AMBER-ff03 parameterisation as a function of time. Green corresponds to turn, white is
unordered, pink is α-helix, blue is 310-helix and gold is β-strand.
6.4.4.4 Tetramer Cross-sections
The collision cross-sections were evaluated for all three tetramer systems under the CHARMM22
(Fig. 6.34) and AMBER-ff03 (Fig. 6.35) parameterisations. Interestingly, under both para-
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meterisations, the ‘cuboid’ tetramer was found to adopt a more compact geometry than the
previously reported simulations; over the last 1ns, AMBER-ff03 resulted in an average col-
lision cross-section of 708Å2, CHARMM22 731Å2, cf. 737Å2 for the previously simulated
[4M+3H]3+ [209]. The values calculated herein were found to differ from the experimental
value of 663Å2 (also for a [4M+3H]3+ system) by 6.79% and 10.26% respectively and presen-
ted the second smallest deviation from the experimental mean; the smallest deviation was found



























Figure 6.34: Collision cross-sections of the tetramer simulations under the CHARMM22 para-
meterisation as a function of time, compared to the previously reported values of [4M+3H]3+
obtained experimentally and via simulation. Tetramer 1, 2, and 3, refer to ‘cuboid’, ‘intra’, and
‘inter’ tetramers respectively.
Such a sudden decrease in deviation from experimental mean was unexpected, and if the
neutral species in any way reflected the actual species measured experimentally, then the cuboid
tetramer could be an unrealistic geometry. In comparison, the intra-sheet tetramer was found to
result in collisional cross-sections of 779Å2 and 767Å2 for the CHARMM22 and AMBER-ff03
systems respectively. These results equated to deviations from the previous simulations of 5.70%
(CHARMM22) and 4.07% (AMBER-ff03) and the experimental mean by 17.5% (CHARMM22)
and 15.7% (AMBER-ff03). These values were found to be comparable to those obtained in the





































Figure 6.35: Collision cross-sections of the tetramer simulations under the AMBER-ff03 para-
meterisation as a function of time, compared to the previously reported values of [4M+3H]3+
obtained experimentally and via simulation. Tetramer 1, 2, and 3, refer to ‘cuboid’, ‘intra’, and
‘inter’ tetramers respectively.
The inter-sheet tetramer similarly resulted in collisional cross-sections of 778Å2 and 763Å2
under the CHARMM22 and AMBER-ff03 parameterisations, which corresponded to deviations
from the previous simulations of 5.56% (CHARMM22) and 3.53% (AMBER-ff03) and the pre-
vious experiments by 17.3% (CHARMM22) and 15.1% (AMBER-ff03).
6.4.5 Comparison to Experiment
The previous investigation into the early aggregates of TTR105−115 revealed that the collision
cross-sections of the oligomers increased linearly with respect to the highest charge state of
each oligomer [209]. The authors noted that oligomers above a trimer resulted in near identical
cross-sections for identical charges (i.e. tetramer and pentamer of charge 3+). The simulations
presented herein resulted in a linear increase for both an intra- and inter-sheet progression under
both parameterisations (Fig. 6.36) which was inline with the observed trend in the oligomers
up to the tetramer; it should be noted that the reported species did increase in charge and the
linear relationship for the highest charge state in the full set of oligomers was rationalised as
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due to a competition between packing and Coulombic repulsion. As the species studied above
should not have presented such a repulsion, then logically one would have expected the collision
cross-sections to be on par or smaller than those reported previously. As evident in the values for
the neutral species, the rate of increase was found to be higher for the neutral species than the
highest charge state oligomers (Fig. 6.36). Furthermore, as the neutral simulations extended to
only a tetrameric system, no comparison could be made in regards to the observed trend in the





























Figure 6.36: Observed collision cross-sections of simulations over last 1-2ns as a function of
size of oligomer under the CHARMM22 and AMBER-ff03 parameterisation. Series are divided
into extensions from within a sheet (Intra-sheet, ‘I’) or between sheets (Inter-sheet, ‘N’). Values
are compared to the experimentally obtained collision cross-sections.
6.4.6 Comparison to Simulations in Solution
In addition to simulations conducted on charged oligomers, previous investigation of TTR105−115
has focused on utilising molecular dynamics to explore the process of self-assembly and the res-
ulting structures of aggregates of neutral TTR105−115 peptides in solution (using an implicit
solvent model) [208], focusing on the monomeric, trimeric and tetrameric aggregates: dimeric
aggregates have been investigated separately [210]. The monomeric species was found to exhibit
a high propensity for α-helical content between the Thr106-Leu110 residues, which the authors
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noted was consistent with experimental evidence of TTR105−115 displaying propensity for α-
helical or β-turn content [212]; experimentally the peptide was however found to remain pre-
dominantly unordered. While the simulations of the monomer species conducted herein did not
display any α-helical content under either parameterisation, they did reveal evidence of turn-like
structure in agreement with the previous experimental findings [212].
The propensity for helical content was however observed in the dimeric, trimeric and tetra-
meric simulations conducted as part of this body of work; such structure was observed partic-
ularly in the inter-sheet oligomers. This would suggest that as the inter-sheet models resulted
in similar structure to the monomer in solution, one could regard each peptide in these sys-
tems as an isolated chain. Furthermore, while the α-helical propensity was found to decrease
with respect to size of oligomer, the authors noted that the propensity for β-strand conformation
increased. This was certainly consistent with the observed trends in the intra-sheet models con-
ducted herein, which revealed the AMBER-ff03 parameterisation to display increased stability
in β-sheet structure.
Having revealed similarities in the secondary structural trends in the oligomers and differ-
ences in the reported end-to-end distances for the monomeric species, it was of interest to com-
pare the end-to-end distances of the gas phase and solution trimer simulations. To that end, the
distance between the N atom of the Tyr105 N-terminus and the C atom of the Ser115 C-terminus
were evaluated for every peptide over the last 1ns in each of the simulations conducted herein
(Tab. 6.1). The original starting structure was characterised by a distance of ∼35.7Å, therefore
the length of all peptides in the gas phase would appear to have contracted by at least 8.3Å (based
on the maximum length of 27.4Å). The authors of the investigation into the solution structure of
TTR105−115 aggregates defined a peptide to be extended of the average end-to-end distance was
in excess of 20Å, a value chosen as it was between than the average distance in the monomeric
simulation and the fully extended length (one can regard this as similar to that of the initial start-
ing length of 35.7Å); within the crystal structure of native TTR105−115, this distance is found to
be 22.6Å (Protein Data Bank ID code 1BMZ) [213].
Of the four trimer systems studied herein, only the CHARMM22 intra-sheet trimer was found
to result in an average length in excess of the 20Å cut-off for an extended conformation. Further-
more, all trimer systems were found to be more contracted than the average lengths of 25Å re-
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Force Field Monomer Dimer Trimer Tetramer
Intra Inter Intra Inter Cuboid Intra Inter
3.14 13.8 14.2 20.6 12.2 19.2 22.2 16.6
CHARMM22 16.2 14.0 21.8 11.3 19.8 20.5 15.0
18.6 16.6 24.6 20.2 14.6
24.6 19.8 19.8
2.95 13.8 14.2 19.4 18.2 19.4 27.4 14.6
AMBER-ff03 17.8 17.8 17.0 16.6 18.2 25.8 17.0
17.4 21.0 19.8 24.6 11.4
14.2 25.8 18.6
Table 6.1: Separation between N atom of the Tyr105 N-terminus and C atom of the Ser115 C-
terminus over the last 1ns in each simulation. The values are representative of each peptide in
the oligomer (e.g. Peptide 1, Peptide 2, etc.) and are all in Å.
ported for trimer systems in solution; the length of each peptide in the TTR105−115 trimer in
solution was found to vary between 13Å and 32Å, and only the CHARMM22 inter-sheet trimer
resulted in lengths outwith this range. From the results of the simulations, the intra-sheet sys-
tems generally resulted in more extended conformations as the size of oligomer increased, which
was coupled with the increase in stability in β-sheet conformation. This was exemplified in the
intra-sheet tetramer under the AMBER-ff03 parameterisation, which was regarded as displaying
the greatest β-sheet content. This system was found to result in the most extended end-to-end
distances of all the models tested (Tab. 6.1); it should be noted that there was obviously some
contraction from the original starting length of ∼35.7Å, however the distances recorded were in
excess of that in the native TTR crystal structure.
6.5 Conclusions
Intermolecular interactions between the TTR105−115 molecules were apparent from the dimeric
to tetrameric systems, with the AMBER-ff03 force field presenting the greater amount of such
structure; only the intra-sheet trimer was found to display any significant β-sheet characteristics
under CHARMM22, while the intra-sheet tetramer and dimer displayed little and none respect-
ively. Such structure was only apparent in the intra-sheet dimer and trimer models, while all
tetramer models presented evidence of β characteristics under both parameterisations. It can
be concluded that such assignment may be more apparent and stable (especially under AMBER-
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ff03) as the size of the oligomer increases. Helical structure may persist in the inter-sheet systems
due to the apparent high affinity for such motifs, and as evident from the tetramer system, β-sheet
structuring may also become more apparent and could potentially supersede that of the helix. In
the simulations studied herein, both intra- and inter-sheet systems resulted in comparable colli-
sion cross-sections. This may present a difficulty in establishing which of the two configurations
was measured experimentally. The possibility of extended cuboid-esque starting structures may
also reveal whether such an initial geometry consistently results in smaller collisional cross-
sections than their intra- and inter-sheet counterparts. The collision cross-sections of all neutral
species were found to be higher than anticipated; the increase in size in the charge series was
attributed to coulombic repulsion, which would be absent in the neutral species. While the recor-
ded collision cross-sections of certain models appeared to be steady over the course of the 5ns
simulations, all species were shown to be significantly shorter than their original extension and
further contraction could not be ruled out. As such, the simulation times may be too short in order
to draw meaningful comparisons with the experimentally recorded collision cross-sections. In
regards to the previous simulation, while the conventional MD simulations were of comparable
length (both 5ns), the reported collision cross-sections were from subsequent simulated anneal-
ing (not performed in this study) [209]. As the study revealed the peptide geometries to be more
collapsed when subjected to simulated annealing, it is of note that the simulations conducted




Conclusions and Future Outlook
The aims of this doctoral study have centred around investigating whether small model peptide
systems provided insight into biological phenomena such as antibody discrimination, viral fu-
sion or self-assembly, and whether the MD simulations reflected results obtained experimentally.
From the peptides studied herein, one can conclude that the simulations have had some success
in providing information about the systems of interest. Furthermore, the peptide systems stud-
ied within were found to be characterised by rugged free-energy landscapes unlike their protein
counterparts (defined by singular, deep minima). These landscapes were subsequently shown to
be highly plastic and sensitive to changes in the local environment.
In the investigation into the glycoprotein gp41 covered in Chapters 3 & 4, the models have
revealed secondary structure propensity supported by utilising circular dichroism. Furthermore,
these models have predicted tryptophan residues to be contained within a hydrophobic core;
fluorescence spectroscopy suggested that these residues would not be exposed in order to interact
with a membrane. The systems representing antibody epitopes investigated in Chapter 5, have
suggested that such models may be of significant use in rationalising differences in antibody-
antigen interactions. These peptides have indicated that variations in binding affinities may be
attributed to minute alterations in the peptide backbone and that MD provides the high sensitivity
required for evaluating such structure. Finally the investigation into the formation of amyloid
aggregations in Chapter 6 has highlighted that in utilising models systems, care should be taken
in regards to the choice of force field used to represent the system; force fields have been shown
7.1. GP41
to differ widely in the regions of dihedral space sampled, as suggested in a previous in depth
study [32].
While conclusions have been drawn on the basis of work performed for this thesis, a number
of projects could be taken up in order to ensure a thorough investigation into the areas covered
in this work in addition to advancing our current understanding of the molecules of interest.
7.1 GP41
Having simulated the monomeric gp41532−544 and gp41659−671, in addition to the dimer, the
next logical step would be to simulate these systems in the presence of membranes. This would
reveal whether the reported interplay was measurable by means of molecular dynamics and if
the gp41532−544 peptide exhibited β-sheet structure in the presence of anionic membranes. The
experimentally observed stabilisation of helical content in the gp41532−544:659−671 dimer may be
difficult to elucidate using the current molecular dynamics methodology, as the simulation under
aqueous conditions displayed a high degree of helical content. In order to compensate for this,
it may be necessary to explore additional force fields or water models, for example the explicit
4-site TIP4P force field or implicit water models; however, some implicit models have been
shown to overestimate the degree of secondary structure and number of intramolecular hydrogen
bonds [38], and therefore may not be appropriate for this system.
7.2 hCG
Having revealed minute differences in the structure of hCGβ66−80 and LHβ86−100, it would be
natural to extend this investigation to include the corresponding full proteins. This would reveal
whether the variations detected in the peptide fragments were retained in the native structure
of the glycoproteins human chorionic gonadotropin and luteinizing hormone respectively. The
aim of which would be to explore if studying model peptide fragments representative of anti-
body epitopes resulted in meaningful structural information and helped to rationalise antibody
discrimination; certainly, the study conducted herein was found to support the findings of point
mutation binding results by suggesting that hCGβ66−80 and the histidine mutant shared structural
features lacking in the other three main models tested. If so, such an approach could be applied
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to a theoretically unlimited number of antibody-antigen systems. Furthermore, the synergistic
approach applied in this study is unashamedly believed to be the correct strategy in exploring
such biomolecular phenomena, and could lead to high-value commercial products.
7.3 TTR
The simulations of TTR105−115 investigated herein have revealed β-sheet structure to be sta-
bilised (from an intra-sheet perspective) as the size of the oligomer was increased. It would
therefore be interesting to investigate these peptide fragments in the presence of water to probe
the competition of intermolecular interactions between peptide & peptide and peptide & water,
revealing whether the presence of water had an impact on the stability of β-sheet conformation
as a factor of oligomer size. Previous MD investigations into TTR105−115 have focused on the
aggregation utilising an implicit solvent model [208, 210]. As such solvents may overestimate
the number of intramolecular hydrogen bonds, it may be of interest to investigate the stability




[1] R. W. Woody. Theory of Circular Dichroism of Proteins. In G. D. Fasman, editor, Circular Di-
chroism and the Conformational Analysis of Biomolecules. Springer, 1996.
[2] G. Barbato, E. Bianchi, P. Ingallinella, W. H. Hurni, M. D. Miller, G. Ciliberto, R. Cortese,
R. Bazzo, J. W. Shiver, and A. Pessi. Structural Analysis of the Epitope of the Anti-HIV Antibody
2F5 Sheds Light into Its Mechanism of Neutralization and HIV Fusion. J. Mol. Biol., 330:1101–
1115, 2003.
[3] V. Buzon, G. Natrajan, D. Schibli, F. Campelo, M. M. Kozlov, and W. Weissenhorn. Crystal
Structure of HIV-1 gp41 Including Both Fusion Peptide and Membrane Proximal External Regions.
PLoS Pathog., 6:e1000880, 2010.
[4] A. J. Lapthorn, D. C. Harris, A. Littlejohn, J. W. Lustbader, R. E. Canfield, K. J. Machin, F. J.
Morgan, and N. W. Isaacs. Crystal structure of human chorionic gonadotropin. Nature, 369:455–
461, 1994.
[5] C. E. MacPhee. Theoretical model of TTR105−115 antiparallel β-sheet stacking. Unpublished data.
[6] D. Hames and N. Hooper. Biochemistry. Taylor & Francis, 2005.
[7] S. Krimm and J. Bandekar. Vibrational spectroscopy & conformation of peptides, polypeptides and
proteins. Adv. Prot. Chem., 38:181–367, 1986.
[8] C.M. Venkatachalam. Stereochemical criteria for polypeptides and proteins. V. Conformation of a
system of three linked peptide units. Biopolymers, 6:1425–1436, 1968.
[9] J.S. Richardson. The anatomy and taxonomy of protein structure. Adv. Protein Chem., 34:167–339,
1981.
[10] E. G. Hutchinson and J. M. Thornton. A revised set of potentials for β-turn formation in proteins.
Protein Science, 3:2207–2216, 1994.
[11] P. Y. Chou and G. D. Fasman. Prediction of protein conformation. Biochemistry, 13:222–245,
1974.
[12] G. M. Whitesides and M. Boncheva. Beyond molecules: self-assembly of mesoscopic and macro-
scopic components. Proc. Natl. Acad. Sci., 99:4769–4774, 2002.
[13] G. M. Whitesides, J. P. Mathias, and C. T. Seto. Molecular self-assembly and nanochemistry: a
chemical strategy for the synthesis of nanostructures. Science, 254:1312–1319, 1991.
[14] S. Zhang, D. M. Marini, W. Hwang, and S. Santoso. Design of nanostructured biological materials
through self-assembly of peptides and proteins. Current Opinion in Chemical Biology, 6:865–871,
2002.
[15] K. E. Drexler. Building molecular machine systems. Trends Biotechnol., 17:5–7, 1999.
[16] R. C. Merkle. Biotechnology as a route to nanotechnology. Trends Biotechnol., 17:271–274, 1999.
[17] A. Aggeli, M. Bell, L. M. Carrick, C. W. G. Fishwick, R. Harding, P. J. Mawer, S. E. Radford, A. E.
Strong, and N. Boden. pH as a trigger of peptide β-sheet self-assembly and reversible switching
between nematic and isotropic phases. J. Am. Chem. Soc., 125:9619–9628, 2003.
[18] K. Lu, J. Jacob, P. Thiyagarajan, V. P. Conticello, and D. G. Lynn. Exploiting amyloid fibril
lamination for nanotube self-assembly. J. Am. Chem. Soc., 125:6391–6393, 2003.
[19] S. Santoso, H. Hwang, H. Hartman, and S. Zhang. Self-assembly of surfactant-like peptides with
variable glycine tails to form nanotubes and nanovesicles. Nano Lett., 2:687–691, 2002.
REFERENCES
[20] G. Xu, W. Wang, J. T. Groves, and M. H. Hecht. Self-assembled monolayers from a designed
combinatorial library of de novo β-sheet proteins. Proc. Natl. Acad. Sci., 98:3652–3657, 2001.
[21] S. K. Maji, D. Haldar, A. Banerjee, and A. Banerjee. Fibril-forming model synthetic peptides
containing 3-aminophenylacetic acid. Tetrahedron, 58:8695–8702, 2002.
[22] A. Aggeli, M. Bell, N. Boden, J. N. Keen, P. F. Knowles, T. C. B. McLeish, M. Pitkeathly, and
S. E. Radford. Responsive gels former by the spontaneous self-assembly of peptides into polymeric
β-sheet tapes. Nature, 386:259–262, 1997.
[23] J. C. Rochet and P. T. Lansbury Jr. Amyloid fibrillogenesis: themes and variations. Curr. Opin.
Struct. Biol., 10:60–68, 2000.
[24] M. Goedert, M. G. Spillantini, and S. W. Davies. Filamentous nerve cell inclusions in neurodegen-
erative diseases. Curr. Opin. Neurobiol., 8:619–632, 1998.
[25] S. B. Prusiner. Prions. Proc. Natl. Acad. Sci., 95:13363–13383, 1998.
[26] M. P. Allen and D. J. Tildesley. Computer Simulation of Liquids. Clarendon Press, 1989.
[27] A. Leach. Molecular Modelling: Principles and Applications. Prentice Hall, 2001.
[28] D. Frenkel and B. Smit. Understanding Molecular Simulation: From Algorithms to Applications.
Academic Press, 2001.
[29] B.R. Brooks, C. L. Brooks III, A. D. MacKerell Jr., L. Nilsson, R. J. Petrella, B. Roux, Y. Won,
G. Archontis, C. Bartels, S. S. Boresch, A. Caflisch, L. Caves, Q. Cui, A. R. Dinner, M. Fieg,
S. Fischer, J. Gao, M. Hodoscek, W. Im, K. Kuczera, T. Lazaridis, J. Ma, V. Ovchinnikov, E. Paci,
R. W. Pastor, C. B. Post, J. Z. Pu, M. Schaefer, B. Tidor, R. M. Venable, H. L. Woodcock, X. Wu,
W. Yang, D. M. York, and M. Karplus. CHARMM: The Biomolecular Simulation Program. J.
Comput. Chem., 30:1545–1614, 2009.
[30] W. D. Cornell, P. Cieplak, C. I. Bayly, I. R. Gould, K. M. Merz, D. M. Ferguson, D. C. Spellmeyer,
T. Fox, J. W. Caldwell, and P. A. Kollman. A second generation force field for the simulation of
proteins, nucleic acids, and organic molecules. J. Am. Chem. Soc., 117:5179–5197, 1995.
[31] A. MacKerell, D. Bashford, M. Bellott, R. Dunbrack, J. Evanseck, M. Field, S. Fischer, J. Gao,
H. Guo, S. Ha, D. Joseph-McCarthy, L. Kuchnir, K. Kuczera, F. Lau, C. Mattos, S. Michnick,
T. Ngo, D. Nguyen, B. Prodhom, W. Reiher, B. Roux, M. Schlenkrich, J. Smith, R. Stote, J. Straub,
M. Watanabe, J. Wiorkiewicz-Kuczera, D. Yin, and M. Karplus. All-Atom Empirical Potential for
Molecular Modeling and Dynamics Studies of Proteins. J. Phys. Chem. B, 102:3586–3616, 1998.
[32] R. B. Best, N.-V. Buchete, and G. Hummer. Are Current Molecular Dynamics Force Fields too
Helical? Biophysical Journal, 95:L07–L09, 2008.
[33] A. MacKerell. Empirical Force Fields for Biological Macromolecules: Overview and Issues. J.
Comput. Chem., 25:1584–1604, 2004.
[34] A. MacKerell, M. Feig, and C. L. Brooks III. Improved Treatment of the Protein Backbone in
Empirical Force Fields. J. Am. Chem. Soc., 126:698–699, 2004.
[35] V. Hornak, R. Abel, A. Okur, B. Strockbine, A. Roitberg, and C. Simmerling. Comparison of
multiple Amber force fields and development of improved. Proteins, 65:712–725, 2006.
[36] Y. Duan, C. Wu, S. Chowdhury, M. C. Lee, G. Xiong, W. Zhang, R. Yang, P. Cieplak, R. Luo,
and T. Lee. A point-charge force field for molecular mechanics simulations of proteins based on
condensed-phase quantum mechanical calculations. J. Comput. Chem., 24:1999–2012, 2003.
172
REFERENCES
[37] M.C. Lee and Y. Duan. Distinguish protein decoys by using a scoring function based on a new
Amber force field, short molecular dynamics simulations, and the generalized Born solvent model.
Proteins, 55:620–634, 2004.
[38] M. J. Feige and E. Paci. Rate of Loop Formation in Peptides: A Simulation Study. J. Mol. Biol.,
382:556–565, 2008.
[39] S. M. Kelly and N. C. Price. The application of circular dichroism to studies of protein folding and
unfolding. Biochim. Biophys. Acta., 1338:161–185, 1997.
[40] S. M. Kelly and N. C. Price. The Use of Circular Dichroism in the Investigation of Protein Structure
and Function. Curr. Protein Pept. Sci., 1:349–384, 2000.
[41] R. W. Woody. Circular dichroism. Methods Enzymol, 246:34–71, 1995.
[42] J. F. Towell III and M. C. Manning. Analysis of protein structure by circular dichroism spectro-
scopy. In N. Purdie and H. G. Brittain, editors, Analytical Applications of Circular Dichroism.
Elsevier Science B. V., 1994.
[43] B. A. Wallace. Synchrotron radiation circular-dichroism spectroscopy as a tool for investigating
protein structures. J. Synchrotron Rad., 7:289–295, 2000.
[44] W. C. Johnson Jr. Protein secondary structure and circular dichroism: A practical guide. Proteins
Struct. Funct. Genet., 7:205–214, 1990.
[45] A. Perczel and G. D. Fasman. Quantitative analysis of cyclic β-turn models. Protein Science,
1:378–395, 1992.
[46] B.I. Baello, P. Pancoska, and T.A. Keiderling. Enhanced prediction accuracy of protein second-
ary structure using hydrogen exchage fourier transform IR spectrscopy. Analytical Biochemistry,
280:46–57, 2000.
[47] A.T. Tu. Raman Spectroscopy in biology - Principles & Applications. Wiley-Interscience, New
York, 1982.
[48] T. Miyazawa, T. Shimanouchi, and S.I. Mizushima. Normal vibrations of N-Methylacetamide.
Journal of Chemical Physics, 29:611–616, 1958.
[49] A. Barth and C. Zscherp. What vibrations tell us about proteins. Quality reviews of Biophysics,
35:369–430, 2002.
[50] R. Schweitzer-Stenner. Advances in vibrational spectroscopy as a sensitive probe of peptide and
protein structure. A critical review. Vibrational Spectroscopy, 42:98–117, 2006.
[51] J. Bandekar. Amide modes and protein conformation. Biochimica et Biophysica Acta, 1120:123–
143, 1991.
[52] P. I. Haris and D. Chapman. The conformational Analysis of Peptides using Fourier Transform IR
Spectroscopy. Biopolymers, 37:251–263, 1995.
[53] M. Hollósi, Z.S. Majer, A.Z. Rónai, A. Magyar, K. Medzihradszky, S. Holly, A. Perczel, and G.D.
Fasman. CD & FTIR Spectroscopic studies of Peptides: II. Detection of β-turns in Linear Peptides.
Biopolymers, 34:177–185, 1994.
[54] W. K. Surewicz, H. H. Mantsch, and D. Chapman. Determination of Protein Secondary Structure
by Fourier Transform Infrared Spectroscopy: A Critical Assessment. Perspectives in Biochemistry,
32:389–394, 1993.
[55] W. K. Surewicz, T. M. Stepanik, A. G. Szabo, and H. H. Mantsch. Lipid-induced changes in the
secondary structure of snake venom cardiotoxins. J. Biol. Chem., 263:786–790, 1988.
173
REFERENCES
[56] S. J. Prestrelski, D. M. Byler, and M. N. Liebman. Comparison of various molecular forms of
Bovine Trypsin; correlation of infrared spectra with x-ray crystal structures. Biochemistry, 30:133–
143, 1991.
[57] C. L. Wilder, A. D. Friedrich, R. O. Potts, G. O. Daumy, and M. L. Francoeur. Secondary Structural
Analysis of Two Recombinant Murine Proteins, Interleukins 1α and 1β: Is Infrared Spectroscopy
Sufficient to Assign Structure? Biochemistry, 31:27–31, 1992.
[58] J. Trewhella, W. K. Liddle, D. B. Heidorn, and N. Strynadka. Calmodulin and troponin C structures
studied by Fourier transform infrared spectroscopy: effects of Ca2+ and Mg2+ binding. Biochem-
istry, 28:1294–1301, 1989.
[59] M. Jackson and H. H. Mantsch. Protein secondary structure from FT-IR spectroscopy: correlation
with dihedral angles from three-dimensional Ramachandran plots. Can. J. Chem., 69:1639–1642,
1991.
[60] D. F. Kennedy, M. Crisma, C. Toniolo, and D. Chapman. Studies of peptides forming 310 and
α-helices and β-bend ribbon structures in organic solution and in model biomembranes by Fourier
transform infrared spectroscopy. Biochemistry, 30:6541–6548, 1991.
[61] S. J. Prestrelski, D. M. Byler, and M. P. Thompson. Infrared spectroscopic discrimination between
α- and 310-helices in globular proteins. Re-examination of Amide I infrared bands of α-lactalbumin
and their assignment to secondary structures. Int. J. Peptide Protein Res., 37:508–512, 1991.
[62] S. M. Miick, G. V. Martinez, W. R. Fiori, A. P. Todd, and G. L. Millhauser. Short alanine-based
peptides may form 310-helices and not α-helices in aqueous solution. Nature, 359:653–655, 1992.
[63] D. M. Byler and H. Susi. Examination of the secondary structure of proteins by deconvolved FTIR
spectra. Biopolymers, 25:469–487, 1986.
[64] Y. N. Chirgadze and N. A. Nevskaya. Infrared spectra and resonance interaction of Amide I
vibration of the parallel-chain pleated sheet. Biopolymers, 15:627–636, 1976.
[65] H. Susi and D. M. Byler. Fourier transform infrared study of proteins with parallel β-chains.
Archives of Biochemistry and Biophysics, 258:465–469, 1987.
[66] R. Khurana and A. L. Fink. Do parallel β-helix proteins have a unique Fourier transform infrared
spectrum? Biophysics, 78:994–1000, 2000.
[67] H. Torii and M. Tasumi. Model calculations on the Amide I infrared bands of globular proteins. J.
Chem. Phys., 96:3379–3387, 1992.
[68] J. L. R. Arrando, F. J. Blanco, L. Serrano, and F. M. Goñi. Infrared evidence of a β-hairpin peptide
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A.1 The Primary Structure of Peptides
All peptides and polypeptides are biopolymers made of amino acids, with 20 relevant α-amino
acids (Table. A.1) available for protein synthesis [214]. The α-amino acids contain a carboxylic
acid (-COOH) and an amino (-NH2) functional group attached to the same carbon (known as the
α-carbon). In addition to these groups, the amino acids can be distinguished by distinct R groups
which are also attached to this carbon.
Name 3 (1)-letter Polarity Charge R - pKa Structure
Alanine Ala (A) non-polar neutral
Arginine Arg (R) polar positive 12.48
Asparagine Asn (N) polar neutral
Aspartic Acid Asp (D) polar negative 3.90
Continued on next page
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Table A.1 – continued from previous page
Name 3 (1)-letter Polarity Charge R - pKa Structure
Cysteine Cys (C) non-polar neutral 8.37
Glutamic Acid Glu (E) polar negative 4.07
Glutamine Gln (Q) polar neutral
Glycine Gly (G) non-polar neutral
Histidine His (H) polar neutral 6.04
Isoleucine Ile (I) non-polar neutral
Leucine Leu (L) non-polar neutral
Lysine Lys (K) polar positive 10.54
Methionine Met (M) non-polar neutral
Continued on next page
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Table A.1 – continued from previous page
Name 3 (1)-letter Polarity Charge R - pKa Structure
Phenylalanine Phe (F) non-polar neutral
Proline Pro (P) non-polar neutral
Serine Ser (S) polar neutral
Threonine Thr (T) polar neutral
Tryptophan Trp (W) non-polar neutral
Tyrosine Tyr (Y) polar neutral 10.46
Valine Val (V) non-polar neutral
Table A.1: Amino Acids found in peptides, indicating their standard abbreviations, structure,
side-chain polarity, side-chain charge at pH 7.4 and side-chain pKa [6]
These various peptides can be polymerised via a condensation reaction (Fig. A.1) between a







































Figure A.1: Condensation reaction between two amino acids forming a peptide bond (red) and
water (blue).
A.2 Secondary Structure
Due to the presence of the carbonyl group in the peptide bond, electron resonance stabilisation
is permitted giving the peptide bond rigidity and a partial double-bond character. This results
in the peptide bond being essentially planar. The shape of the peptide chain can be determined
by three consecutive bond torsion angles (Fig. A.2), NH to Cα (phi, φ), Cα to C=O (psi, ψ) and
C=O to NH (omega, ω). The latter relating to the rigid (planar) peptide bond and is usually fixed
at 180◦. This constraint limits the number of arrangements the peptide chain can take without

















Figure A.2: The geometry of a peptide bond. The C(O)NH bond forms a single plane (ω = 180◦).
The Ramachandran, or dihedral angles φ and ψ are variable: -180◦ < φ,ψ < 180◦.
It is found that two general patterns emerge [215], which conform to the atomic geometry
and dominate the structure of peptides. The first is the helical conformation (Fig. A.3a), which
forms the most dominant uniform secondary structure element in proteins [216]. These helices
are formed through intramolecular hydrogen bonding between the carbonyl oxygen of one pep-
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tide bond and the hydrogen atom of another [47]. The α-helix was originally discovered by
Pauling et. al. [217] and is regarded as being the most dominant of the helical conformations [9].
Other helical structures which had been proposed [218], were subsequently discovered and dif-
ferentiated using their structural parameters (Tab. A.2). An important variation on the helical
conformation is that of the 310-helix which is believed to be an intermediate in helix folding




Figure A.3: Schematic showing hydrogen bonding in (a) α-helix, (b) Antiparallel β-sheet and
(c) Parallel β-sheet (the latter two displaying boundaries of individual amino acids).
The other major conformation is that of an extended β-strand, originally derived from the
conformation of fibrous proteins known as β-keratins [220]. Amino acid residues in this β-
conformation have negative φ and positive ψ angles, typically -140◦ and +130◦ respectively [51],
resulting in the peptide chain alternating in direction and a zigzag structure emerging. In a β-
strand, it is not possible for intramolecular hydrogen bonding to occur; instead, strands running
alongside one another pair up via hydrogen bonds to form extended pleated β-sheets. Depending
on how these strands line up, β-sheets can be formed in either an antiparallel (Fig. A.3b) or a
parallel manner (Fig. A.3c), with the strands running in an opposite or in the same direction to
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Structure n m φ ψ ω H-bond
αI -helix 3.60 13 -57◦ -47◦ 180◦ i to i+ 4
αII -helix 3.60 13 -70◦ -36◦ 180◦ i to i+ 4
310-helix 2.99 10 -45◦ -30◦ 176◦ i to i+ 3
ω-helix -4.00 13 64◦ 55◦ 175◦ i to i+ 4
π-helix 4.40 16 -57◦ -70◦ 180◦ i to i+ 5
π-helix -4.25 16 51◦ 74◦ 177◦ i to i+ 5
2.27-helix 2.17 7 -78◦ 59◦ 180◦ i to i+ 2
Table A.2: Parameters of various intramolecular helical structures [7]. n, number of residues
per turn (positive for right-handed, negative for left-handed), m, number of atoms in hydrogen-
bonded ‘ring’.
one another. Parallel sheets are proposed to be less stable than their counterparts as they are
usually buried within the hydrophobic interior of proteins [221], however the validity of this
statement is not clear. Parallel sheets are also less common than antiparallel sheets due to their
structural formation. β-turns (see later) serve to reverse the direction of a peptide chain allowing
the formation of antiparallel sheets, parallel sheets however require two peptide segments which
are not close in sequence to be brought together [222]. The segment connecting the strands
may be a loop (above or below the plane of the sheet) or may exhibit secondary structure of its
own (usually α-helix). Studies have shown that these long loops required to connect the strands
are both kinetically and thermodynamically unfavourable [223]. In addition, finite β-sheets (as
opposed to the ideal, infinite periodic models) are known to develop a twist; with the smaller the
sheet, the larger the deviation [224].
As mentioned above, antiparallel sheets can be formed by reversing the direction of a poly-
peptide chain by 180◦. This can be achieved through reverse turns which are characterised by
their intramolecular hydrogen bonding which causes the reversal in direction [7]; an other defini-
tion of a turn is the close approach (< 7Å) of the two Cα. There are two major types of turns [225]
which involve either four (β-turn) or three (γ-turn) successive amino acid residues; other turn
types do exist. The conformation of β-turns can be described through the torsion angles of the
second and third residues (Tab. A.3), while the γ-turns need only concern the torsion angles of
the central residue [225, 226]. The majority of turns in folded proteins adopt type I and II β-
turns [227], while type III β-turns are regarded as the building blocks of the 310-helix [7]. The
simplest way to bring two antiparallel strands together is a short peptide segment between the
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Residue 2 Residue 3
Designation Phi Psi Phi Psi Comments
I -60 -30 -90 0 Most common type
II -60 120 80 0
III -60 -30 -60 -30 Like 310-helix
IV
V -80 80 80 -80
VIa -60 120 -90 0 2-3 peptide bond is cis, residue 3 is Pro.
VIb -120 120 -60 0 2-3 peptide bond is cis, residue 3 is Pro.
VII
VIII -60 -30 -120 120
Table A.3: Torsional angles of second and third residue in different β-turns. [8–10]
C-terminus of one strand and the N-terminus of the other. Referred to as a β-hairpin; the shortest
common loop that this strand-loop-strand arrangement adopts is two residues, which constitute
the middle two residues of a β-turn. While type I and type II β-turns are the dominant turn
classes in folded proteins, they are rare in two-residue hairpins. Instead, β-hairpins are stabilised
by the corresponding ‘mirror image’ type I’ and type II’; these are diastereomers of type I and II
β-turns where the torsional angles of the residues are of opposite sign, and as the chirality of the
Cα is maintained, are not true mirror images. Furthermore, common type turns such as type I and
type II are actually regarded as an impediment to the formation of the two-residue hairpin [227].
A.3 Structural Predictions
In order to predict the structure adopted by different peptides, a number of predictive programs
have been designed which focus on the amino acid composition of the peptide [11, 228]. These
classify individual amino acids as to whether they have the propensity to form (or break) an α-
helix or β-sheet (Tab. A.4). Although these programs can be effective in predicting the structure
to some extent, it has been shown experimentally that the periodicity of the polar and non-polar
amino acids has a major impact on the secondary structure. Both α-helices and β-sheets can
be amphiphilic and have well-defined hydrophobic (non-polar) and hydrophilic (polar) faces.
These faces aid in the self-assembly of such structures by hydrophobic interactions, for example
in water, the hydrophobic faces would be buried and the polar surfaces exposed. These two








E 1.53 M 1.67
A 1.45 Hα V 1.65 Hβ
L 1.34 I 1.6
H 1.24 C 1.30
M 1.20 Y 1.29
Q 1.17 hα F 1.28
W 1.14 Q 1.23 hβ
V 1.14 L 1.22
F 1.12 T 1.20
K 1.07 Iα W 1.19
I 1.00 A 0.97 Iβ
D 0.98 R 0.90
T 0.82 G 0.81 iβ
S 0.79 iα D 0.80
R 0.79 K 0.74
C 0.77 S 0.72
N 0.73 bα H 0.71 bβ
Y 0.61 N 0.65
P 0.59 Bα P 0.62
G 0.53 E 0.26 Bβ
Table A.4: Hα, strong α-helix former; hα, α-helix former; Iα, weak α-former; iα, α-indifferent;
bα, α-helix breaker; Bα, strong α-helix breaker. Hβ , strong β-sheet former; hβ , β-sheet
former; Iβ , weak β-sheet former; iβ , β-sheet indifferent; bβ , β-sheet breaker; Bβ , strong β-sheet
breaker [11].
(P ) amino acids would favour a particular secondary structure over the other; HPHPHP -type





For systems comprising of a large number of particles it is critical to avoid calculating the in-
teraction between all pairs of particles due to the computational effort that this would require.
This is usually resolved by truncation of interaction potentials at a cut-off rc, where interactions
between particles separated by a distance >rc are set to zero. If one was to truncate a potential at






dr U(r) 4πr2 (B.1)
A caveat for such a truncation is that this contribution will diverge unless the potential energy
function associated with U(r) decays faster than r−3. In the case of long-range interactions such
as the Coulombic interaction this truncation is therefore not possible (decays as r−1) and one
must therefore find an alternative method that will effectively handle long-ranged intermolecular
interactions. One such method is that of the Ewald Summation method, originally devised by
Ewald in 1921 in order to study the energetics of ionic crystals. This Appendix aims to present an
outline of the Ewald sum for the calculation of long-range electrostatic interactions in a system
with periodic boundary conditions.
B.1. INTRODUCTION
B.1 Introduction
To begin with, one must consider a system of N charged particles (qi) located within a cube of
diameter L. One must assume that the sum of such charged particles results in the system being
electrically neutral (i.e.
∑
i qi = 0) and the system is subjected to periodic boundary conditions.







In order to compute this contribution, one makes use of the electrostatic potential at the
position of the ith charge, φ(ri), (Eq. B.3). This summation is over all periodic images n and
over all particles j. The prime indicates that the summation excludes the interaction of the particle
with itself (i.e. j=i when n=0). Unfortunately this equation contains a poorly convergent sum





| rij + nL |
(B.3)
The trick associated with the Ewald sum is in converting the summation into two parts which
both individually converge quickly (Fig. B.1). One can represent the charge density as a sum of
δ-functions, with their contribution to the electrostatic potential decaying as 1/r. Every particle i
with charge qi can subsequently be assumed to be surrounded by a diffuse charge distribution of
opposite sign to qi, with the total charge of the ‘cloud’ exactly cancelling qi.
!
!





Figure A.1: Pictorial representation of the Ewald method showing how a set of Gaussian charge
distributions can be introduced in order to separate the single poorly converging summation of
point charge contributions into two components, each of which is rapidly convergent.
This fractional unscreened charge falls quickly to zero as the distance increases and therefore
the potential for this diagram can be summed in real space. A second set of smoothly varying
Gaussians must then be introduced to compensate for the screening charges and these are shown
in the final diagram of Figure A.1. The summation for this contribution converges rapidly in
Fourier space.
A.1 Screening charge contributions : the Fourier space summation














where the parameter ! can be chosen to optimise the speed of the Ewald calculation. The charge
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Figure B.1: Representation of the Ewald summation method for a 1-dimensional point charge
system, revealing the introduction of Gaussia charge distributions.
The potential experienced at a distance from a point charge is now due to the fraction of
qi not screened by the cloud at that distance. Obviously this function of unscreened charge
194
B.2. FOURIER-SPACE
rapidly falls to zero as the distance is increased, with the rate being dependent on the functional
form of the screening charge distribution. It is usually assumed that this takes the form of a
Gaussian distribution of width
√
2/α, (Eq. B.4). This potential can be easily computed by direct







In order to ensure that the potential due to a set of point charges (and not screened charges)
is evaluated, one must now add a term that corrects for the presence of the screening charge via a
compensating charge cloud of charge qi. This can be expressed as a rapidly converging Fourier
series and is this regarded as the ‘Fourier-space’ part of the Ewald sum.
B.2 Fourier-space
In Fourier space one can evaluate the electrostatic potential, φscreen(r), at a point ri due to a











exp[−α|r− (rj + nL)|2] (B.5)
This can be achieved using Poisson’s equation which can be expressed either in its Gaussian
form (Eq. B.6) or Fourier form (Eq. B.7).
−∇2φscreen(r) = 4πρscreen(r) (B.6)
k2φscreen(k) = 4πρscreen(k) (B.7)
In order to use the latter, one must perform a Fourier transform of the charge density ρscreen











































The expression φscreen(k) is undefined for k=0 and is usually assumed to be equal to 0.
One must then evaluate the electrostatic potential φscreen(r) (Eq. B.10) in order to compute the
































An important note regarding the computation of Uscreen (Eq. B.11) is that this contribution to
the potential energy contains a term (1/2)qiφself (ri). This arises due to the interaction between
the point charge qi and the compensating continuous Gaussian charge cloud of charge qi. As
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previously mentioned it is desired to exclude Coulomb self-interactions and focus only on in-
teractions between a point charge and all other charges in the fundamental box and the periodic
images (including its own). Therefore one must correct for this term.
From the over counted charge distribution ρgauss(r) (Eq. B.12), one can compute the elec-
trostatic potential from the Gaussian form of Poisson’s Equation (Eq. B.6) while exploiting the












A slight rearrangement of this expression (Eq. B.14) allows for a partial integration (Eq. B.15)





















Subsequently, by employing the definition of an error function erf(x) (Eq. B.17) one can














As the point charge qi is located at the centre of the Gaussian, one need only concern them-
selves with the value of φgauss(r) at r = 0 in order to evaluate the φself term (Eq. B.19).
φgauss(r = 0) = 2qi(α/π)
1/2 (B.19)
This self-interaction potential Uself (Eq. B.20) would subsequently be subtracted from both












The final quantity that one must concern themselves with is the electrostatic energy resultant
from the point charges screened by oppositely charged Gaussians. A short-ranged electrostatic




























B.5. TOTAL ELECTROSTATIC POTENTIAL ENERGY
B.5 Total electrostatic potential energy
The total electrostatic contribution to the potential energy Ucoulomb is a combination of three
terms, Uscreen, Uself and Us.r. (Eq. B.23). It should be noted that previously it was stated that
one must subtract the Uself term from both the Fourier and ‘real-space’ expressions. In regards
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